Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.7404120740440874,-2.1388477088164906,0.0,0.0023447742144140082,0.002,11/19,16.29%,GRM7;GRM1;GRID2;GRIK4;GRM8;GRIA2;GRM3;GRIA1;GRIN2D;GRIK2;GRM5
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6379123231791195,-2.088856221159452,0.0,0.003517161321621013,0.006,15/29,22.19%,GRID2;GRIK4;GABRA2;GABRB1;GLRA3;GABRG3;GRIA2;GABRA5;GABRB2;GRIN2D;GRIK2;CHRNB1;GLRA2;GABRG1;GABRE
prerank,chemokine activity (GO:0008009),0.8031460696418089,2.0230212936594447,0.0,0.001884719290758503,0.002,8/31,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCL5;CXCL10
prerank,chemokine receptor binding (GO:0042379),0.7812085867651437,1.9976516489363623,0.0,0.00329825875882738,0.006,8/35,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCL5;CXCL10
prerank,platelet-derived growth factor binding (GO:0048407),0.957168976912233,1.9931611647054144,0.0,0.0028270789361377544,0.008,7/11,2.67%,COL4A1;COL1A2;COL1A1;COL3A1;PDGFRA;COL5A1;PDGFRB
prerank,serine-type endopeptidase activity (GO:0004252),0.6823897455743745,1.9473590481507237,0.0,0.009659186365137329,0.034,8/80,6.23%,FAP;HP;HPR;MMP2;MASP1;PRTN3;KLK2;PLAT
prerank,metalloendopeptidase activity (GO:0004222),0.6586316314477552,1.8567222470000257,0.0,0.048248813843417684,0.187,24/76,12.77%,MMP3;MMP13;MMP27;MMP2;MMP14;ADAM19;ADAMTS2;MMP11;ADAMTS15;ADAMTS5;OMA1;ADAMTS4;ADAMTS14;ADAMTS12;ADAMTS1;ADAMTS9;ADAMTS18;PMPCB;MMP16;NLN;ADAMTS6;MMP15;ADAMTS7;SPG7
prerank,serine-type peptidase activity (GO:0008236),0.6395664193666073,1.8520226071914145,0.0,0.043505603628342104,0.202,9/96,6.23%,FAP;HP;HPR;MMP2;MASP1;PRTN3;KLK2;HTRA3;PLAT
prerank,lipoprotein particle receptor binding (GO:0070325),0.7415487788068235,1.8493677263976636,0.0026490066225165563,0.03971372791241131,0.216,5/27,3.78%,CLTC;LRP1;HSPG2;CRP;APOE
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5681343052356242,-1.8442322715019386,0.00398406374501992,0.16139862509216427,0.312,12/26,12.26%,ABCG2;SLC6A6;MPC1;SLC6A1;SLC6A12;SLC16A11;SLC5A6;SLC16A1;SLC27A1;SLC16A9;SLC16A4;MPC2
prerank,monocarboxylic acid binding (GO:0033293),0.8002134026142134,1.835500075687622,0.0014705882352941176,0.044997673066859256,0.271,3/18,5.34%,NR1H4;NR2F2;PYGL
prerank,CXCR chemokine receptor binding (GO:0045236),0.8711782757462005,1.8194097056260978,0.0,0.053923913041146056,0.347,5/11,6.48%,CXCL5;CXCL1;CXCL12;CXCL10;YARS1
prerank,semaphorin receptor binding (GO:0030215),-0.5685410825091711,-1.794586553896159,0.0035587188612099642,0.208391808306045,0.464,17/23,29.80%,SEMA6A;SEMA3C;SEMA3D;RIT2;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,endopeptidase activity (GO:0004175),0.5900738692999056,1.7931728913868843,0.0,0.07708501899202277,0.487,47/257,10.17%,PSMA7;MMP3;MMP13;FAP;MMP27;CASP4;HP;HPR;MMP2;MMP14;ADAM19;ADAMTS2;MASP1;PRTN3;PDIA3;CASP1;MMP11;USP9X;KLK2;CTSS;ADAMTS15;ADAMTS5;OMA1;SFRP1;HTRA3;PLAT;ADAMTS4;CTSK;ADAMTS14;CTSL;ADAMTS12;ADAMTS1;TPP2;ADAMTS9;USP42;ADAMTS18;PMPCB;USP24;PSMB8;MMP16;HTRA4;PSMA6;NLN;USP12;CTSB;USP40;USP38
prerank,cholesterol transfer activity (GO:0120020),0.7818914802958918,1.7930654649440245,0.0,0.07007728999274797,0.487,6/16,11.03%,ABCA1;PLTP;ABCG1;GRAMD1A;NPC2;GRAMD1C
prerank,cytokine activity (GO:0005125),0.5931768329933189,1.75728121434032,0.0,0.11017754853892416,0.673,26/131,12.48%,CCL11;CXCL5;CCL7;IL34;ADIPOQ;WNT2;CXCL1;CXCL12;TNFSF11;IL16;TIMP1;XCL1;WNT9A;TSLP;CCL5;TGFB3;CXCL10;INHBB;AIMP1;WNT5A;IL7;BMP5;CCL2;TGFB2;TNF;FGF2
prerank,GABA receptor activity (GO:0016917),-0.584860157030491,-1.752330728579537,0.012145748987854251,0.25628382163545116,0.618,6/21,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GPR156;GABRB2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.718406332707522,1.748009748451751,0.0040595399188092015,0.11830238009684142,0.723,4/22,3.78%,CLTC;HSPG2;CRP;APOE
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.819042037060072,1.7377141352675527,0.003169572107765452,0.12674737230350933,0.771,3/13,3.47%,SLC7A2;SLC38A3;SLC7A7
prerank,triglyceride lipase activity (GO:0004806),0.7398008517697913,1.7276262849831028,0.008784773060029283,0.13645367665091562,0.814,2/20,1.54%,CEL;LIPC
prerank,metallopeptidase activity (GO:0008237),0.5841164423076157,1.7132226064699994,0.0010626992561105207,0.15437028940868863,0.874,30/113,12.77%,MMP3;MMP13;MMP27;MMP2;MMP14;ADAM19;ADAMTS2;ADAM12;MMP11;ANPEP;BMP1;ADAMTS15;ADAMTS5;OMA1;ADAMTS4;ADAMTS14;EIF3H;ADAMTS12;ADAMTS1;ADAMTS9;ADAMTS18;PMPCB;MMP16;NLN;PAPPA2;ADAM21;ADAMTS6;MMP15;ADAMTS7;SPG7
prerank,sterol transfer activity (GO:0120015),0.7357122331524545,1.6935509382677552,0.008797653958944282,0.1890262582790146,0.938,6/17,11.03%,ABCA1;PLTP;ABCG1;GRAMD1A;NPC2;GRAMD1C
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6490078103374806,-1.687282661196318,0.02247191011235955,0.3937266701703523,0.838,5/12,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GABRB2
prerank,CCR chemokine receptor binding (GO:0048020),0.6941566856665102,1.6820925429508073,0.009150326797385621,0.20239791050201034,0.952,4/28,5.67%,CCL11;CCL7;XCL1;CCL5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.7402536497943938,1.6814098930535604,0.011594202898550725,0.19323332517881914,0.954,7/15,16.10%,SH3PXD2B;SESTD1;PLEKHF1;PLA2G4A;PLEKHA5;PLA2G4E;RUBCNL
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6006391280548741,-1.6812970854428533,0.014577259475218658,0.3564056805909293,0.855,8/16,25.77%,SLC26A7;SLC26A2;SLC1A1;CLCN7;SLC4A8;SLC26A6;CFTR;SLC26A8
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5916396598272947,-1.6785490561703371,0.003484320557491289,0.3196220351023095,0.86,9/19,22.19%,GRID2;GRIK4;GABRA2;GABRG3;GABRA5;GRIK2;CHRNB1;GABRG1;GABRE
prerank,GABA-A receptor activity (GO:0004890),-0.5846380531401012,-1.6718831218259909,0.022222222222222223,0.30091269084979777,0.871,5/18,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GABRB2
prerank,steroid hydroxylase activity (GO:0008395),0.7420160683776132,1.6703821644301928,0.02014388489208633,0.20859130750469732,0.969,5/16,12.52%,CYP1B1;CYP7B1;CYP2A6;CYP1A1;CYP2R1
prerank,poly(U) RNA binding (GO:0008266),0.7005507758356013,1.663147838021321,0.019553072625698324,0.2144092564581935,0.978,5/20,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,metalloaminopeptidase activity (GO:0070006),0.7380766480699987,1.6625081750526196,0.020202020202020204,0.20590558251536645,0.978,9/16,14.50%,MMP14;ANPEP;XPNPEP1;NPEPPS;MMP16;ENPEP;MMP15;LVRN;XPNPEP3
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6026520027110351,-1.6520048066621726,0.015384615384615385,0.3220547383497641,0.904,8/15,25.77%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC4A3;SLC26A6;CFTR;SLC26A8
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.789655818047975,1.6473433874607974,0.012987012987012988,0.23419685795599138,0.988,2/11,7.31%,ROR2;SASH1
prerank,E-box binding (GO:0070888),0.6335129363269161,1.6465325651491793,0.011278195488721804,0.22624484486146862,0.988,8/34,7.46%,ZEB1;TCF4;SNAI1;SNAI2;MITF;PPARG;AHR;BHLHE40
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.7971152985796484,1.642160351246148,0.012558869701726845,0.22805103418177886,0.992,4/10,5.37%,APOBEC1;LACC1;CDADC1;GDA
prerank,PDZ domain binding (GO:0030165),-0.4290516775686224,-1.6361854170957855,0.008333333333333333,0.3330645190928989,0.928,21/61,8.95%,CRIM1;GRID2;TGFBR3;ARHGAP29;CADM1;PRKN;CIT;CXADR;KIDINS220;RAPGEF2;ATP2B4;ATP2B2;DOCK4;USHBP1;PLEKHA1;GRIA1;FZD4;CLCN3;NSF;SLC22A4;CRIPT
prerank,cytokine receptor binding (GO:0005126),0.5660385404562588,1.6260171077046777,0.001098901098901099,0.25998252831943736,0.997,22/83,15.47%,IL34;IL23R;OSMR;CXCL12;TNFSF11;JAK1;JAK2;XCL1;SPRED1;SMAD2;TSLP;SPRED2;CCL5;PXDN;LIFR;TGFB2;TGFBRAP1;VEGFC;SMAD3;IL22;IL6R;TIMM50
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5875226964949678,-1.6183460461091765,0.02654867256637168,0.35279082034370773,0.945,9/15,15.69%,HS3ST3A1;HS3ST1;HS6ST2;HS6ST3;NDST3;NDST1;HS6ST1;HS3ST2;HS3ST3B1
prerank,ligand-gated channel activity (GO:0022834),-0.49643421601429905,-1.6102241369446326,0.013574660633484163,0.34738731822779845,0.956,10/29,16.55%,GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2;CHRNB1
prerank,protease binding (GO:0002020),0.5488373035648093,1.6091727715712383,0.0,0.29789035456710783,0.999,17/99,8.75%,FAP;COL1A2;COL1A1;COL3A1;CLTC;CCBE1;SLC2A13;TIMP1;TNFAIP3;CFLAR;PTEN;BCL2;ADAMTS4;BAG6;PZP;ITGA3;RAD23A
prerank,ligand-gated ion channel activity (GO:0015276),-0.4927936605694351,-1.6089220876109505,0.014084507042253521,0.32575613193108904,0.961,10/30,16.55%,GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2;CHRNB1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.779258711790643,1.6024573192613651,0.027906976744186046,0.30677172027256705,1.0,4/11,4.67%,CASP4;CFLAR;CASP1;CASP12
prerank,MHC class II protein complex binding (GO:0023026),-0.6337347495828372,-1.5976221575673042,0.0111731843575419,0.33014420938949235,0.968,4/11,3.44%,ATP1B1;CD81;ANXA11;HSP90AA1
prerank,anion channel activity (GO:0005253),-0.4077109469223076,-1.5971567400157733,0.00819672131147541,0.3106093092156557,0.968,16/61,9.33%,SLC26A7;LRRC8D;GABRA2;GABRB1;GLRA3;GABRG3;GPR89B;GPR89A;GABRA5;GLRA1;CLCN3;VDAC1;GABRB2;ANO3;CLCC1;CLCN7
prerank,aminopeptidase activity (GO:0004177),0.6452314976248452,1.592490834502104,0.02807486631016043,0.3256989905391806,1.0,10/26,14.50%,MMP14;XPNPEP2;ANPEP;XPNPEP1;NPEPPS;MMP16;ENPEP;MMP15;LVRN;XPNPEP3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.7918387977827847,1.5910953536903802,0.02377179080824089,0.3190515639372352,1.0,4/10,4.67%,CASP4;CFLAR;CASP1;CASP12
prerank,chloride channel activity (GO:0005254),-0.41362829306196847,-1.589060459411507,0.0,0.31054465551489063,0.98,24/59,25.77%,SLC26A7;GABRA2;GABRB1;GLRA3;GABRG3;GABRA5;CLCN2;GLRA1;CLCN3;GABRB2;ANO3;CLCC1;CLCN7;CLIC4;ANO4;TTYH2;ANO1;GLRA2;FXYD1;GABRG1;GABRE;ANO2;CFTR;SLC26A8
prerank,calcium-release channel activity (GO:0015278),0.6880161182822783,1.5814928508615123,0.025745257452574527,0.3353280402638233,1.0,6/17,12.14%,MCOLN2;RASA3;ITPR1;PKD2;FKBP1B;TPCN2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.49339989938630424,-1.5760248186489425,0.028,0.32338344373793204,0.984,9/28,22.19%,GRID2;GRIK4;GABRA2;GABRG3;GABRA5;GRIK2;CHRNB1;GABRG1;GABRE
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5710061798520205,-1.5642266382363668,0.027522935779816515,0.33252600635466034,0.989,8/15,16.35%,COX5A;COX8A;COX4I1;COX6B1;COX6A1;COX10;CYB5A;COX5B
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.6554142885854861,1.5527767748904282,0.028925619834710745,0.42073413292291767,1.0,6/22,8.81%,RBMS3;ZFP36L1;ZFP36L2;ILF3;CPEB1;EXOSC4
prerank,neurexin family protein binding (GO:0042043),0.7485362200486873,1.542486366776367,0.04666666666666667,0.4463357956750818,1.0,1/10,0.08%,CEL
prerank,poly-pyrimidine tract binding (GO:0008187),0.6315289182307421,1.5341095542967929,0.03537414965986395,0.4643338570305471,1.0,5/23,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6016354560195134,-1.5118034217314076,0.05099150141643059,0.45048974594429136,0.999,6/11,30.28%,KCND3;KCNJ3;KCNQ1;KCNE4;KCNJ8;KCNH2
prerank,cytokine receptor activity (GO:0004896),0.5250737475013855,1.5062995074239771,0.014412416851441241,0.5653350135436612,1.0,9/83,7.36%,IL23R;IL1RL2;OSMR;GHR;CMKLR1;IL1R1;CCR1;IL3RA;IFNAR2
prerank,anion transmembrane transporter activity (GO:0008509),-0.5884568211995072,-1.5061010539124091,0.04892966360856269,0.4453396168662035,0.999,3/12,5.49%,ABCG2;SLC22A6;SLC39A8
prerank,sterol binding (GO:0032934),0.5451728150693014,1.5030722659487916,0.029797377830750895,0.5638190111617695,1.0,13/56,11.03%,RORA;ABCA1;APOD;INSIG2;ABCG1;OSBPL11;VDAC2;SOAT1;GRAMD1A;OSBPL3;NPC2;OSBPL5;GRAMD1C
prerank,growth factor receptor binding (GO:0070851),0.5166393758198239,1.5028580023365268,0.012048192771084338,0.5495994266929424,1.0,25/95,16.56%,GLMN;IL23R;PDGFRA;IL1R1;PDGFRB;FGF7;JAK2;ATXN2;TSLP;EGF;GRB2;FRS2;PTPRJ;ARF4;SNX2;VEGFC;FGF2;BTC;ITGA5;PSEN1;SRC;IL6R;TIMM50;FGF18;SNX4
prerank,active ion transmembrane transporter activity (GO:0022853),-0.4331282591510751,-1.4944973662543017,0.041025641025641026,0.45760400407211566,0.999,14/37,16.35%,SLC22A8;SLCO1C1;COX5A;COX8A;SLC22A6;SLCO3A1;COX4I1;SLCO2A1;SLC22A4;COX6B1;COX6A1;COX10;CYB5A;COX5B
prerank,AMP binding (GO:0016208),-0.5982818698514378,-1.4921485245944115,0.06933333333333333,0.44367206004912024,0.999,2/11,0.10%,PRKAG2;MPPED2
prerank,ligand-gated anion channel activity (GO:0099095),-0.5274631249286258,-1.487030948356392,0.044673539518900345,0.4393520684258249,0.999,7/17,8.10%,GABRA2;GABRB1;GLRA3;GABRG3;GABRA5;GLRA1;GABRB2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5247427413459677,-1.4849769705850124,0.047619047619047616,0.4282026670362863,0.999,7/17,15.65%,GRIK4;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2
prerank,phosphatase inhibitor activity (GO:0019212),0.639270720355534,1.4769580640012154,0.05945945945945946,0.6488394147816509,1.0,3/20,1.92%,MGAT5;PPP1R9B;PTN
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.656735883524885,1.4760653160558657,0.06801736613603473,0.6365035327841088,1.0,5/15,12.81%,KMT2A;CXXC1;RBBP5;SETMAR;KMT2B
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5609302397105114,-1.4746409978413022,0.07142857142857142,0.436984748305503,1.0,3/13,3.01%,BMP6;BMP4;CDH5
prerank,phospholipid transfer activity (GO:0120014),-0.4841665557112679,-1.474287045083294,0.04844290657439446,0.4214948759132737,1.0,6/21,9.97%,PITPNC1;CERT1;PITPNM2;PITPNA;ABCA3;TNFAIP8L3
prerank,retinoic acid receptor binding (GO:0042974),0.6547349280727779,1.4712496333264022,0.05742296918767507,0.6431840169624737,1.0,5/17,5.97%,NRIP1;ASXL1;TACC1;ARID5A;PPARG
prerank,peptidoglycan binding (GO:0042834),0.7340455443593115,1.469351049056541,0.06591639871382636,0.6354721823279401,1.0,3/10,5.65%,TLR2;NOD1;RNASE7
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5650686658097085,1.4667229717608024,0.04326328800988875,0.6320092021676846,1.0,6/38,8.82%,SERPING1;TFPI2;SERPINE2;SERPINH1;SERPINF1;SERPINA2
prerank,CARD domain binding (GO:0050700),0.670678860744508,1.4617323613686886,0.0900763358778626,0.639073246951264,1.0,3/14,5.14%,CASP4;CASP1;NOD1
prerank,neuropeptide receptor binding (GO:0071855),0.6585904494542608,1.4571067717010118,0.09090909090909091,0.6447881700860851,1.0,1/14,0.47%,QRFP
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6621744103335914,1.4511215008830225,0.07749627421758569,0.6572644406638486,1.0,2/15,4.31%,CMKLR1;CCR1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.5116082293041004,1.4507284066552226,0.02869757174392936,0.6447583721526344,1.0,22/78,13.19%,CASP4;PDIA3;CFLAR;CASP1;USP9X;CASP12;CTSS;SFRP1;CAPN5;CTSK;CTSL;CAPN2;CAPN15;USP42;USP24;USP12;CTSB;USP40;USP38;CASP8;CTSC;CTSW
prerank,frizzled binding (GO:0005109),0.5677060487627823,1.4505255916995519,0.06741573033707865,0.6319022677398403,1.0,6/34,9.14%,WNT2;WNT9A;FZD1;SFRP1;LRP6;WNT5A
prerank,protein phosphatase inhibitor activity (GO:0004864),0.5924495227556374,1.4456168288334095,0.06568364611260054,0.640784926365279,1.0,6/26,13.24%,MGAT5;PPP1R9B;PTN;PABIR1;PPP1R2;PPME1
prerank,cell adhesion mediator activity (GO:0098631),-0.45334041525661295,-1.444398039040349,0.051470588235294115,0.48461458495763815,1.0,9/24,12.02%,LRRC4C;BSG;NTNG1;CNTN4;CD47;ESAM;DSCAML1;NEXN;ROBO4
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5815039502873502,1.4426912642158756,0.061518324607329845,0.6413238182543244,1.0,11/28,16.63%,TNFSF11;STAT1;CASP8AP2;SIVA1;BABAM2;EDA;TRAP1;TNF;TRAF2;RIPK1;TRAF5
prerank,chloride channel inhibitor activity (GO:0019869),-0.5902784813577102,-1.4373430416172066,0.09536082474226804,0.4871066294736964,1.0,5/10,24.46%,WNK4;WNK3;VAMP8;WNK2;CFTR
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5934643570225283,1.4369629119914373,0.06821282401091405,0.6530929286336364,1.0,9/23,15.97%,SH3PXD2B;WIPI1;SESTD1;MAPKAP1;GBF1;KIF16B;PLEKHA5;WDR45;PLA2G4E
prerank,ubiquitin-specific protease binding (GO:1990381),0.6218824527241614,1.4319065720954194,0.10422535211267606,0.6611484406140196,1.0,6/19,14.19%,CLTC;PTEN;BAG6;RAD23A;LCOR;RHBDD2
prerank,adenylate cyclase binding (GO:0008179),-0.5868102842842249,-1.4291460024327256,0.09635416666666667,0.4927933807293441,1.0,5/10,4.54%,ADCY5;AKAP6;CALM1;AKAP12;CAP1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.465968157501683,1.4271082222274933,0.012307692307692308,0.6696371395463215,1.0,29/173,10.21%,CREB3L1;TRPS1;ZEB2;POU5F1;ZEB1;ETV6;DEAF1;SNAI1;TBX18;BCL6;BACH1;SNAI2;MITF;TBX2;PRDM5;PRDM2;FOXK2;PPARG;ENO1;E2F8;ZBTB12;BHLHE40;HEYL;ZBTB5;FOXO3;FOXP4;PRDM1;NR2F1;TBX3
prerank,actinin binding (GO:0042805),0.5966045309885883,1.4223137020371923,0.09308510638297872,0.6775921457690168,1.0,6/21,8.37%,CSRP1;CACNA1C;KCNA5;PKD2;PPARG;PDLIM4
prerank,anion:anion antiporter activity (GO:0015301),-0.503897908500838,-1.4210030391588742,0.07792207792207792,0.49996637281537404,1.0,4/17,10.82%,SLC26A7;SLC26A2;SLC25A4;SLC4A3
prerank,mRNA 5'-UTR binding (GO:0048027),0.5927232467376847,1.4209693375412356,0.08367071524966262,0.6704714365827934,1.0,3/24,2.23%,IGF2BP1;IGF2BP2;SYNCRIP
prerank,alkali metal ion binding (GO:0031420),-0.5478198473734224,-1.4189556496996105,0.08743169398907104,0.48873887531691995,1.0,3/13,11.89%,ATP1A2;HDAC4;PDXK
prerank,low-density lipoprotein particle binding (GO:0030169),0.6312263192798402,1.4179709827008933,0.08428571428571428,0.6716968214145963,1.0,6/16,5.55%,LIPC;COLEC12;CRP;TREM2;PLTP;CD36
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3976805688540378,-1.4162661099206222,0.04371584699453552,0.48018133760635967,1.0,14/42,12.02%,LRRC4C;STXBP6;BSG;NTNG1;CNTN4;CD47;ESAM;TMOD3;BAIAP2L1;DSCAML1;CD200;PDLIM5;NEXN;ROBO4
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.4504122414227667,-1.4160547400702823,0.09876543209876543,0.4667824785370947,1.0,10/25,12.16%,NOS3;MICAL3;FMO2;CYP26B1;FMO5;MSMO1;FMO1;CYP27A1;MICAL1;SQLE
prerank,BMP receptor binding (GO:0070700),-0.5609321155801947,-1.4159117034297022,0.07692307692307693,0.4537808040380939,1.0,3/12,3.01%,BMP6;BMP4;CDH5
prerank,alpha-actinin binding (GO:0051393),0.587570347848537,1.4104601930981302,0.09908735332464146,0.6918770860672844,1.0,6/24,8.37%,PALLD;CACNA1C;KCNA5;PKD2;PPARG;PDLIM4
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6594837594331097,1.4102743765812704,0.12305295950155763,0.6807143164709701,1.0,7/12,16.63%,TNFSF11;STAT1;BABAM2;TRAP1;TNF;TRAF2;TRAF5
prerank,hexosaminidase activity (GO:0015929),0.6586464046613495,1.4101949086983843,0.11229135053110774,0.6693190619206598,1.0,2/12,5.03%,CEMIP;CEMIP2
prerank,protein tyrosine kinase activity (GO:0004713),0.4775166079033625,1.4094379763046732,0.03763440860215054,0.6609135553584415,1.0,18/108,8.07%,ROR2;ROR1;EPHA7;PDGFRA;TEC;JAK1;PEAK1;PDGFRB;JAK2;EGFR;EPHB3;BLK;DDR2;EPHA1;STYK1;HIPK4;MERTK;FRK
prerank,I-SMAD binding (GO:0070411),0.6516278230234976,1.40503387216892,0.08702290076335878,0.6686355803847582,1.0,8/13,15.51%,SMAD2;TGFBR1;SMAD5;TGFB1I1;SMAD3;SMAD4;SMAD1;SMURF1
prerank,acylglycerol lipase activity (GO:0047372),-0.5507135146569166,-1.403683916031297,0.12188365650969529,0.47081112246921275,1.0,4/11,10.71%,MGLL;ABHD6;ABHD3;LIPE
prerank,hyaluronic acid binding (GO:0005540),0.6835606248355459,1.4015831866528128,0.0976,0.6710991041790174,1.0,1/10,0.40%,CEMIP
prerank,receptor antagonist activity (GO:0048019),0.6132126520105796,1.3992742063586339,0.0950354609929078,0.6695465280419581,1.0,4/17,8.73%,CCL5;DKK2;WFIKKN1;PXDN
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4958764516148247,1.3989150183123964,0.07317073170731707,0.6602500753498438,1.0,15/60,12.55%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;EGFR;EPHB3;DDR2;ACVR1;EPHA1;MERTK;ACVR1B;FGFR1;ACVR2A;NTRK3
prerank,lipase activity (GO:0016298),0.5322799763565668,1.3976711040032563,0.07946210268948656,0.6549546779080387,1.0,3/43,1.54%,CEL;PLA1A;LIPC
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.45883027618542566,1.3968997013659268,0.01627670396744659,0.6481114705697547,1.0,55/188,18.79%,RUNX1;CREB3L1;POU5F1;YAP1;TCF7L2;TBX18;SOX5;CREB3L3;GATA6;ARID5B;STAT3;RBBP5;ARID5A;PRDM5;TAF7;TCF12;FOXK2;PPARG;ZBTB48;ETV5;AHR;IRF1;CARM1;CREB3L2;AHRR;NONO;FOXO3;TBL1X;HMGB2;TCF7;LIN54;NFE2L2;ARID4B;TNF;ZBTB20;ELK1;SPI1;CTCF;SMAD3;EGR2;SMAD4;MAFK;GABPB1;BNC2;CALCOCO1;MZF1;ATF4;TAF2;GLI1;ETS1;PAX8;HDAC5;SOX2;HINFP;ARID4A
prerank,transcription coactivator binding (GO:0001223),0.5875867980590863,1.3905537835842843,0.1111111111111111,0.6627929505834068,1.0,5/20,14.44%,RORA;AHR;TERT;SMAD3;SMAD4
prerank,Toll-like receptor binding (GO:0035325),0.6753590295202437,1.3904636307026723,0.125,0.6532380801491634,1.0,3/11,7.77%,TLR2;CD36;TIRAP
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6621121342778452,1.386902674685378,0.1036036036036036,0.6575037261032145,1.0,5/12,13.29%,GAB2;IRS1;SH2B2;FRS2;PIK3R1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6350782415819183,1.3864705962216906,0.11450381679389313,0.6497364894097465,1.0,5/14,18.95%,AKR1A1;RDH12;RDH10;ADH1A;DHRS3
prerank,hormone activity (GO:0005179),0.5131872895990347,1.3859019134904726,0.07861271676300578,0.6423392588517944,1.0,7/54,14.33%,QRFP;ADIPOQ;EDN3;INHBB;HCRT;INSL6;NPY
prerank,nuclear receptor binding (GO:0016922),0.47341733054065055,1.3851371337249092,0.04246284501061571,0.635960033920378,1.0,44/111,22.80%,NR1H4;NCOR2;TCF7L2;NRIP1;ASXL1;DNAAF4;STAT1;WIPI1;TACC1;PADI2;ARID5A;PPID;TAF7;STRN;GTF2H1;TGFB1I1;OASL;RERG;CALR;LCOR;MED13;SMAD3;HMGN3;MMS19;BAZ2A;HIF1A;STAT5B;NSD1;SMARCA4;THRAP3;ZBTB7A;BCAS3;KDM1A;MED12;MED1;TMF1;FOXP1;TADA3;RNF14;PKN1;LATS1;MED14;NCOR1;SMARCD3
prerank,transcription cis-regulatory region binding (GO:0000976),0.44648911474242164,1.3850415151315574,0.002004008016032064,0.627441375553277,1.0,99/406,18.89%,RORA;RUNX1;NR1H4;CREB3L1;TRPS1;RUNX3;POU5F1;ETV6;YAP1;DEAF1;TCF7L2;SNAI1;TBX18;SOX5;GLI3;CREB3L3;SATB2;GATA6;SNAI2;NPAS4;ARID5B;SMAD2;STAT3;RBBP5;ZBTB10;ARID5A;E2F1;PRDM5;PRDM2;TAF7;TCF12;FOXK2;PPARG;ZBTB48;ETV5;ENO1;AHR;MLXIP;E2F8;ARNT;IRF1;CARM1;CREB3L2;SNAPC3;AHRR;HDAC1;ZBTB5;NONO;FOXO3;TBL1X;HMGB2;TCF7;TEAD1;FOXN2;KLF10;BBX;NFE2L2;SP3;ARID4B;E2F3;TNF;ZBTB20;ELK1;SPI1;CTCF;SMAD3;EGR2;DRAP1;TFAP2C;TAF4;SMAD4;MAFK;GABPB1;SETX;BNC2;CREB3;HIF1A;MAX;NFXL1;TCF3;SREBF1;POLRMT;CALCOCO1;MZF1;ZNF25;ATF4;TAF2;GLI1;ETS1;ZNF3;LHX6;PAX8;ZBTB9;HDAC5;NR2C2;SOX2;HINFP;ARID4A;NR3C1
prerank,lipoprotein particle binding (GO:0071813),0.5871442773253545,1.3795235184407553,0.1092896174863388,0.6388165672772279,1.0,7/20,8.76%,LIPC;COLEC12;CRP;TREM2;PLTP;CD36;LPL
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5800296976068651,1.3791504572939168,0.11950549450549451,0.6316738579695542,1.0,1/20,0.13%,SLC39A14
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.44268858372333836,1.3786024318340937,0.0,0.6253372958783995,1.0,179/731,18.67%,RORA;RUNX1;NR1H4;RUNX2;CREB3L1;SOHLH2;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ZNF250;AHR;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;CREB3L2;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;KLF10;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;MAX;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;NFE2L1;ATF4;GLI1;ETS1;PRDM4;SALL3;ZSCAN29;PAX8;ZBTB40;RBPJ;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4920861595843921,1.3779455714313942,0.08878504672897196,0.6194030753325674,1.0,11/60,7.98%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;NRP1;EGFR;EPHB3;DDR2;EPHA1;MERTK
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5361977415040032,1.3766624469163111,0.1034047919293821,0.6159727702803001,1.0,13/34,17.85%,MYO1B;MYO10;GAB2;CYTH3;DAPP1;MAPKAP1;GBF1;OGT;KIF16B;PLA2G4E;ARHGAP9;AKT1;ZFYVE16
prerank,transcription corepressor binding (GO:0001222),0.5559608544387741,1.3738042910442807,0.11375661375661375,0.618502047250582,1.0,4/27,6.40%,RORA;NEK6;PHF1;EHMT1
prerank,ferrous iron binding (GO:0008198),0.570901783578132,1.3720445054649175,0.12091038406827881,0.6173290679451522,1.0,5/21,12.02%,HEPH;FXN;FTO;ALKBH1;TET2
prerank,SH2 domain binding (GO:0042169),0.550822346485081,1.3693915732752855,0.10714285714285714,0.619365876925513,1.0,8/31,11.01%,DLC1;SH3PXD2B;IRS1;JAK2;KHDRBS1;SH2B2;LAT2;PTK2
prerank,myosin II binding (GO:0045159),-0.5678268428047559,-1.3688758302693897,0.12146892655367232,0.553208283911543,1.0,4/10,4.91%,SHROOM4;GSN;STXBP5L;TRIOBP
prerank,retinoid binding (GO:0005501),-0.4439930193631578,-1.3674563069357395,0.1103202846975089,0.5419513664525852,1.0,5/22,7.83%,PTGDS;RBP4;ABCA4;CYP26B1;CRABP2
prerank,transforming growth factor beta binding (GO:0050431),0.5706383710314342,1.3671501158349852,0.10975609756097561,0.6194676750353534,1.0,7/23,9.75%,LTBP3;ACVR1;CD36;TGFB3;WFIKKN1;TGFBR1;LTBP1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4388390784624224,1.3663782662439234,0.0,0.6146253482216236,1.0,178/732,18.67%,RORA;RUNX1;NR1H4;RUNX2;SOHLH2;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ZNF250;AHR;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;HMGB2;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;FOXN2;KLF10;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;NFE2L1;ATF4;GLI1;ETS1;PRDM4;SALL3;ZSCAN29;PAX8;ZBTB40;RBPJ;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,sialyltransferase activity (GO:0008373),-0.45908588047708543,-1.3633679870365967,0.10416666666666667,0.5390876408600823,1.0,8/20,12.49%,ST3GAL6;ST6GALNAC3;ST8SIA4;ST3GAL4;ST3GAL5;ST8SIA6;ST8SIA2;ST6GALNAC5
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5623600784762102,-1.360488107368442,0.1345646437994723,0.533611991845268,1.0,3/10,5.87%,CD47;CXADR;CD200
prerank,lipase activator activity (GO:0060229),0.6693659416847973,1.3601771108036698,0.1130030959752322,0.6295189505746744,1.0,4/10,14.06%,APOH;CCL5;ARHGAP6;SRC
prerank,carbohydrate kinase activity (GO:0019200),0.6375697670699495,1.3592316664539024,0.15472312703583063,0.6255697445909265,1.0,6/11,22.76%,HK2;GALK2;GALK1;KHK;POMK;GNE
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5699961903841919,-1.3563898451799934,0.13114754098360656,0.5310055751422944,1.0,5/10,22.19%,GABRA2;GABRG3;GABRA5;GABRG1;GABRE
prerank,sequence-specific DNA binding (GO:0043565),0.4367579849115778,1.3563130711669527,0.002,0.6287423553970366,1.0,108/590,14.46%,RORA;NR1H4;RUNX2;KMT2A;CREB3L1;SOHLH2;RUNX3;ZEB2;POU5F1;CXXC1;PAX1;GLI2;TCF7L2;TCF4;SNAI1;TBX18;GLI3;BCL6;MEIS2;EGR3;RARB;IRF7;GATA6;MAFB;SNAI2;BATF;RXRG;NFIX;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;TBX2;PKNOX2;ELF4;NR2F2;ARID5A;MBD2;E2F1;PRDM5;PRDM2;BCL2;CEBPD;SMG7;TCF12;HIVEP1;FOXK2;PPARG;ETV5;ZNF250;MBD1;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;BHLHE40;TERT;SMG6;HOXA1;POU2F1;FOXO3;ZBTB38;SMAD5;PRDM1;NR2F1;JUNB;CXXC5;TGIF2;ZIC1;TBX3;TCF7;CBFB;TEAD1;FOXN2;KLF10;BBX;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;KDM2A;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;KMT2B;ELK1;FOXJ3;NFKB2;TFCP2L1;SAFB2;CTCF;SMAD3;LRWD1;IRF9;CTC1;EGR2;HOXB5;TFAP2C;SMAD4;MAFK
prerank,protein phosphorylated amino acid binding (GO:0045309),0.509833329793767,1.3494687319799328,0.12454655380894801,0.6460423252589524,1.0,18/42,19.95%,SH3BP2;VAV2;IRS1;PTPN3;NCK2;PTPN6;FBXW7;GRB2;SHB;VAV1;PIK3R1;NEDD4;YES1;RASA1;PTPN5;YWHAE;SHD;PIN1
prerank,DNA secondary structure binding (GO:0000217),0.5386421191365915,1.3478368500973066,0.12010113780025285,0.6441623920770585,1.0,5/31,11.00%,RAD51B;KMT2A;XRCC3;HMGB2;LIN54
prerank,chloride channel regulator activity (GO:0017081),-0.49405123766527526,-1.3468288283479914,0.13595166163141995,0.5440434457015361,1.0,5/14,24.46%,WNK4;WNK3;VAMP8;WNK2;CFTR
prerank,glutamate receptor binding (GO:0035254),-0.46921619371827256,-1.3451625385527641,0.13214285714285715,0.5358354376264943,1.0,8/17,12.51%,SHANK3;SHISA6;HOMER2;NSF;SYNDIG1;SHANK1;IGSF11;HIP1
prerank,cysteine-type peptidase activity (GO:0008234),0.47414765145570315,1.3450635272783762,0.08250825082508251,0.6466300548475081,1.0,19/73,13.19%,CASP4;PDIA3;CASP1;USP9X;OTULINL;CTSS;SFRP1;CTSK;CTSL;CAPN2;USP42;USP24;USP12;CTSB;USP40;USP38;CASP8;CTSC;CTSW
prerank,mRNA 3'-UTR binding (GO:0003730),0.47377075290528203,1.3445085950200548,0.08543263964950712,0.6412175029721583,1.0,13/79,8.81%,RBMS3;IGF2BP1;RBMS1;ZFP36L1;IGF2BP2;ZFP36L2;ILF3;PUM1;CPEB1;CARHSP1;PABPC4;CELF1;EXOSC4
prerank,estrogen receptor binding (GO:0030331),0.5294839594147562,1.3439935721417764,0.12894736842105264,0.6358624060510132,1.0,12/32,16.10%,NRIP1;DNAAF4;WIPI1;TACC1;PADI2;ARID5A;PPID;STRN;RERG;LCOR;MMS19;NSD1
prerank,retinoid X receptor binding (GO:0046965),0.6539309415541201,1.3427775070824834,0.15338345864661654,0.6332139036923636,1.0,4/11,5.97%,NRIP1;TACC1;ARID5A;PPARG
prerank,phosphotyrosine residue binding (GO:0001784),0.5168167204784321,1.3421482895068464,0.13686806411837238,0.6286665569038213,1.0,14/37,18.62%,SH3BP2;VAV2;IRS1;PTPN3;NCK2;PTPN6;GRB2;SHB;VAV1;PIK3R1;YES1;RASA1;PTPN5;SHD
prerank,four-way junction DNA binding (GO:0000400),0.5848539981407547,1.3385810162638754,0.1473533619456366,0.6336304660737135,1.0,3/17,10.06%,RAD51B;XRCC3;HMGB2
prerank,NAD binding (GO:0051287),-0.4193076501515155,-1.3309388110396334,0.08713692946058091,0.5601878759527286,1.0,14/26,25.72%,ALDH1A1;ME1;GLUD1;ALDH2;SIRT5;NUDT6;HPGD;CTBP1;CRYZ;NNT;ZC3HAV1;CRYL1;UXS1;HADH
prerank,ephrin receptor binding (GO:0046875),0.5566550868007126,1.3294294679014496,0.1362397820163488,0.6583986139391739,1.0,6/21,8.60%,EFNA4;ANKS1B;PTPN1;CBL;GRB2;EFNA5
prerank,poly-purine tract binding (GO:0070717),0.5414226680445069,1.3270774434565755,0.13642384105960265,0.6597707866680502,1.0,5/27,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,endopeptidase inhibitor activity (GO:0004866),0.46206133244542796,1.3259540567015164,0.07886089813800658,0.6569522840313167,1.0,15/82,14.45%,KNG1;SERPING1;TFPI2;FETUB;SERPINE2;TIMP1;PROS1;SERPINH1;SERPINF1;PZP;SERPINA2;GAPDH;PSMF1;SERPINB8;ITIH3
prerank,carboxylic acid binding (GO:0031406),-0.3838942515036025,-1.3254255730645401,0.11931818181818182,0.5623550157569598,1.0,13/38,17.88%,GRM7;GLRA3;NOS3;GCLC;GRIN3A;GLUD1;GLRA1;SESN2;SESN3;GRIN2B;PHYH;MAG;GLRA2
prerank,solute:anion antiporter activity (GO:0140323),-0.4988388617302659,-1.322349636987765,0.14331210191082802,0.5590502434040356,1.0,3/14,10.82%,SLC26A7;SLC26A2;SLC4A3
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.34449542441904957,-1.3221988898524246,0.06172839506172839,0.5474299458460621,1.0,29/57,28.94%,COX5A;COX8A;NDUFS1;COX4I1;NDUFV2;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFB6;NDUFA8;CYB5A;NDUFB7;NDUFS3;COX5B;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;CYBRD1;CYB561A3;UQCR10;UQCR11;NDUFS5;NDUFV1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4984939746882021,1.3199162652484249,0.12195121951219512,0.670862917031122,1.0,14/44,16.10%,KMT2A;CXXC1;RBBP5;KMT5A;EHMT1;SETMAR;SETD2;SETDB1;KMT2E;SETDB2;KMT2B;NSD3;ASH1L;NSD1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5096866442924304,1.3172389474544965,0.14268142681426815,0.6735371326626969,1.0,9/35,16.15%,TEC;PEAK1;BLK;STYK1;FRK;PTK2;SRC;FES;YES1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5359159808573193,-1.3149402189856687,0.14594594594594595,0.5561022845185224,1.0,8/10,30.10%,DNAJC2;ANKRD13A;IDE;FAAP20;USP15;FAN1;DNAJB2;ANKRD13D
prerank,Wnt-activated receptor activity (GO:0042813),0.5936309691304753,1.3143561666283465,0.17050691244239632,0.6761478049517613,1.0,2/15,5.85%,ROR1;FZD1
prerank,MAP-kinase scaffold activity (GO:0005078),0.6365355275232691,1.310193762054073,0.16051364365971107,0.6837761586871848,1.0,9/11,28.10%,SH3RF1;MAP2K1;AKAP13;MAPK8IP1;SPAG9;MAPK8IP3;MAPK8IP2;MAP2K2;KSR1
prerank,vinculin binding (GO:0017166),-0.5112711699210364,-1.3053512423921547,0.16711590296495957,0.5696605027651339,1.0,3/11,4.72%,DMD;RTCB;SORBS3
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6112259767121562,1.3053115638237498,0.1838905775075988,0.6934740657704244,1.0,5/12,15.15%,SULF1;GALNS;ARSG;GNS;IDS
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.41885713820729786,1.304683656193484,0.002,0.6889572889727602,1.0,189/831,18.67%,RORA;RUNX1;NR1H4;RUNX2;SOHLH2;TRPS1;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;ETV6;DEAF1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;ZBTB10;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;PRDM2;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ETV5;ENO1;ZNF250;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;KLF10;BBX;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;MAX;NFXL1;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;ZNF25;NFE2L1;ATF4;GLI1;ETS1;ZNF3;PRDM4;SALL3;LHX6;ZSCAN29;PAX8;ZBTB40;RBPJ;ZBTB9;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,receptor ligand activity (GO:0048018),0.4286870246192196,1.3039502812733188,0.03528225806451613,0.6848209885075955,1.0,41/245,15.01%,CCL11;EPHA7;IL34;ADIPOQ;WNT2;CXCL1;EDN3;TNFSF11;PTN;IL16;TIMP1;FGF7;WNT9A;TSLP;JAG1;MDK;SHH;CCL5;EGF;TGFB3;CXCL10;INHBB;AIMP1;GPNMB;WNT5A;IL7;BMP5;GREM2;HMGB2;SEMA3E;TGFB2;EDA;TNF;VEGFC;FGF2;BTC;INSL6;BMP7;NPY;CX3CL1;FAM3C
prerank,pseudouridine synthase activity (GO:0009982),0.595342157142407,1.3005216682043974,0.18819776714513556,0.6904415409481558,1.0,4/13,9.72%,RPUSD3;PUS7L;TRUB2;PUS3
prerank,diacylglycerol kinase activity (GO:0004143),-0.5098944159445185,-1.2987040308189974,0.18112244897959184,0.5764158451293957,1.0,5/11,16.74%,DGKB;DGKI;DGKA;DGKG;DGKQ
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5398004729141989,-1.2986443733571913,0.18888888888888888,0.5652285135687415,1.0,4/10,7.90%,PRKAG2;PRKAR1A;PRKAR2A;PKIA
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6237068413319993,1.2955436706514067,0.1735668789808917,0.7011335258696942,1.0,6/10,18.48%,SETMAR;SETD2;NSD3;ASH1L;NSD1;SETD3
prerank,protein kinase inhibitor activity (GO:0004860),0.4900142453499765,1.291713438985996,0.13414634146341464,0.7082277244291764,1.0,18/42,20.44%,SPRED1;PARVA;SPRED2;NCK1;TAOK3;GSKIP;RPTOR;IBTK;GMFB;SPRY2;SMCR8;SH3BP5L;CDKN1B;TRIB1;DNAJC3;MAPK8IP1;DUS2;SPRY4
prerank,inward rectifier potassium channel activity (GO:0005242),-0.412926692449541,-1.2910526223368837,0.12719298245614036,0.5733423872360407,1.0,8/24,15.79%,KCNJ2;KCNJ3;KCNJ13;ABCC9;KCNJ10;KCNJ12;KCNN2;KCNN3
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.37617932021697953,-1.2892999435052834,0.13658536585365855,0.5666611419872043,1.0,8/31,7.17%,SLC12A2;SLC12A7;KCNK5;TMEM175;SLC12A6;KCNK10;ABCC9;KCNQ4
prerank,double-stranded DNA binding (GO:0003690),0.41566487105327654,1.2892444002019086,0.002,0.7100459750445421,1.0,83/531,13.00%,RUNX2;RAD51B;ZBP1;CREB3L1;SOHLH2;RUNX3;POU5F1;PAX1;RBMS1;GLI2;TCF4;SNAI1;TBX18;GLI3;BCL6;MEIS2;STAT1;EGR3;RARB;IRF7;GATA6;SNAI2;BATF;RXRG;SMAD2;NFIX;EGFR;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;CGGBP1;TBX2;PKNOX2;ELF4;E2F1;CEBPD;TCF12;HIVEP1;PPARG;ZBTB48;DDX11;ETV5;ZNF250;MBD1;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;BHLHE40;HOXA1;FOXO3;SMAD5;SETMAR;PRDM1;NR2F1;JUNB;FBH1;HMGB2;TGIF2;ZIC1;TBX3;TCF7;TEAD1;FOXN2;KLF10;BBX;ELK4;SAFB;SP3;E2F3;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;FOXJ3;NFKB2
prerank,glucuronosyltransferase activity (GO:0015020),0.554625461968658,1.2889328757945013,0.17753120665742025,0.7045534437573431,1.0,3/19,9.33%,EXT1;EXT2;CHSY1
prerank,poly(A) binding (GO:0008143),0.5516593426302792,1.2886796730827856,0.181058495821727,0.6988245183087182,1.0,4/21,7.97%,RBMS3;RBMS1;KHDRBS1;PABPC4
prerank,cation:chloride symporter activity (GO:0015377),-0.5281728936887614,-1.2884974323720113,0.19491525423728814,0.5582082391370238,1.0,4/10,4.88%,SLC12A2;SLC12A7;SLC12A6;SLC6A1
prerank,ADP binding (GO:0043531),-0.3992520394091208,-1.285495552429322,0.13877551020408163,0.5550080565517959,1.0,10/25,17.00%,PRKAG2;GCLC;ME1;GLUD1;MYO18A;MSH2;PPP5C;ERN1;PGK1;ATP5F1D
prerank,bHLH transcription factor binding (GO:0043425),0.558733575887548,1.2837876800830348,0.15948275862068967,0.7094426086649689,1.0,8/19,19.43%,FHL2;USF1;TCF12;CREBBP;BHLHE40;SMAD3;TCF3;KDM1A
prerank,neuropeptide binding (GO:0042923),-0.447126618753413,-1.2811584768107123,0.16216216216216217,0.556339553337838,1.0,11/18,46.62%,SORL1;GPR37;OPRK1;OPRM1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4132189680164057,1.2796939167481105,0.005,0.7173224641173792,1.0,137/597,18.89%,RUNX1;RUNX2;CREB3L1;SOHLH2;RUNX3;POU5F1;PAX1;GLI2;YAP1;TCF7L2;TCF4;SNAI1;TBX18;SOX5;GLI3;BCL6;CREB3L3;MEIS2;EGR3;RARB;IRF7;GATA6;SNAI2;BATF;RXRG;ARID5B;NFIX;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;TBX2;PKNOX2;RBBP5;ELF4;ARID5A;MBD2;E2F1;PRDM5;CEBPD;MCM2;TAF7;TCF12;HIVEP1;FOXK2;PPARG;ZBTB48;DDX11;ETV5;ZNF250;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;IRF1;BHLHE40;CARM1;CREB3L2;HOXA1;MCM7;AHRR;NONO;FOXO3;TBL1X;SMAD5;PRDM1;NR2F1;GRWD1;JUNB;HMGB2;TGIF2;ZIC1;TBX3;TCF7;MCM9;TEAD1;FOXN2;KLF10;BBX;ELK4;NFE2L2;SP3;ARID4B;E2F3;TNF;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;IRF9;EGR2;HOXB5;TFAP2C;SMAD4;MAFK;GABPB1;BNC2;CREB3L4;CREB3;NR6A1;NPAS2;MAX;CLOCK;TCF7L1;SREBF1;HSPD1;BACH2;CALCOCO1;MZF1;ATF4;TAF2;GLI1;ETS1;PRDM4;LHX6;ZSCAN29;PAX8;HDAC5;NR2C2;SOX2;HINFP;ZBTB7A;ARID4A;NR3C1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.6047482330508807,1.2783048273453588,0.18484848484848485,0.7161176051595846,1.0,3/12,5.14%,CASP8AP2;CASP1;NOD1
prerank,hormone receptor binding (GO:0051427),0.5775337884293221,1.2767601503368027,0.1924198250728863,0.7152009340475219,1.0,2/14,2.75%,JAK1;JAK2
prerank,nuclease activity (GO:0004518),0.47472068595778716,1.2738725047510753,0.1471291866028708,0.7191940019906229,1.0,10/52,9.99%,ENPP1;ERN2;DNA2;REXO1;MAP1S;RNASE7;RNASEH1;SND1;SETMAR;RNASEH2A
prerank,exopeptidase activity (GO:0008238),0.4722084297474303,1.272435506000495,0.17761557177615572,0.7180534664838928,1.0,15/50,18.97%,FAP;XPNPEP2;ANPEP;DPEP2;XPNPEP1;NPEPPS;ENPEP;DPP7;XPNPEP3;DPP8;CNDP2;GGH;CTSA;LAP3;DPEP3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3772888341523574,-1.2691621515948979,0.12903225806451613,0.5754775240797328,1.0,9/33,13.36%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA;LLPH
prerank,kinase inhibitor activity (GO:0019210),0.49523747271874524,1.2669581026151908,0.18364779874213835,0.7310029997427689,1.0,14/33,20.44%,PARVA;NCK1;LRP6;TAOK3;GSKIP;GMFB;SMCR8;SH3BP5L;CDKN1B;TRIB1;DNAJC3;MAPK8IP1;DUS2;SPRY4
prerank,nuclear receptor coactivator activity (GO:0030374),0.46089675892784177,1.2667376402677692,0.16647127784290738,0.7254558398231554,1.0,22/52,22.53%,CCAR1;ZMIZ1;TACC1;PPRC1;CARM1;CCAR2;PSMC3IP;MED13;FGF2;ELK1;USP22;SLC30A9;CALCOCO1;THRAP3;ETS1;KDM1A;MED12;MED1;TMF1;ACTN1;PKN1;MED14
prerank,potassium ion leak channel activity (GO:0022841),-0.45416634827948754,-1.2641987051111412,0.17096774193548386,0.5783506881277036,1.0,7/15,25.92%,KCNK5;TMEM175;KCNK10;KCNK2;KCNK13;KCNK6;KCNK12
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3772576449330622,-1.2641274542299004,0.15763546798029557,0.5686872308670722,1.0,10/32,24.07%,KCNC2;KCNB2;KCNQ5;KCNQ3;KCNQ4;KCNQ1;KCNC1;KCNQ2;KCNC3;KCNE4
prerank,pentosyltransferase activity (GO:0016763),0.4816357391979092,1.2640813491554161,0.17964071856287425,0.7285478251611269,1.0,4/36,6.77%,PARP8;PARP3;LACC1;PARP11
prerank,thyroid hormone receptor binding (GO:0046966),0.5137152875225965,1.2639012437859782,0.18267929634641408,0.7230590936188513,1.0,11/28,19.61%,TACC1;ARID5A;TAF7;GTF2H1;OASL;MED13;HMGN3;NSD1;THRAP3;MED12;MED1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.48264923175233093,-1.25923369341845,0.19767441860465115,0.57077666314373,1.0,5/13,7.25%,GABRA2;GLRA3;GABRG3;GABRA5;GLRA1
prerank,calcium ion binding (GO:0005509),0.409922548855612,1.258812476421993,0.04020100502512563,0.7350954943751299,1.0,63/323,15.97%,MMP13;SCUBE1;ENPP1;LRP1;FBLN1;SPARC;CDH11;THBS4;PCDHB6;MASP1;CRP;SLIT3;SLIT1;PAM;CALR3;ADGRL3;CALML4;ITSN1;GALNT3;CALU;PADI2;SHH;FBN1;ITPR1;AIF1;PKD2;CEMIP2;DCHS1;ASTN2;NUCB2;RCN2;CDH6;CANX;SYT2;LPL;LCP1;S100A6;ANXA1;MAN1C1;PGS1;TNNC1;ATP2A2;PPP3CA;CDH18;CDH24;RCN3;CALR;MICU2;AIF1L;CALM2;COLEC11;PLSCR4;TPM4;FKBP9;TRPM4;PLA2G4A;HSPA5;ANXA6;IDS;KCNIP2;HPCA;BGLAP;PLA2G4E
prerank,neuropeptide hormone activity (GO:0005184),0.5325583777864558,1.2580715039391257,0.1900138696255201,0.7316293372414682,1.0,3/22,14.33%,QRFP;HCRT;NPY
prerank,copper ion binding (GO:0005507),0.4701151360046957,1.2540791330614665,0.1963855421686747,0.7393661086532947,1.0,3/42,2.51%,HEPH;LACC1;PAM
prerank,insulin-like growth factor I binding (GO:0031994),-0.48629513252031176,-1.2540366773806624,0.17261904761904762,0.5740276349336326,1.0,6/13,10.36%,IGF1R;IGFBP2;ITGA6;INSR;IGFBP3;ITGB4
prerank,phosphatase binding (GO:0019902),0.42767694781754023,1.252975615539891,0.12247071352502663,0.7370554875156109,1.0,36/105,20.51%,JAK1;SPRED1;AP3B1;SMAD2;EGFR;STAT3;IKBKE;STX17;CDC27;CARHSP1;DLG4;MAST2;PDLIM4;MVP;PTK2;RCAN3;CTSC;TRAF2;PPME1;PIK3R1;GTF2F1;SMAD3;CDKN1B;VRK3;MTMR9;CEP192;ITGA1;SH3YL1;MAPK1;MTMR3;EIF2AK3;TRPC4AP;HSP90B1;SPTBN4;KIFAP3;DLG1
prerank,metalloexopeptidase activity (GO:0008235),0.46498952998134047,1.2527579137783462,0.16071428571428573,0.7319170571518575,1.0,13/51,14.50%,MMP14;ANPEP;CPQ;XPNPEP1;CPXM1;NPEPPS;CPA6;MMP16;ENPEP;AGTPBP1;MMP15;LVRN;XPNPEP3
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6206855109641869,1.2482096724345622,0.2070063694267516,0.7419612126314815,1.0,1/10,0.09%,FAP
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5877223937190605,1.2480877766203584,0.2381679389312977,0.7363643143262298,1.0,3/12,9.16%,STAT1;POU2F1;HDAC1
prerank,cholesterol binding (GO:0015485),0.46112533134050043,1.2473625842258276,0.17926829268292682,0.7330222413206733,1.0,10/47,11.03%,ABCA1;APOD;ABCG1;VDAC2;SOAT1;GRAMD1A;OSBPL3;NPC2;OSBPL5;GRAMD1C
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6139827688204349,1.2451308170798576,0.2440944881889764,0.7347313116371761,1.0,3/10,3.91%,CACNA1A;CACNA1C;CACNB1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5980978007178468,1.2413512227695873,0.21861152141802068,0.7418708045464333,1.0,2/11,4.84%,RASA3;ITPR1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.4172358947288369,-1.241314748925917,0.15412186379928317,0.5974446879387951,1.0,4/21,16.55%,GRM1;GRIA1;GRM5;CHRNB1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.40414115677993184,1.2404994250928685,0.0872210953346856,0.7390926698709469,1.0,59/254,18.89%,RUNX1;NR1H4;CREB3L1;TCF4;PRRX1;CREB3L3;SATB2;MEIS2;NPAS4;MITF;SMAD2;REL;UBP1;STAT3;LITAF;MEIS1;HOXB3;ELF4;MYBL1;PRDM2;TCF12;FOXK2;ETV5;MLXIP;IRF1;HOXA1;FOXO3;KLF10;ELK4;E2F3;ZSCAN21;HOXB2;KLF6;NKX2-8;ELK1;FOXJ3;NFKB2;TFCP2L1;SMAD3;EGR2;ZFP62;TFAP2C;SMAD4;SMAD1;CREB3;HIF1A;CLOCK;TCF3;ZNF445;MZF1;MDM2;ATF4;ETS1;RLF;PRDM4;RBPJ;NR2C2;HINFP;NR3C1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4094510039151825,1.2381803009989107,0.10858324715615306,0.7414931692118863,1.0,47/181,18.77%,NR1H4;MDFIC;NCOR2;TCF7L2;NRIP1;PRRX1;STAT1;RERE;ZFPM2;MIER2;TACC1;STAT3;TEAD3;CREBBP;PPARG;PIAS2;ARNT;BHLHE40;PSMA6;HDAC1;MTA2;TBX3;NFE2L2;GSK3B;DUSP26;ELK1;COMMD7;SPI1;DDRGK1;SMAD3;DACT1;EGR2;TAF4;DTX3L;BAZ2A;HIF1A;TCF3;SMARCA4;MTA3;TCERG1;ATF4;RBPJ;HDAC5;NFKBIA;SPEN;RBBP8;BCAS3
prerank,insulin-like growth factor binding (GO:0005520),-0.46216114978465256,-1.2377807360072575,0.19314641744548286,0.5972102705474156,1.0,6/15,10.36%,IGF1R;IGFBP2;ITGA6;INSR;IGFBP3;ITGB4
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.47983055955001913,1.235826000199744,0.1997471554993679,0.7438287409977998,1.0,17/35,26.44%,STAT1;SNAPC3;POU2F1;HDAC1;KLF10;DRAP1;TAF4;BAZ2A;SMARCA4;NR3C1;AGO2;FOXP1;AGO1;RRN3;RELA;FOS;PIH1D1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5653848813614581,1.23396924251545,0.23889739663093415,0.7444074365626686,1.0,5/13,13.51%,PDGFRA;IL1R1;PDGFRB;PTPRJ;ITGA5
prerank,chemokine receptor activity (GO:0004950),0.5267632021326902,1.2317119432381045,0.20027247956403268,0.7464191644870373,1.0,3/24,9.00%,CMKLR1;CCR1;CXCR4
prerank,chemorepellent activity (GO:0045499),-0.3918304905189468,-1.231060659624802,0.1673469387755102,0.60423732392536,1.0,7/25,3.17%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;NRG3;SEMA7A;DPP4
prerank,nucleotidyltransferase activity (GO:0016779),0.5297716622680092,1.2305836261187963,0.24273255813953487,0.7445478851514201,1.0,7/19,20.33%,PAPSS2;TERT;REV1;CGAS;CRPPA;TUT7;TENT4A
prerank,metal ion binding (GO:0046872),0.3970264203527527,1.226352560516324,0.03206412825651302,0.7529592148881011,1.0,92/477,16.28%,MMP13;SCUBE1;ENPP1;POSTN;NEK6;LRP1;FBLN1;SPARC;CDH11;PDXP;THBS4;PCDHB6;MASP1;CRP;ERN2;LRRK2;SLIT3;SLIT1;PAM;CALR3;PPA1;ADGRL3;MARK1;IRAK3;APOE;CALML4;ITSN1;GALNT3;CALU;PADI2;ADCY2;SHH;FBN1;ITPR1;EPHX2;AIF1;PKD2;CEMIP2;DCHS1;ASTN2;NUCB2;RCN2;MVK;FOXK2;RAP2A;PLK1;CDH6;HSPE1;CANX;MAST2;SYT2;RRAGC;IDH2;LPL;LCP1;S100A6;ANXA1;MAN1C1;PGS1;TNNC1;ATP2A2;PPP3CA;CDC42BPA;GNAI1;CDH18;CDH24;RCN3;CALR;TDP2;MICU2;ACVR1C;PAPOLG;ADPRH;AIF1L;MAP3K6;CALM2;COLEC11;PLSCR4;TPM4;FKBP9;TRPM4;PLA2G4A;HSPA5;DXO;ANXA6;IDS;KCNIP2;HPCA;BGLAP;PLA2G4E;STK4;MCTP2
prerank,signal sequence binding (GO:0005048),0.47594178395906667,1.2258931063560803,0.22948717948717948,0.7492653390647526,1.0,14/35,19.93%,CEMIP;KDELR3;BABAM2;KPNA3;BRAP;NUP153;TNPO1;KDELR2;SEC61A1;SEC61A2;KCNIP2;NFKBIA;NUP214;KPNA2
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4750036604436858,1.2224723608967012,0.21428571428571427,0.7553217418507175,1.0,11/34,16.20%,TAOK1;RICTOR;FAM20A;CKS1B;MAP2K1;DBF4;SPRY2;CALM2;CCNT1;ALS2;STK4
prerank,DNA-binding transcription factor binding (GO:0140297),0.4023613098431867,1.2217195257751357,0.1168032786885246,0.7522674000786124,1.0,53/189,19.43%,NEK6;YAP1;TCF7L2;PRRX1;STAT1;RERE;ZFPM2;FHL2;SMAD2;MIER2;TLE1;USF1;STAT3;CGGBP1;TEAD3;PRDM5;BCL2;TCF12;CREBBP;PPARG;RUNX1T1;PIAS2;NOC2L;BHLHE40;CRTC1;HDAC1;MTA2;CXXC5;TBX3;YWHAZ;CRTC3;NFE2L2;GSK3B;DUSP26;ELK1;SPI1;DDRGK1;SMAD3;DACT1;EGR2;TCF3;MTA3;TCERG1;ATF4;RBPJ;DDX20;HDAC5;SPEN;RBBP8;ZBTB7A;TLE5;GABPA;KDM1A
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3695479176892538,-1.2208734711686429,0.18032786885245902,0.6212208730219022,1.0,8/27,9.76%,SLC12A2;ITPR2;TMEM165;MRS2;ATP2B4;SLC9B2;ZDHHC13;SLC4A8
prerank,zinc ion binding (GO:0008270),0.3990862213587441,1.219721716542832,0.07452165156092648,0.7539550277066426,1.0,48/293,14.00%,MMP13;ENPP1;KMT2A;KNG1;CBLB;GLI2;ZEB1;SEC24D;SEC23A;CSRP1;MYCBP2;PAM;TIMP1;RASSF1;ZFPM2;ANPEP;LITAF;SHH;PHF2;RABIF;SEC24A;CDADC1;PRDM2;GDA;LIMS1;RNF2;PPARG;MBD1;PTPN1;NPEPPS;TRIM8;MMP16;ARIH1;ENPEP;MSRB3;TARS1;PAPPA2;CXXC5;UBA5;EEA1;CALR;TET2;KDM2A;KMT2B;LVRN;CTCF;SMAD3;RNF11
prerank,leak channel activity (GO:0022840),-0.41765502115378167,-1.218910169218721,0.19798657718120805,0.6172262850624511,1.0,7/18,21.31%,KCNK5;TMEM175;KCNK10;KCNK2;NALCN;KCNK13;KCNK6
prerank,glycerophospholipid flippase activity (GO:0140333),-0.482366934720074,-1.2186798820533133,0.2391304347826087,0.6084689086404352,1.0,5/11,9.89%,ATP10A;ATP8A1;ABCA4;ABCA3;ATP8A2
prerank,R-SMAD binding (GO:0070412),0.5243429008656451,1.2167836375430094,0.24964539007092199,0.7576371046796974,1.0,7/18,17.22%,PMEPA1;SMAD2;LDLRAD4;SMAD3;SMAD4;SMURF1;TRIM33
prerank,heme binding (GO:0020037),0.4376567990583143,1.2159804476844187,0.2072480181200453,0.7550092570081132,1.0,12/65,15.31%,CYP1B1;STEAP4;BACH1;JAK2;CYP2A6;PTGES2;PXDN;HEBP1;CYP2R1;TBXAS1;SRC;CYCS
prerank,NAD+ binding (GO:0070403),-0.46866370287187387,-1.213805073220686,0.2257142857142857,0.6121584798307632,1.0,7/12,25.72%,GLUD1;SIRT5;HPGD;ZC3HAV1;CRYL1;UXS1;HADH
prerank,iron ion binding (GO:0005506),0.451894109943195,1.2132609970609058,0.19975186104218362,0.7585929246027073,1.0,10/48,12.52%,HEPH;FXN;PHF2;ABCE1;ACO2;SCD5;FTO;ALKBH1;TET2;CYP2R1
prerank,phospholipase activator activity (GO:0016004),0.5869995082067843,1.2108980272671794,0.2648401826484018,0.7609881344647657,1.0,3/10,14.06%,CCL5;ARHGAP6;SRC
prerank,mannose binding (GO:0005537),0.5710515857802815,1.2108711019672662,0.24539877300613497,0.7558504239786048,1.0,3/12,13.95%,LMAN2L;LMAN1;COLEC11
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.49861235813882476,1.210552720755103,0.23876765083440307,0.7516802711066909,1.0,3/25,6.77%,PARP8;PARP3;PARP11
prerank,peptidase inhibitor activity (GO:0030414),0.4764811839291794,1.2105157980031966,0.2371392722710163,0.7467014226811555,1.0,5/33,7.34%,KNG1;FETUB;TIMP1;PROS1;PZP
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3603553349059795,-1.2097328974973274,0.140625,0.6136851817116317,1.0,8/33,11.32%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA
prerank,transcription coregulator binding (GO:0001221),0.44580827728675576,1.2093602981000706,0.2283653846153846,0.7455465599828146,1.0,10/50,14.44%,RORA;NEK6;PHF1;EHMT1;AHR;TERT;LCOR;CTCF;SMAD3;SMAD4
prerank,MAP kinase activity (GO:0004707),-0.44579884992889746,-1.2088669436332853,0.23529411764705882,0.6070620441117868,1.0,8/14,24.49%,MAPK4;MAPK12;MAPK9;MAPK10;MAPK3;MAPK6;MAPK14;MAPK7
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4483970680167876,-1.2083075263150267,0.23248407643312102,0.5999154365061644,1.0,2/14,1.78%,SLC26A7;SLC26A2
prerank,neuropeptide receptor activity (GO:0008188),-0.3662706766046938,-1.2076362543663157,0.21610169491525424,0.593162743629677,1.0,19/29,48.24%,SORCS1;SORCS3;SORCS2;GPR37;NPSR1;HCRTR2;OPRM1;NPY5R;NMUR2;GRPR;KISS1R;SSTR2;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4308962479569573,1.2074272599732492,0.1946607341490545,0.7471773566809355,1.0,13/70,16.66%,CHSY3;B4GALNT2;EXT1;EXT2;GXYLT2;B4GALNT1;OGT;MGAT4A;CHSY1;GCNT2;POGLUT3;CHPF2;B3GNT9
prerank,sodium channel regulator activity (GO:0017080),-0.3453331620873145,-1.207009763591562,0.16230366492146597,0.5866592964269132,1.0,8/37,10.52%,FGF12;FGF14;FXYD5;SNTA1;ATP2B4;GPD1L;FXYD6;GPLD1
prerank,MAP kinase phosphatase activity (GO:0033549),0.5697669730419593,1.206513355869345,0.2786144578313253,0.7450923596131948,1.0,2/12,3.00%,DUSP2;DUSP5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5913766912404408,1.2049056906025808,0.2954898911353033,0.7402545001179474,1.0,2/10,3.00%,DUSP2;DUSP5
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5913766912404408,1.2049056906025808,0.2954898911353033,0.7402545001179474,1.0,2/10,3.00%,DUSP2;DUSP5
prerank,leucine zipper domain binding (GO:0043522),0.5969915728994944,1.2026644023339412,0.28821656050955413,0.7424562162914803,1.0,4/10,19.75%,MRTFA;PAWR;ATF4;PMF1
prerank,lysine N-methyltransferase activity (GO:0016278),0.5079578988598623,1.2023883616233675,0.2692307692307692,0.7383143052807375,1.0,12/20,27.81%,ANTKMT;KMT5A;EHMT1;SETD2;VCPKMT;ETFBKMT;SETD3;EEF2KMT;SETD7;SETD4;METTL21A;EEF1AKMT3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.46706532047011584,1.200525583546891,0.24872448979591838,0.7396489660487031,1.0,7/30,18.03%,SLC39A14;SLC11A2;SLC25A37;SLC31A1;SLC39A6;TTYH1;ATP7A
prerank,transition metal ion binding (GO:0046914),0.3908364861526677,1.1990776667383236,0.05811623246492986,0.7394925686435373,1.0,69/397,15.81%,MMP13;HEPH;ENPP1;KMT2A;MGAT5;KNG1;CBLB;GLI2;ZEB1;SEC24D;SEC23A;CSRP1;LACC1;MYCBP2;PAM;TIMP1;RASSF1;ZFPM2;SLC11A2;ANPEP;LITAF;GALNT3;ADCY2;SHH;PHF2;XPNPEP1;RABIF;SEC24A;CDADC1;PRDM2;GDA;LIMS1;RNF2;PPARG;MBD1;PTPN1;NPEPPS;ABCE1;ACO2;NEK4;TRIM8;SCD5;MMP16;ARIH1;ENPEP;MSRB3;TARS1;PAPPA2;CXXC5;LOXL3;UBA5;EEA1;CALR;TDP2;TET2;KDM2A;CYP2R1;KMT2B;LVRN;CTCF;SMAD3;RNF11;XPNPEP3;SIRT3;RABGGTB;SMPDL3B;B4GALT7;FNTB;FBXL19
prerank,ATPase binding (GO:0051117),0.4256495175231037,1.197815922556809,0.21452894438138478,0.7388159642680681,1.0,19/71,16.67%,ABCA1;NKD2;SLC2A13;DNAJB1;EGFR;CHMP4A;BBC3;PTPN3;PKD2;RALA;PPP3CA;VCPKMT;PEX19;SNX10;PSEN1;SRC;TMTC4;TOR1AIP2;ATP6V1G1
prerank,histone acetyltransferase binding (GO:0035035),0.511431402514972,1.1971329911994706,0.2671232876712329,0.7364779200700972,1.0,8/21,18.77%,GLI3;STAT1;TAF7;KANSL1;EID1;HIF1A;ZBTB7A;BCAS3
prerank,muscle alpha-actinin binding (GO:0051371),0.5479536133850069,1.1943766271709473,0.26627218934911245,0.7401375629871757,1.0,3/15,8.37%,PALLD;PKD2;PDLIM4
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.43673229117055407,1.1925979219769258,0.22679200940070504,0.7411894200819158,1.0,4/53,3.47%,SLC7A2;SLC1A3;SLC38A3;SLC7A7
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3641331328514132,-1.1902263753001545,0.23766816143497757,0.6195115277448039,1.0,4/29,3.71%,SLC13A3;SLC26A7;SLC26A2;SLC1A1
prerank,endopeptidase regulator activity (GO:0061135),0.45377023186850635,1.1901443803158953,0.24116930572472595,0.7440017197751679,1.0,10/40,17.78%,KNG1;FETUB;PROS1;ABCA2;PZP;PSMF1;ITIH3;PSENEN;PSMD14;PCSK1N
prerank,WW domain binding (GO:0050699),0.48019641968212673,1.1878172093891253,0.25492772667542707,0.7461801451297747,1.0,3/26,8.17%,PMEPA1;LITAF;PRRG4
prerank,DNA binding (GO:0003677),0.379998510632497,1.1840232126046353,0.033,0.753251768076458,1.0,159/694,18.79%,RORA;NR1H4;RAD51B;ZBP1;ZEB2;POU5F1;RBMS1;C1D;GLI2;MPG;TCF7L2;TCF4;BCL6;MEIS2;STAT1;RARB;IRF7;BRIP1;MAFB;SNAI2;SMC1A;DNA2;BATF;RAD52;ZNF496;ARID5B;SMAD2;EGFR;ZIC4;USF1;STAT3;CGGBP1;MEIS1;TBX2;SOX21;ILF3;NR2F2;ARID5A;MAP1S;E2F1;PRDM5;PHF1;KHDRBS1;PRDM2;BCL2;MCM2;HIVEP2;INO80;FOXK2;CREBBP;PPARG;YAF2;ZNF292;DDX11;ETV5;MBD1;AHR;PDS5B;TSHZ3;FOXE1;SUB1;ARNT;IRF1;FUBP1;DCLRE1C;AIFM2;SNAPC3;TERT;HOXA1;POU2F1;MCM7;RAD23A;FOXO3;RAD23B;SETMAR;NR2F1;OASL;JUNB;FBH1;HMGB2;CXXC5;TBX3;MCM9;CBFB;ZMYM4;TEAD1;CHD2;XRN1;ELK4;NFE2L2;ZGPAT;SAFB;CALR;TIMELESS;TDP2;SPTY2D1;E2F3;HOXB2;GLYR1;NKX2-8;FOXJ3;SAFB2;CTCF;SMAD3;RBM6;COLEC11;RNF11;CTC1;EGR2;DRAP1;TFAP2C;TAF4;SMAD4;MAFK;SIRT3;SETX;PATZ1;POLG;NR6A1;CCNT1;HIF1A;GTF3C4;PRKDC;NPAS2;NUP35;CGAS;POU3F3;MAX;LIN9;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;HMGN1;PNKP;AIFM1;POLRMT;HSPD1;NUCKS1;RC3H2;CALCOCO1;THRAP3;DDB1;ATF4;GLI1;ETS1;ZNF3;RLF;PAX8;RBPJ;NR2C2;SOX2;RBBP8;CDK9;HINFP;ZBTB7A;HMCES;ARID4A
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2795785401140439,-1.1836604201299512,0.06976744186046512,0.6273677888086122,1.0,21/80,16.07%,KCNC2;KCND3;KCNB2;KCND2;KCNQ5;KCNH5;KCNH7;KCNJ2;KCNJ3;KCNJ13;KCNQ3;KCNQ4;KCNJ10;KCNK2;KCNQ1;LRRC38;KCNJ12;KCNN2;KCNN3;KCNC1;KCNT1
prerank,solute:proton symporter activity (GO:0015295),0.5239241709768305,1.1822066162499174,0.29088277858176553,0.754272704695111,1.0,4/16,10.09%,SLC2A13;SLC11A2;SLC36A2;SLC15A1
prerank,O-methyltransferase activity (GO:0008171),0.5785363361324932,1.181586770830362,0.288961038961039,0.7517574123777863,1.0,5/10,24.63%,ASMT;COMT;BCDIN3D;FTSJ3;COQ3
prerank,ligand-gated cation channel activity (GO:0099094),-0.28276524192368174,-1.1811892084178246,0.10309278350515463,0.6252525556488724,1.0,16/75,16.55%,GRIK4;KCNJ2;KCNJ3;GRIN3A;GRIA2;KCNJ13;GRIA1;KCNJ10;GRIN2D;GRIN2B;KCNJ12;CCDC51;KCNN2;GRIK2;KCNN3;CHRNB1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.4772619763963453,-1.176241792247188,0.27089337175792505,0.6294196185042903,1.0,4/10,8.27%,SLCO1C1;SLC22A6;SLCO3A1;SLCO2A1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.48436958994876095,1.1740767931904716,0.2784313725490196,0.7704301018855406,1.0,4/26,9.33%,CHSY3;B4GALNT2;B4GALNT1;CHSY1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5688667233077791,1.1740331107657282,0.2833078101071976,0.766014248506515,1.0,1/11,4.11%,PADI2
prerank,potassium channel activity (GO:0005267),-0.2777915230608458,-1.1732189845401793,0.14864864864864866,0.6288353769771723,1.0,22/89,16.07%,KCNC2;KCND3;GRIK4;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;KCNK10;ABCC9;KCNQ3;KCNQ4;KCNK2;KCNQ1;LRRC38;CCDC51;KCNN2;GRIK2;KCNC1;KCNT1
prerank,protein phosphatase regulator activity (GO:0019888),0.4320476350424888,1.1715379466038864,0.267688679245283,0.7691449677047796,1.0,14/53,13.64%,MGAT5;PPP1R9B;PTN;RCAN2;EIF2AK2;PPP4R1;PPP2R2A;PPP2R5A;RCAN3;PPP4R2;PPP1R2;PPP1R16A;PPME1;CALM2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5343201521746731,1.1682455939612688,0.31390134529147984,0.775138205111332,1.0,3/14,12.47%,TSEN2;POP1;POP4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5404839297793972,1.162050690507604,0.3052959501557632,0.7898747681728254,1.0,3/14,8.05%,CAPN5;CAPN2;CAPN15
prerank,amino acid binding (GO:0016597),-0.3470294242510886,-1.1614407549114165,0.18592964824120603,0.6504225586666909,1.0,7/31,11.07%,GRM7;GLRA3;NOS3;GCLC;GRIN3A;GLRA1;GRIN2B
prerank,gated channel activity (GO:0022836),0.5291017690540809,1.1606872487314188,0.3235294117647059,0.7896036979507869,1.0,3/14,6.89%,TMC3;PIEZO2;TMEM266
prerank,RNA polymerase II complex binding (GO:0000993),-0.34448319795445215,-1.1596305798181135,0.17391304347826086,0.6470404444675456,1.0,8/32,11.32%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA
prerank,regulatory RNA binding (GO:0061980),0.450479764881847,1.159117736201711,0.299625468164794,0.7898562690470918,1.0,14/38,24.18%,POU5F1;PUM1;TLR7;DICER1;FMR1;RBM10;ZNF346;TUT7;SOX2;AGO2;ZC3H12A;YBX1;DDX21;AGO1
prerank,sulfotransferase activity (GO:0008146),-0.33841591362559836,-1.1556118167908116,0.2413793103448276,0.6490103442859515,1.0,11/33,13.49%,HS3ST3A1;HS3ST1;UST;SULT1A1;CHST8;CHST9;GAL3ST1;TPST2;CHST3;HS6ST1;HS3ST2
prerank,gamma-tubulin binding (GO:0043015),-0.38768604222894315,-1.1554262880885167,0.2558922558922559,0.6414959112946814,1.0,10/21,29.73%,DIXDC1;TUBGCP3;BRCA2;OFD1;GIT1;CDK5RAP2;BLOC1S2;RACGAP1;RAD51D;B9D2
prerank,alpha-tubulin binding (GO:0043014),0.4582036160553066,1.1543841205567265,0.2987012987012987,0.8002322010599716,1.0,5/31,9.84%,DLEC1;TAOK1;EML4;INO80;SETD2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4546208687490845,1.1543781085602378,0.29806451612903223,0.7956439971417577,1.0,19/34,27.81%,ANTKMT;KMT5A;EHMT1;SETD2;SETDB1;CAMKMT;KMT2E;VCPKMT;NSD3;ETFBKMT;SETD3;N6AMT1;EEF2KMT;DOT1L;SETD7;KMT5B;SETD4;METTL21A;EEF1AKMT3
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5162108455423633,1.154161825893511,0.3025936599423631,0.7917490343986099,1.0,4/17,4.34%,ABCA1;ATP8B1;PLTP;ABCG1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.39057332732595507,-1.152724389166945,0.24060150375939848,0.6404058634524236,1.0,5/20,14.31%,LPGAT1;LPCAT2;AGPAT3;DGAT1;GPAT4
prerank,glutathione transferase activity (GO:0004364),0.4732469341801267,1.1509278889623935,0.28936742934051146,0.7972737402040152,1.0,3/23,10.94%,PTGES;MGST1;GSTK1
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2590696185321925,-1.1496233169491297,0.09803921568627451,0.6405001992480552,1.0,30/134,12.26%,ABCC4;ABCG2;SLC6A6;SLC13A3;SLC26A7;SLC26A2;SLCO1C1;SLC6A9;SLC38A9;SLC7A5;SLC1A2;SLC1A1;MPC1;SLC22A6;SLCO3A1;SLC6A1;SLC16A11;SLC39A8;SLC52A1;SLC5A6;SLC16A1;SLC25A42;SLCO2A1;SLC4A8;SLC27A1;SLC4A3;SLC38A5;SLC25A12;SLC25A38;MPC2
prerank,protein phosphatase binding (GO:0019903),0.38568013661628114,1.148138982474179,0.22727272727272727,0.8010269948355362,1.0,32/117,18.76%,PPP1R9B;JAK1;SLC9A1;AP3B1;EGFR;STAT3;IKBKE;SMG7;STRN;STX17;CDC27;DLG4;PDLIM4;MVP;PTK2;TRAF2;PPP1R16A;PPME1;PIK3R1;AKAP11;GTF2F1;CTTNBP2NL;CDKN1B;VRK3;MTMR9;ITGA1;PTPA;MTMR3;EIF2AK3;ANKLE2;MFHAS1;HSP90B1
prerank,cAMP binding (GO:0030552),-0.4605439530897706,-1.1462874671464995,0.28212290502793297,0.6404405946934452,1.0,5/11,11.42%,PDE4B;RAPGEF2;PDE4D;PDE10A;PDE2A
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5230525896750441,1.1459487077169122,0.3141122913505311,0.8032133613371005,1.0,1/13,0.79%,EHHADH
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.502072910960619,1.1449696428964309,0.30503597122302156,0.7972886133044789,1.0,4/17,6.61%,EPHA7;EFNA4;EPHB3;EPHA1
prerank,ephrin receptor activity (GO:0005003),0.502072910960619,1.1449696428964309,0.30503597122302156,0.7972886133044789,1.0,4/17,6.61%,EPHA7;EFNA4;EPHB3;EPHA1
prerank,double-stranded RNA binding (GO:0003725),0.4077162458695869,1.1426130538333186,0.2797752808988764,0.8001154029957901,1.0,11/70,9.83%,ZBP1;CLTC;RFTN1;ILF3;ZFR;EIF4A1;EIF2AK2;TLR7;MSN;DICER1;OASL
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5195750046711642,1.1415370464534216,0.3054331864904552,0.7992659576885867,1.0,3/15,12.90%,P2RX5;P2RY14;P2RX7
prerank,Notch binding (GO:0005112),0.4780040761868177,1.1408443542213424,0.30536451169188444,0.7970766252968208,1.0,5/22,11.76%,NCOR2;JAG1;GALNT11;SNED1;KCTD10
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5224775348051716,1.1395115045974706,0.3201820940819423,0.7968419029653349,1.0,1/14,0.63%,SLC1A3
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4973861709155071,1.139225672144505,0.3248587570621469,0.7934464460656458,1.0,6/18,13.74%,SMAD2;TGFB3;TGFBR1;TGFB2;TGFBRAP1;SMAD3
prerank,cAMP response element binding (GO:0035497),0.549795060270617,1.1360803428092094,0.31789137380191695,0.7986497994589157,1.0,2/10,7.92%,CREB3L1;CREB3L2
prerank,semaphorin receptor activity (GO:0017154),0.5341498899064017,1.1359680323871775,0.315541601255887,0.794721621151038,1.0,4/11,8.57%,NRP1;PLXNC1;PLXND1;PLXNA3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3996882763947707,1.1358747401870253,0.2809364548494983,0.7907800939097378,1.0,8/73,12.75%,MC5R;EDNRA;RXFP2;ADCYAP1R1;GLP2R;S1PR2;CALCRL;MC1R
prerank,ribosome binding (GO:0043022),0.4200128415711119,1.133921734003445,0.3007246376811594,0.7924496713159045,1.0,17/46,21.08%,RPSA;CPEB1;SHFL;ERI1;BAG6;SRP68;SEC61A1;YTHDF3;FMR1;CPEB4;SEC61A2;NAA15;MAIP1;SRP72;MRPS27;ETF1;ZC3H12A
prerank,methylation-dependent protein binding (GO:0140034),0.41593117055177514,1.1309954285113701,0.28390804597701147,0.7972412197784541,1.0,21/57,24.39%,CXXC1;RBBP5;PHF1;PHF2;MORC3;CBX8;KMT2E;GLYR1;LRWD1;ATRX;FMR1;NCAPG2;ING5;THAP7;SUZ12;CHD8;CBX5;MSH6;MPHOSPH8;ZMYND8;KDM7A
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5398115870572671,1.13060400713142,0.33436532507739936,0.7941624900480652,1.0,2/11,5.18%,AKR1A1;RDH12
prerank,nucleotide diphosphatase activity (GO:0004551),0.5096629862416867,1.1303313766730667,0.32106038291605304,0.7908360673993127,1.0,1/14,0.33%,ENPP1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3879104114028971,1.1274812574847477,0.28523862375138737,0.7953857195473298,1.0,14/85,16.48%,CEL;LIPC;ASPG;PLA2G7;LPL;PLA2G12A;H6PD;ABHD16A;LYPLAL1;ABHD8;PLA2G4A;PLA2G4E;DDHD2;LYPLA2
prerank,hydro-lyase activity (GO:0016836),0.43211117870682303,1.1250933159500212,0.3073110285006196,0.7985526489800107,1.0,14/41,20.42%,EHHADH;PCBD1;GMDS;ENO1;HACD2;ACO1;ACO2;IREB2;TBXAS1;ECHS1;FAHD2A;PCBD2;AUH;ECHDC2
prerank,protein kinase binding (GO:0019901),0.36367048654573897,1.1240150799793396,0.168,0.7975987060083003,1.0,123/479,18.91%,ROR2;TRIML2;CLTC;NEK6;FAM83A;TCF7L2;RND3;GHR;TNIP1;PTN;JTB;DUSP2;IRS1;PDGFRB;GATA6;JAK2;DUSP5;SLC12A4;SPRED1;NELL1;PRKCSH;SUFU;CDKN2B;IRAK3;TREM2;USF1;STAT3;RICTOR;ERRFI1;SPRED2;KHDRBS1;KIF13B;KCNA5;PRKD2;ACVR1;RHOD;LIMS1;TRIM21;CACUL1;CCND3;PLK1;CKS1B;PTPN6;CDC42;EPHA1;TOM1L1;LLGL1;ADD2;SASH1;IFNAR2;PTPN1;GSKIP;RPTOR;TIRAP;NEK9;MAPKAP1;BORA;NISCH;MSN;PRKAR1B;GRB2;FOXO3;TPX2;IRAK4;MVP;IBTK;PTPRJ;PTPN23;PTPN2;PTK2;TOP2B;YWHAZ;FBXO7;NBR1;TRAP1;SPRY2;UTRN;RHOA;PPP1CB;TPCN2;PJA2;MAP3K2;MAML1;GSK3B;TRAF2;SMCR8;CALM2;SMAD3;DACT1;TRIB3;CDKN1B;PDCD10;RAC1;AP2A2;TRIB1;SMAD1;HIF1A;NBEA;RHOF;PRKAB1;WDR45;SQSTM1;RELB;CEP192;TCF3;PLEK;ACVRL1;PTPRC;DUSP6;DNAJC3;KIF20A;STX1B;TEX14;RAD9A;ATF4;MAP3K12;GYS1;HDAC5;FBXO5;SHC2;TBL2;NR3C1;PARN
prerank,kinase binding (GO:0019900),0.3622112356619235,1.1231492304377781,0.171,0.7960727343062458,1.0,114/434,18.91%,TRIML2;CLTC;NEK6;FAM83A;TCF7L2;SNAI1;RND3;GHR;PTN;JTB;PDGFRB;GATA6;JAK2;SLC12A4;SPRED1;CASP1;SUFU;CDKN2B;EGFR;IRAK3;USF1;STAT3;RICTOR;ERRFI1;SPRED2;KIF13B;KCNA5;RHOD;LIMS1;TRIM21;CACUL1;CCND3;PLK1;CKS1B;PTPN6;CDC42;EPHA1;TOM1L1;LLGL1;DLG4;ADD2;SASH1;IFNAR2;PTPN1;GSKIP;ABI2;RPTOR;NEK9;MAPKAP1;BORA;NISCH;MSN;BTG1;GRB2;RAD23A;TTC28;SP100;FOXO3;CDC37;TPX2;IRAK4;PPP2R5A;MVP;IBTK;PTPRJ;PTPN23;PTPN2;PTK2;YWHAZ;FBXO7;TRAP1;SPRY2;UTRN;RHOA;PPP1CB;TPCN2;MAP3K2;MAML1;GSK3B;TRAF2;SMCR8;CALM2;SMAD3;SRC;TRIB3;CDKN1B;PDCD10;RAC1;AP2A2;SMAD1;HIF1A;NBEA;RHOF;PRKAB1;WDR45;SQSTM1;RELB;CEP192;ACVRL1;PTPRC;DNAJC3;KIF20A;STX1B;TEX14;RAD9A;ATF4;MAP3K12;GYS1;FBXO5;PIP5K1A;SHC2;TBL2;NR3C1;PARN
prerank,tau-protein kinase activity (GO:0050321),0.47636848972842505,1.1227750264702692,0.3252840909090909,0.7932132931798622,1.0,9/20,22.93%,TAOK1;MARK1;GSK3B;SIK3;PHKG2;DYRK1A;MARK2;ROCK2;ROCK1
prerank,syntaxin-1 binding (GO:0017075),-0.37584903812596404,-1.1226093212507464,0.25830258302583026,0.6914902747205591,1.0,5/22,9.63%,UNC13C;SNAP25;UNC13B;NSF;CPLX1
prerank,Tat protein binding (GO:0030957),0.5561282764477666,1.1225327270418375,0.3657331136738056,0.7899163148666382,1.0,1/10,0.69%,MDFIC
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4282009835132002,1.1216770503824416,0.3268529769137303,0.788608223438681,1.0,9/42,15.58%,CDKN2B;CCNE2;CCNL1;CCND3;CKS1B;CCNB2;CCNI;CDKN1B;CCNT1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5092109621147841,1.1202992946552166,0.33903133903133903,0.7885806866480384,1.0,3/14,5.14%,CASP8AP2;CASP1;NOD1
prerank,amyloid-beta binding (GO:0001540),0.3901308905025137,1.1178448900648574,0.30957683741648107,0.7916852459603541,1.0,9/79,5.55%,CACNA1A;LRP1;HSPG2;IAPP;TLR2;TREM2;APOE;GSAP;CD36
prerank,outward rectifier potassium channel activity (GO:0015271),0.5461641731366522,1.1163479248279213,0.3611111111111111,0.7921979014907992,1.0,3/11,5.01%,KCNT2;KCNA5;PKD2
prerank,beta-tubulin binding (GO:0048487),0.44345560632290526,1.1160633583364306,0.33642384105960266,0.7891124699444739,1.0,4/31,4.52%,DLEC1;TAOK1;EML4;MAP1S
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3004157308383726,-1.112393371348467,0.27848101265822783,0.7112347026583733,1.0,7/48,5.75%,TRPM3;SLC12A2;SLC12A7;TRPM6;TMEM165;SLC12A6;ABCC9
prerank,miRNA binding (GO:0035198),0.44291058104971315,1.111520492167399,0.3478818998716303,0.7982109555064105,1.0,12/30,24.18%,POU5F1;PUM1;FMR1;RBM10;ZNF346;TUT7;SOX2;AGO2;ZC3H12A;YBX1;DDX21;AGO1
prerank,ATP binding (GO:0005524),0.36210620142219224,1.102046840787074,0.27419354838709675,0.8224317390948647,1.0,37/266,10.56%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;TAOK1;PEAK1;ERN2;MARK1;P2RX5;IRAK3;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;ACVR1;PYGL;MVK;CDK6;PLK1;VPS4A;CARS2;ABCE1;PXK;MAST2;TGFBR1;GUK1;MAP4K5;TARS1;MLKL;ACVR1B;CDC42BPA;GALK1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.51602098375136,1.1013791392413537,0.3663522012578616,0.8203698169164917,1.0,2/12,3.43%,PDE3A;PDE7B
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.36042117287129066,1.1011419101188233,0.2717171717171717,0.8171214142469655,1.0,47/232,16.40%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;BIRC3;SMURF2;UBR5;TRIM21;UBR4;RNF2;RNF144A;ANAPC11;CDC42;PIAS2;SIAH2;RNF111;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;PELI3;TRIM44;NEURL2;RNF19B;RNF181;RNF149;KCMF1;NSMCE2;FBXO2;RNF11;EGR2;DTX3L;RNFT2;SMURF1;ITCH;NEDD4;TRIM56;PELI2;TRAF3IP2
prerank,methylated histone binding (GO:0035064),0.40069273203404326,1.1007440684594645,0.32992036405005687,0.8143890177668365,1.0,22/62,24.39%,CXXC1;RBBP5;PHF1;PHF2;MORC3;TAF7;CBX8;KMT2E;GLYR1;LRWD1;ATRX;FMR1;NCAPG2;ING5;THAP7;SUZ12;CHD8;CBX5;MSH6;MPHOSPH8;ZMYND8;KDM7A
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.37904677288214567,1.096396164989458,0.33150984682713347,0.8231308601985646,1.0,24/100,17.85%,SH3PXD2B;MYO1B;MYO10;GAB2;WIPI1;CYTH3;SESTD1;DAPP1;ZFYVE26;MAPKAP1;GBF1;OGT;ANKFY1;OSBPL5;PLEKHF1;KIF16B;PLA2G4A;PLEKHA5;WDR45;PLA2G4E;RUBCNL;ARHGAP9;AKT1;ZFYVE16
prerank,palmitoyltransferase activity (GO:0016409),-0.3299982735174045,-1.094134828219633,0.30991735537190085,0.7531388131536267,1.0,8/28,16.77%,GLUL;ZDHHC13;ZDHHC21;ZDHHC17;ZDHHC14;ZDHHC5;ZDHHC15;ZDHHC2
prerank,fatty acid synthase activity (GO:0004312),-0.45866721133059873,-1.0939965286170603,0.34584450402144773,0.7450059015190936,1.0,5/10,22.99%,ELOVL7;ELOVL5;ELOVL4;CBR4;OXSM
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.42297687111875754,1.0925488699525743,0.3682896379525593,0.830061787638224,1.0,11/38,16.10%,SH3PXD2B;WIPI1;SESTD1;ZFYVE26;PLEKHF1;KIF16B;PLA2G4A;PLEKHA5;WDR45;PLA2G4E;RUBCNL
prerank,nucleosomal DNA binding (GO:0031492),0.4587714378327084,1.085961311943458,0.36605890603085556,0.8448723167567951,1.0,10/21,21.53%,MBD2;SMARCC1;HDAC1;MTA2;GATAD2B;RCC1;SMARCA4;MBD3;HMGA2;HNRNPC
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4927238794777504,1.0852983484812007,0.36538461538461536,0.8428962518650717,1.0,1/15,0.63%,SLC1A3
prerank,ubiquitin protein ligase activity (GO:0061630),0.35546385101932587,1.0849442441493093,0.3006072874493927,0.8399078974541466,1.0,45/228,16.40%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;BIRC3;SMURF2;UBR5;TRIM21;UBR4;RNF2;RNF144A;ANAPC11;CDC42;SIAH2;RNF111;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;PELI3;TRIM44;NEURL2;RNF19B;RNF181;RNF149;UBE2K;KCMF1;FBXO2;RNF11;DTX3L;RNFT2;SMURF1;ITCH;NEDD4;TRIM56;PELI2;TRAF3IP2
prerank,protein homodimerization activity (GO:0042803),0.349049664281811,1.0846056821295689,0.226,0.8369342609398839,1.0,114/589,17.14%,FAP;ENPP1;KMT2A;ADIPOQ;SOHLH2;TRIML2;PDGFRA;MID1;ASMT;TBX18;GHR;MASP1;JAML;CREB3L3;STAT1;LRRK2;XCL1;ST6GAL1;EXT1;CRYM;TENM3;IRAK3;CPQ;APOE;USF1;STAT3;MTHFD1L;CHMP4A;CHMP4B;PADI2;MAD2L1;NR2F2;MYH9;ABCG1;CAMK2D;XPNPEP1;CDADC1;EPHX2;BCL2;PKD2;TRPC6;NOD1;ACVR1;PIP4K2A;EXT2;TRIM21;CCL5;LRP6;ENO1;ZHX2;GLDC;AHR;INHBB;TMEM266;IRAK2;BCL2L2;ARNT;TENM4;ACOX1;KYAT1;ADD2;BHLHE40;AIMP1;MIGA2;TRIM8;GOLGA5;TERT;PDLIM4;LPL;HSD11B1;S100A6;ZBTB38;TNNC1;SETMAR;FGFR1;UBA5;EEA1;SNX9;TGFB2;CLN6;ATG7;SNX2;CYP2R1;PSMF1;TPST1;SPPL3;GGCT;ABCG4;DPYD;SMAD3;MKLN1;TPM4;FMR1;SMAD4;XPNPEP3;PDCD10;PEX11A;RIPK1;ALDH3A2;IL6R;PANK1;NR6A1;ALS2;POU3F3;STK4;TCF3;PLEK;CRPPA;ZDHHC3;SH3GLB1;GNPTG;PTPA;AKT1;KLHL7
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4579452852649493,1.0814438796034498,0.35335195530726254,0.8424169261516343,1.0,3/21,12.90%,P2RX5;GLRB;P2RX7
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.49767397447906475,1.0800946991559297,0.38509316770186336,0.8424782485213229,1.0,4/12,19.71%,DHRS4;AIFM2;NDUFS7;DCXR
prerank,phospholipase inhibitor activity (GO:0004859),0.5226147622823656,1.0786915218049944,0.391653290529695,0.8427040272126013,1.0,6/10,31.21%,ANXA1;ANXA9;ANXA5;ANXA2;APOC1;ANXA4
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.323907818492749,-1.0777200908048419,0.3333333333333333,0.7825423410138486,1.0,8/32,11.55%,SLC6A6;SLC6A9;SLC38A9;SLC7A5;SLC1A1;SLC43A2;SLC38A5;SLC25A38
prerank,potassium channel regulator activity (GO:0015459),-0.2908739564437675,-1.0753847821718416,0.3076923076923077,0.7803588952817083,1.0,7/49,5.75%,KCNIP4;DPP10;DPP6;WNK4;WNK3;ARPP19;ABCC9
prerank,protein serine/threonine kinase activity (GO:0004674),0.34879688024846933,1.0747851758277853,0.3139418254764293,0.8499522043734155,1.0,99/335,22.19%,MAP3K14;NEK6;MAP4K4;TAOK1;MAST4;ERN2;LRRK2;ALPK1;PRKCA;MARK1;EGFR;KALRN;NUAK1;IRAK3;STK36;IKBKE;CASK;AKT3;CAMK2D;PRKD2;ACVR1;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;IRAK2;TAOK3;CDK10;HIPK4;NEK4;MAPK11;MAST2;ATR;TRIO;TGFBR1;MAP2K1;MYLK;CSNK2A1;CSNK2A2;RPS6KC1;MAP4K5;HIPK3;IRAK4;RPS6KB1;ACVR1B;CDC42BPA;GAK;NRK;CSNK1G2;CDK7;ACVR2A;MAP3K2;GSK3B;CSNK1A1;ACVR1C;MAP3K6;MKNK1;STK24;DAPK2;VRK3;RIPK1;PIK3R4;PRKDC;SQSTM1;MOK;STK4;ACVRL1;CSNK1D;MAPK1;AKT1;LATS2;BRD4;CDKL1;EIF2AK3;TESK2;MAP3K12;SIK3;CDK16;CDK9;CPNE3;FAM20C;CDK13;PLK2;PRKCD;PHKG2;BMPR1A;MAP3K20;CDK12;DYRK1A;VRK2;PKN1;PAK1;RPS6KA4;MARK2;CDC7;RAF1;LATS1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5348412186635751,1.0734868360800733,0.39553429027113235,0.8498577947093073,1.0,1/10,0.79%,EHHADH
prerank,protein heterodimerization activity (GO:0046982),0.3548900694588322,1.0734702904371243,0.32991803278688525,0.8460547730744254,1.0,35/178,14.87%,SOHLH2;KRT25;TCF4;CREB3L3;SMC1A;NPAS4;EXT1;TENM3;IRAK3;USF1;ABCG1;BCL2;TAF7;EXT2;ZHX2;AHR;IRAK2;BCL2L2;ARNT;TENM4;ADD2;VAPA;BHLHE40;MIGA2;RRAGC;ITGA3;TOP2B;FBXO7;SNX2;MICU2;PSMF1;ABCG4;TPM4;FMR1;NOLC1
prerank,chemoattractant activity (GO:0042056),0.4362420323240604,1.071194029933035,0.3944954128440367,0.8487888758851235,1.0,11/26,21.75%,FGF7;CCL5;CXCL10;GPNMB;HMGB2;VEGFC;FGF2;CX3CL1;CCL15;GDNF;VEGFB
prerank,amino acid transmembrane transporter activity (GO:0015171),0.39906961581607864,1.0686597051855493,0.37976190476190474,0.8523303403393931,1.0,7/47,11.38%,SLC7A2;SLC38A3;SLC7A7;SLC38A4;SLC36A2;SLC7A8;PDPN
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.3112846937024809,-1.064673302076437,0.32367149758454106,0.8022950814732454,1.0,19/35,28.35%,TRMT9B;DTWD2;DUS4L;MTFMT;TRDMT1;PUS10;GATB;NT5C3A;QTRT1;LCMT2;TRMT5;ELAC1;QRSL1;MRPL58;GATC;TYW3;TRMT12;AARS1;DUS3L
prerank,ion channel activity (GO:0005216),-0.24950086674299918,-1.0644700069957114,0.2828282828282828,0.7942229304113515,1.0,19/80,16.55%,TRPM3;TRPM6;GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;ABCC9;GRIA1;TMC7;MCUB;GRIN2D;GRIN2B;TRPV2;TMC6;TRPV4;NALCN;GRIK2;CHRNB1
prerank,mechanosensitive ion channel activity (GO:0008381),0.5035933380694422,1.0640376942556218,0.3960546282245827,0.8615575880729884,1.0,2/12,4.18%,TMC3;PIEZO2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4387215313950303,-1.0636493547663564,0.3971830985915493,0.7878815526529114,1.0,6/10,17.62%,SHANK3;SHISA6;NSF;SHANK1;IGSF11;SHISA7
prerank,1-phosphatidylinositol binding (GO:0005545),0.47502202658993026,1.063103800745503,0.41802067946824223,0.8603028378653126,1.0,8/15,20.47%,SESTD1;WDFY3;EEA1;SNX9;SNX10;PICALM;ZFYVE16;ZFYVE1
prerank,"DNA binding, bending (GO:0008301)",-0.3894587205142026,-1.0628387116095954,0.39644970414201186,0.7818341095040563,1.0,5/14,19.57%,LEF1;FOXD1;FOXL1;TFAM;HHEX
prerank,androgen receptor binding (GO:0050681),0.4430117409202745,1.0625429172337955,0.3938223938223938,0.8580959400219841,1.0,12/25,21.80%,WIPI1;ARID5A;TGFB1I1;CALR;NSD1;SMARCA4;ZBTB7A;KDM1A;TMF1;FOXP1;RNF14;PKN1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.3927124291999893,-1.061596728170091,0.36335403726708076,0.7768896440101415,1.0,3/14,4.59%,KCND3;KCNJ2;KCNJ3
prerank,protein tyrosine kinase binding (GO:1990782),-0.26664266405083586,-1.0604320036411792,0.3508771929824561,0.7721196450485057,1.0,22/71,16.29%,EPHA4;TJP2;NEDD9;GRB14;NRG3;CDH5;GAS6;PITPNM2;HSP90AA1;DOCK4;CRK;FLT3LG;TOB1;RNF41;BLNK;FIZ1;RACK1;PIK3R2;PCNA;SHC4;MAP3K7;GRM5
prerank,phospholipase C activity (GO:0004629),0.43478661289792064,1.0596736603093628,0.4099462365591398,0.8623299609820657,1.0,6/25,10.87%,PDIA3;EDNRA;CCR1;CCL5;PLCL1;PLCB3
prerank,single-stranded DNA binding (GO:0003697),0.36715873448593866,1.057730043520127,0.39476553980370777,0.863932075244869,1.0,15/93,11.85%,RAD51B;RBMS1;RAD52;MCM2;DDX11;SUB1;FUBP1;MCM7;RAD23A;RAD23B;SETMAR;FBH1;HMGB2;MCM9;TDP2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3864819419025858,-1.0561876117860816,0.3611111111111111,0.7761322281047838,1.0,6/17,14.16%,LBR;TECR;BLVRB;BLVRA;MECR;DHCR24
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.37631268848889116,-1.0535772390517222,0.4,0.767280466182696,1.0,7/16,14.61%,PTPRB;PTPRT;PTPRO;PTPRK;PTPRG;PTPRD;PTPRN2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.37631268848889116,-1.0535772390517222,0.4,0.767280466182696,1.0,7/16,14.61%,PTPRB;PTPRT;PTPRO;PTPRK;PTPRG;PTPRD;PTPRN2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.37280661027336204,1.0508920426370816,0.39727582292849034,0.8802383055983298,1.0,27/71,20.59%,PTPN7;PTPN3;PTPN13;PTEN;PTPRZ1;PTPN6;HACD2;PTPN18;PTPN1;PTPRJ;PTPN23;PTPN9;PTPN2;PTPRM;DUSP26;UBASH3B;CDC14A;TIMM50;PALD1;PTPRC;PTPN5;PTPRA;MTMR3;MTMR6;CDC14B;DUSP11;DUSP15
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.34141470994355755,1.0508599227981519,0.36,0.8764973478932474,1.0,84/431,17.22%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;RND3;TAOK1;PEAK1;ERN2;RHOJ;LRRK2;MARK1;P2RX5;IRAK3;RAB2A;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;TUBG1;ACVR1;RHOD;GNL1;PYGL;MVK;RAB42;RALA;CDK6;RAP2A;ATL2;PLK1;RAB21;CDC42;VPS4A;CARS2;RAB7A;ABCE1;PXK;MAST2;RRAGC;PSMA6;TGFBR1;GUK1;RAB9A;MAP4K5;TARS1;MLKL;RAB32;RAB27B;GBP7;ACVR1B;RERG;CDC42BPA;GALK1;ARF4;GNAI1;RIT1;GCK;RHOA;GNL3;P2RX7;RAB10;MAP3K6;ARF1;MKNK1;DAPK2;RAC1;HSPA5;TRIB1;ANXA6;RHOF;STK4;TUBG2;ACVRL1;PNKP;PEX6;MTREX;PTPA;AKT1;LATS2
prerank,cGMP binding (GO:0030553),-0.42077883495139123,-1.0507858957648155,0.39058171745152354,0.767042970735038,1.0,4/11,16.91%,RAPGEF2;PDE10A;PDE2A;PDE11A
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3927949320474502,1.0506034737676075,0.4019138755980861,0.8733789193374902,1.0,8/46,16.66%,MGAT5;EXT1;EXT2;OGT;MGAT4A;GCNT2;PIGP;B3GNT9
prerank,magnesium ion binding (GO:0000287),0.3521481875439223,1.0496466847075716,0.3958115183246073,0.8724292166299392,1.0,21/135,13.57%,NEK6;PDXP;ERN2;LRRK2;PPA1;MARK1;IRAK3;ADCY2;EPHX2;MVK;FOXK2;RAP2A;PLK1;MAST2;RRAGC;IDH2;CDC42BPA;GNAI1;TDP2;ADPRH;MAP3K6
prerank,CoA hydrolase activity (GO:0016289),0.4645440304066,1.0494647595223405,0.41964285714285715,0.8692049160116639,1.0,5/16,22.83%,HIBCH;ACOT13;ACOT9;NUDT7;ACAA2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4143172609376755,1.0491133345874537,0.4249037227214377,0.8663925156832923,1.0,2/30,2.96%,KNG1;BIRC3
prerank,SH3 domain binding (GO:0017124),0.3788994456348272,1.0432270927869762,0.42857142857142855,0.8784523581462458,1.0,9/62,8.42%,CBLB;SH3BP2;ADAM12;DPYSL3;WIPF1;KHDRBS1;ABI2;CBL;GRB2
prerank,translation initiation factor activity (GO:0003743),0.40691500777595463,1.0410030606080698,0.4225,0.8809177965005243,1.0,14/36,24.24%,EIF4G2;EIF4G3;EIF4A1;EIF3H;EIF5B;EIF5;EIF1;EIF2B3;EIF3K;AGO2;EIF4G1;EIF3E;EIF2S1;EIF2A
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.30632120035051247,-1.035745233232338,0.3933649289099526,0.7914751213557188,1.0,13/34,21.80%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFB6;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.30632120035051247,-1.035745233232338,0.3933649289099526,0.7914751213557188,1.0,13/34,21.80%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFB6;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3961329590466139,-1.0339667728655055,0.38904899135446686,0.7885205132203417,1.0,3/12,19.98%,SLC2A1;SLC5A3;SLC2A8
prerank,ubiquitin binding (GO:0043130),0.36815393178865663,1.0309283539031775,0.4239733629300777,0.9050326201038056,1.0,19/73,17.55%,TNFAIP3;OTULINL;ILRUN;RAE1;CKS1B;TOM1L1;FBXW7;RAD23A;CXCR4;RAD23B;USPL1;FBXO7;NBR1;RNF19B;SMAD3;NEDD4;SQSTM1;RBCK1;MDM2
prerank,cardiolipin binding (GO:1901612),0.50266686389098,1.030590465435447,0.4521880064829822,0.9021801339169842,1.0,1/10,2.82%,STOML2
prerank,phosphatidylinositol binding (GO:0035091),-0.23967581008254665,-1.030302063732243,0.3258426966292135,0.7900772543425487,1.0,25/91,17.80%,PITPNC1;MCF2L;EPB41;DENND1A;ITPR2;PITPNM2;PITPNA;HIP1R;ESYT2;CCDC88A;ESYT1;SCARB1;PLEKHF2;ITPR3;PARD3;SNX16;TNFAIP8L3;HIP1;GPAA1;ESYT3;MREG;SNX11;SNX13;FCHO2;SNAP91
prerank,galactosyltransferase activity (GO:0008378),0.4937718840975553,1.0297412405304538,0.4527439024390244,0.9006542918297571,1.0,4/11,17.68%,B4GALT5;B4GALT2;B4GALT7;B4GALT4
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.42365804558131537,-1.0287366502181285,0.42699724517906334,0.7869703758405657,1.0,6/10,30.10%,ANKRD13A;IDE;FAAP20;FAN1;DNAJB2;ANKRD13D
prerank,MAP kinase kinase activity (GO:0004708),0.46984344480549595,1.0280353088678442,0.45537065052950076,0.9013729151963338,1.0,3/15,9.11%,LRRK2;MAP2K4;MAP2K1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3769902033084421,1.027455557363093,0.441588785046729,0.8991760146297474,1.0,16/53,20.08%,STEAP4;ETFA;MTHFR;POR;ACOX1;AIFM2;PPOX;ACOX3;DPYD;AIFM1;MTRR;XDH;CYBB;KDM1A;CYB5R3;SQOR
prerank,phospholipase activity (GO:0004620),0.36382018101027136,1.0259137939129022,0.4412442396313364,0.8998126939212778,1.0,16/67,16.48%,LIPC;ASPG;PDIA3;LPL;PLCL1;PLD4;PLA2G12A;PLCB3;ABHD16A;SEC23IP;LYPLAL1;SMPD3;PLA2G4A;PLA2G4E;DDHD2;LYPLA2
prerank,disordered domain specific binding (GO:0097718),0.42825321018153334,1.0255194259326308,0.4470426409903714,0.8972237336040825,1.0,5/23,13.64%,CLTC;SMAD2;BCL2L2;GAPDH;CALM2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3530333760076686,1.0247440055448969,0.43468715697036225,0.8957613182233787,1.0,18/91,16.09%,SVIL;SH3PXD2B;MYO1B;SLC9A1;WIPI1;MARK1;SESTD1;TIRAP;MAPKAP1;GBF1;SNX18;EXOC1;VILL;KIF16B;PLEKHA5;WDR45;PLA2G4E;CGAS
prerank,alanine transmembrane transporter activity (GO:0022858),0.4879436490784474,1.0246976527876408,0.46474358974358976,0.8921983049112773,1.0,3/12,9.69%,SLC38A3;SLC36A2;SLC7A8
prerank,voltage-gated calcium channel activity (GO:0005245),0.40359502875991554,1.0233210124762633,0.4473684210526316,0.8922299586109749,1.0,5/37,5.01%,CACNA1A;CACNA2D1;CACNA1C;CACNB1;PKD2
prerank,motor activity (GO:0003774),0.36946142551763334,1.023280705193449,0.44069767441860463,0.8887217601979497,1.0,16/60,17.50%,KIF26B;KIFC1;KIF1C;MYH9;KIF13B;KIF2A;APPBP2;KIF5B;DYNC2H1;KIF16B;KIF27;MYO1E;GPR88;KIF5A;KIF9;KIF20A
prerank,GTPase regulator activity (GO:0030695),0.33818189080113503,1.023258381435145,0.4566532258064516,0.8851732942675526,1.0,48/212,16.40%,DLC1;RGS16;SYDE1;SEC23A;ARHGAP15;LRRK2;ARHGAP24;VAV3;NRP1;ARHGAP32;ARHGAP42;SIPA1L3;ASAP1;ASAP3;DOCK1;ERRFI1;ARFGAP3;TBC1D16;NF1;OPHN1;ARFGAP1;NPRL2;TBC1D2B;RABGAP1L;GPSM2;LLGL1;TBC1D8B;EIF5;RABGAP1;RAB3GAP2;PREX1;RALGDS;PDE6D;RIN2;RGS10;TBC1D1;ADPRH;RAB3GAP1;ARHGAP22;ACAP2;ARHGAP35;TBC1D10B;RTKN;SIPA1L2;ALS2;ARHGAP9;ITGB1BP1;RASA1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3858310132552451,1.0229171635760022,0.4432497013142174,0.8824818095248715,1.0,11/49,16.50%,TNIP1;TNFAIP3;IKBKE;BABAM2;BAG6;RAD23A;RNF169;RAD23B;EPS15;SQSTM1;ATRIP
prerank,receptor tyrosine kinase binding (GO:0030971),0.3753063485434113,1.0225948110613683,0.45936395759717313,0.8797665282108682,1.0,11/56,11.03%,CBLB;GAB2;IRS1;NCK1;PTPN1;SH2B2;ANGPT1;CBL;FRS2;PTPN2;SOCS5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4991275190218229,1.0221422966478972,0.4620355411954766,0.8774800685141809,1.0,1/10,3.07%,DPYSL3
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4228038752189417,-1.0201320693934368,0.4424552429667519,0.8032056942141744,1.0,7/10,33.95%,DSEL;GALM;RENBP;DSE;GALE;FUOM;RPE
prerank,G protein-coupled receptor activity (GO:0004930),0.334489002773373,1.0192071896622938,0.44242424242424244,0.8823302096423237,1.0,25/239,12.75%,MC5R;P2RY10;GPR176;CMKLR1;GPR63;PDGFRB;ADGRL3;RXFP2;ADCYAP1R1;GLP2R;S1PR3;P2RY14;GPR161;S1PR2;CXCR4;DRD3;HRH1;TM2D1;LPAR3;OPN1MW;OPN1MW3;LPAR2;CALCRL;TAPT1;MC1R
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.39350397283928285,-1.0187934951677295,0.4318181818181818,0.7992966212107309,1.0,5/13,12.33%,EZR;PRKAR1A;PRKAR2A;PKIA;KCNQ1
prerank,mRNA methyltransferase activity (GO:0008174),0.4808363041815342,1.0166414567288435,0.47238372093023256,0.8856273510139792,1.0,8/12,31.41%,METTL16;TRMT61B;TRMT61A;PCIF1;RNMT;METTL14;METTL8;NSUN2
prerank,GDP binding (GO:0019003),0.36486781845868027,1.0161127607426788,0.44495412844036697,0.8835161762974277,1.0,14/63,13.50%,RAB2A;RAB42;RALA;RAP2A;RAB21;RAB8B;RAB7A;RRAGC;RAB9A;RAB27B;RERG;GNAI1;RIT1;RAB10
prerank,hexosyltransferase activity (GO:0016758),0.34917374134823514,1.0159605140226438,0.45493107104984093,0.8804310343529899,1.0,20/101,18.25%,CHSY3;B4GALNT2;B4GALT5;EXT1;EXT2;B4GALNT1;ALG5;OGT;MGAT4A;CHSY1;GCNT2;DPY19L3;POGLUT3;TMTC4;CHPF2;B4GALT2;B4GALT7;B3GNT9;B4GALT4;FUT4
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.41416486616500703,-1.0158011586667335,0.4666666666666667,0.7998799266207641,1.0,3/11,28.05%,SLC5A3;SLC2A9;SLC17A5
prerank,telomerase RNA binding (GO:0070034),0.4280762119890075,1.0150001316980826,0.4617524339360223,0.8793471970915587,1.0,10/22,21.53%,SMG7;PINX1;TERT;SMG6;DCP2;XRN1;TEP1;PARN;SNRPB;HNRNPC
prerank,growth factor activity (GO:0008083),0.362054731209737,1.0148683163254082,0.45454545454545453,0.8762950807088552,1.0,10/74,13.23%,CXCL1;PTN;FGF7;JAG1;MDK;EGF;IL7;VEGFC;FGF2;BTC
prerank,syntaxin binding (GO:0019905),0.3678057492387681,1.013795060691476,0.4552752293577982,0.8757307850049855,1.0,8/61,11.00%,ABCA1;CACNA1A;LRRK2;STX6;STXBP1;SYT2;STXBP3;PTPN2
prerank,Hsp70 protein binding (GO:0030544),0.39781961079303685,1.0132355802157094,0.4576923076923077,0.8737938497859984,1.0,5/31,9.08%,SPN;DNAJB1;IQCG;PPID;CYP1A1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.4002806168530055,-1.0132142819605048,0.4090909090909091,0.7991203684015161,1.0,3/12,4.70%,CDH5;VEGFD;CCDC88A
prerank,single-stranded DNA helicase activity (GO:0017116),0.436899113532711,1.0129051350657285,0.44305555555555554,0.8713261034613399,1.0,3/19,8.70%,DNA2;MCM2;MCM7
prerank,pre-mRNA binding (GO:0036002),-0.3017769195129181,-1.011098073269026,0.42916666666666664,0.7971598606246977,1.0,6/28,11.96%,DDX5;CELF2;HNRNPU;U2AF2;SNRPC;HNRNPA1
prerank,adenyl ribonucleotide binding (GO:0032559),0.33021240501423915,1.0067352688159084,0.4778672032193159,0.883589023649157,1.0,38/291,10.56%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;TAOK1;PEAK1;ERN2;RAPGEF4;MARK1;P2RX5;IRAK3;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;ACVR1;PYGL;MVK;CDK6;PLK1;VPS4A;CARS2;ABCE1;PXK;MAST2;TGFBR1;GUK1;MAP4K5;TARS1;MLKL;ACVR1B;CDC42BPA;GALK1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.47015363625519774,1.0062292256689942,0.46967340590979784,0.8815178737919497,1.0,7/12,26.60%,PHF2;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,protein kinase C activity (GO:0004697),-0.37844736808490664,-1.0060059247036457,0.43312101910828027,0.8033049910193993,1.0,3/14,4.77%,PRKCH;PRKCZ;PRKCB
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.4080784285082999,1.005839084119518,0.4560723514211886,0.8791891780059852,1.0,1/27,0.13%,SLC39A14
prerank,amino acid:sodium symporter activity (GO:0005283),0.4793766023798759,1.005401722827771,0.499194847020934,0.8768817740497442,1.0,1/11,0.63%,SLC1A3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.46331114481299646,1.005273397690298,0.4865269461077844,0.8738315375308011,1.0,5/13,16.70%,GPSM2;ARHGDIG;EIF5;ITGB1BP1;ARHGDIA
prerank,cyclic nucleotide binding (GO:0030551),-0.334318844191916,-1.0051832994546845,0.45263157894736844,0.7982918689365357,1.0,7/21,17.76%,PDE4B;RAPGEF2;PDE4D;PDE10A;PDE2A;PDE11A;HCN1
prerank,death domain binding (GO:0070513),0.48259780343318404,1.0050560165462803,0.47553516819571867,0.8710852515213784,1.0,2/11,4.98%,DAP;BCL2
prerank,phosphatase activator activity (GO:0019211),0.4626493421528794,1.0027656465090227,0.4933530280649926,0.8735390496230961,1.0,10/14,27.73%,FRS2;PPP2R5A;GTF2F1;CALM2;PPP2R5C;PHACTR4;CALM3;PPP2R5E;PPP2R5D;B3GAT3
prerank,DNA replication origin binding (GO:0003688),0.41982563277142315,1.000851355954632,0.46008119079837617,0.8749544599580794,1.0,5/23,10.37%,MCM2;DDX11;MCM7;GRWD1;MCM9
prerank,channel activity (GO:0015267),0.3763449636810143,0.9970879629627885,0.47317073170731705,0.8813524071429453,1.0,7/41,18.56%,P2RX5;TMEM120B;BCL2;TMEM266;PDPN;TMEM120A;PANX1
prerank,GTPase activator activity (GO:0005096),0.32636024273902464,0.9952591731107022,0.5170340681362725,0.882623152171047,1.0,73/313,16.62%,DLC1;RGS16;SYDE1;FARP2;SEC23A;VAV2;ARHGAP15;FARP1;LRRK2;MYCBP2;ARHGAP24;VAV3;RAPGEF4;NRP1;ARHGAP32;CYTH3;ARHGAP42;SIPA1L3;KALRN;ASAP1;ITSN1;ASAP3;DOCK1;ERRFI1;ARFGEF2;RABIF;ARFGAP3;TBC1D16;NF1;NUCB2;OPHN1;FGD4;EGF;ARFGAP1;NPRL2;TBC1D2B;RABGAP1L;LLGL1;DENND4C;TBC1D8B;RABGAP1;RAB3GAP2;PREX1;FNIP1;DENND5A;FGD6;RASGEF1B;VAV1;RIN2;IQSEC2;AKAP13;RGS10;TBC1D1;SMCR8;ADPRH;SH3BP5L;RAB3GAP1;ANKRD27;ARHGAP22;ACAP2;ARHGEF18;ARHGAP35;TBC1D10B;DNMBP;SIPA1L2;ALS2;RCC1;ARHGAP9;RGL1;EIF2B3;RASA1;DOCK2;LAMTOR5
prerank,retinoic acid binding (GO:0001972),0.4656823910950167,0.9933120440954497,0.4774494556765163,0.88419162371299,1.0,1/12,4.15%,NR2F2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4105295904502785,0.9921346929336199,0.4993464052287582,0.8838672778703054,1.0,5/29,11.67%,TNIP1;DUSP2;DUSP5;PTPRJ;NBR1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.44479627174288916,0.9904054656649213,0.4743202416918429,0.8850523994446259,1.0,3/15,15.97%,PLA2G12A;PLA2G4A;PLA2G4E
prerank,phosphate ion binding (GO:0042301),-0.407893698569342,-0.9899384417574146,0.4903047091412742,0.8307391064304789,1.0,4/10,31.93%,PDE2A;MTHFD2;ADSS1;RPH3A
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.32202895206274423,0.9891709684372799,0.5231388329979879,0.8849240331467776,1.0,59/269,18.40%,GLMN;POU5F1;NEK6;NKD2;MID1;JAK1;STAT1;CD40;SMAD2;EGFR;IKBKE;CUL1;BCL2;AMBRA1;RALA;BAG6;SPOP;ABI2;FBXW7;ARIH1;CXCR4;SMAD5;UBE2L3;ACVR1B;UQCRC1;SNX9;YWHAZ;UBE2J1;FBXO7;CASP8;CALR;GSK3B;MC1R;UBE2K;TANK;TRAF2;DDRGK1;SMAD3;UBE2W;EGR2;TRIB3;RPL11;DTX3L;WASHC1;HSPA5;TRIB1;RIPK1;PATZ1;ITCH;HIF1A;SQSTM1;TRAF5;BAG4;HSPD1;YWHAE;MDM2;SLF2;NFKBIA;MFHAS1
prerank,3'-5' exonuclease activity (GO:0008408),-0.26591672762122937,-0.9880390658624348,0.44324324324324327,0.828561650009931,1.0,17/45,25.66%,MRE11;CNOT8;EXOSC7;APLF;CNOT6L;RAD1;EXOSC3;EXD1;ANGEL2;REXO4;TOE1;ANGEL1;PDE12;EXOSC10;NOCT;TATDN1;RAD50
prerank,nuclear localization sequence binding (GO:0008139),0.4318238175931551,0.9867345803451784,0.48099415204678364,0.8877131037535911,1.0,8/18,23.08%,KPNA3;BRAP;NUP153;TNPO1;NFKBIA;NUP214;KPNA2;KPNB1
prerank,carboxy-lyase activity (GO:0016831),-0.3143509754452183,-0.9851174351989164,0.4756554307116105,0.8294840919197696,1.0,7/23,25.24%,PPCDC;ECHDC1;DDC;GAD1;CSAD;UXS1;MLYCD
prerank,N-acetyltransferase activity (GO:0008080),0.42559055664077566,0.9840967749075997,0.5,0.8910233186613367,1.0,3/19,10.81%,NAT1;NAA50;NAT10
prerank,voltage-gated anion channel activity (GO:0008308),-0.36580970626962744,-0.9826859194632813,0.4702194357366771,0.8285570319113297,1.0,5/15,7.65%,GPR89B;GPR89A;CLCN2;CLCN3;VDAC1
prerank,death receptor activity (GO:0005035),0.4677209564655891,0.9825286825364907,0.5237315875613748,0.8916395275092922,1.0,3/11,11.94%,EDA2R;TNFRSF1A;TNFRSF4
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.4646007024476481,0.9806691818355078,0.5070202808112324,0.8931460185559436,1.0,3/11,12.85%,UBR5;ANAPC11;UBE2K
prerank,histone methyltransferase activity (GO:0042054),0.3921257300017239,0.9796123616987629,0.5077720207253886,0.8923840761280776,1.0,14/32,25.64%,KMT5A;EHMT1;CARM1;SETD2;SETDB1;KMT2E;NSD3;N6AMT1;SUZ12;DOT1L;PRMT5;KMT2C;SETD7;KMT5B
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.34410223516449034,0.9780310592631577,0.5195968645016797,0.8930462015708749,1.0,24/74,20.26%,PAPSS2;DCAKD;HK2;FAM20A;MVK;TRPT1;DGKH;GALK2;ADPGK;PANK2;GALK1;GK;KHK;PI4KA;SPHK2;COASY;PANK1;NADK;FAM20B;PIK3C3;POMK;FAM20C;HYKK;ETNK1
prerank,translation elongation factor activity (GO:0003746),-0.3580140326390384,-0.9745962302354572,0.4738372093023256,0.8412771687766601,1.0,8/14,36.78%,EEF1B2;GTPBP2;TSFM;EEF2;GFM1;TUFM;EIF5A;EIF5AL1
prerank,manganese ion binding (GO:0030145),0.36633524157942426,0.9740646645735626,0.5154028436018957,0.8993947766902819,1.0,8/48,15.52%,MGAT5;GALNT3;ADCY2;XPNPEP1;NEK4;TDP2;XPNPEP3;B4GALT7
prerank,DNA polymerase activity (GO:0034061),0.40581082375213584,0.9735055942279043,0.4986111111111111,0.8974952776358934,1.0,5/22,15.53%,POLE3;TERT;POLI;REV1;POLG
prerank,RNA binding (GO:0003723),0.3122434287843826,0.9729358112162387,0.651,0.8956560340181862,1.0,335/1321,22.00%,RBMS3;IGF2BP1;ZBP1;DCN;FNDC3B;RBM46;POU5F1;CLTC;BICC1;RPSA;RRBP1;RBMS1;RFTN1;C1D;LRP1;RPUSD3;ALDH18A1;ZFP36L1;IGF2BP2;APOBEC1;RBFOX1;EIF4G2;MAK16;CCAR1;CSRP1;SYNCRIP;ZFP36L2;ATXN2;ZCCHC24;AFF2;PDIA3;EIF4G3;SMC1A;DNA2;SREK1;DNTTIP2;ASCC3;MRPS26;RPL3L;ARCN1;NOL11;STAT3;FSCN1;ILF3;DYNC1H1;PPRC1;KIF1C;MYH9;ZC3H13;KHDRBS1;PUM1;SNRNP40;DNAJC21;SERPINH1;SMG7;ZFR;SPATS2;PES1;SELENOH;XPOT;TENT5A;SHFL;RAE1;ARL6IP4;SNTB2;CNOT4;CSTF1;METTL16;EIF4A1;ERI1;MYO5A;EIF2AK2;DDX11;ENO1;DHX35;YARS1;PTBP3;STXBP1;CCDC86;TLR7;DAP3;PINX1;SUB1;TRUB2;ACO1;PDAP1;DDX17;NOC2L;EIF3H;HSPE1;CAPRIN1;PTPN1;GIGYF2;FUBP1;ZC3H15;POP1;RRP1B;RRP1;DIDO1;CANX;SAMD4A;AIMP1;NMD3;CCAR2;PABPC4;CKAP4;MSN;CELF1;BUD13;TERT;TNRC6B;GRB2;SMG6;EIF5B;UBFD1;SAP18;EIF5;CCDC9B;PSMA6;DCP2;MTERF4;NONO;RNASEH1;SEC63;DICER1;SND1;NOP14;UBE2L3;OASL;DHX34;DHX8;GRWD1;NOP2;HMGB2;PELP1;NIP7;ALKBH5;NCBP2;ALKBH1;HNRNPH2;DDX28;RAMAC;UTP3;CCDC59;NAT10;CHD2;MOV10;SEC23IP;XRN1;DMGDH;YWHAZ;TNPO1;RPL12;CS;STAU1;MRM1;RCAN3;MTIF2;SNRNP35;SAFB;TRAP1;CALR;ANKRD17;ZCCHC8;RARS2;UBAP2L;SRP68;DDX31;POP4;AGFG1;ANP32A;HEATR6;GNL3;IREB2;SRSF12;RPL22;RPL14;SAFB2;MRPL15;NUDT4;GTF2F1;LSM14B;COL14A1;YBX3;NSRP1;ARF1;RBM6;ELP1;ZCCHC17;MRPS14;YTHDF3;FMR1;RBM10;CCT3;PPHLN1;CPEB4;RPL11;HELZ;AKAP1;DCP1A;BAZ2A;NOLC1;SNRNP200;DXO;PATL1;NAA15;KYAT3;SETX;GSPT1;RTRAF;FLNB;CTNNA1;RBM28;PRPF31;WDR36;NOP16;BYSL;TRIM56;RPN1;LSM7;EIF1AX;EIF1;PRKDC;RBMX;MAP4;SLC4A1AP;SRP14;DDX50;RSRC2;HNRNPUL1;BAG4;RBM47;FNDC3A;RPF1;DHX29;SIDT2;POLRMT;TEP1;PRRC2C;HSPD1;MTREX;NUCKS1;DHX15;RC3H2;TCERG1;THRAP3;YWHAE;RBFOX2;ZNFX1;DDX1;ZCCHC7;RPL36A;ZNF346;TUT7;NUDT7;RPS9;SRFBP1;PRPF3;USP36;MSI1;DDX20;R3HDM1;RBM15;SPEN;CDC42EP4;RBM39;SRSF2;SPTBN1;HSP90B1;TBL2;CPNE3;PARN;GANAB;FASN;MBNL2;SON;RPL6;SRP72;TASOR;MRPS27;EFTUD2;PUF60;KDM1A;CELF5;AGO2;FARS2;SNRPB;LGALS1;MYEF2;DUS2;ETF1;KPNA2;NAP1L1;CDK13;ATP5F1A;DUSP11;HNRNPDL;POLR1G;CAST;UTP11;RBM4B;EIF4G1;ZC3H12B;ACTN1;RBMS2;SCAF11;DDX24;BZW1;NEMF;TOP3B;DHX57;LYAR;YY1;CSDE1;MAP3K20;ZC3H12A;ZRANB2;ERI3;DHX37;BMS1;FAM133B;HNRNPC;RPS27A;KRI1;YBX1;CLUH;FTSJ3;RBBP6;SCAF4;MARK2;RSL1D1;ANKHD1;DDX10;FYTTD1;USO1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.30520291191571725,-0.972180552831494,0.46494464944649444,0.8402271801525157,1.0,6/24,16.77%,GLUL;ZDHHC21;ZDHHC17;ZDHHC14;ZDHHC15;ZDHHC2
prerank,ubiquitin protein ligase binding (GO:0031625),0.3170144118960004,0.9713871294916987,0.5655241935483871,0.8961740330774487,1.0,55/254,18.40%,GLMN;POU5F1;NEK6;NKD2;MID1;JAK1;CD40;SMAD2;EGFR;IKBKE;CUL1;BCL2;AMBRA1;RALA;BAG6;SPOP;ABI2;FBXW7;ARIH1;CXCR4;SMAD5;UBE2L3;ACVR1B;UQCRC1;SNX9;YWHAZ;UBE2J1;FBXO7;CASP8;CALR;GSK3B;MC1R;UBE2K;TANK;TRAF2;SMAD3;UBE2W;EGR2;TRIB3;RPL11;WASHC1;HSPA5;TRIB1;RIPK1;PATZ1;HIF1A;SQSTM1;TRAF5;BAG4;HSPD1;YWHAE;MDM2;SLF2;NFKBIA;MFHAS1
prerank,mRNA binding (GO:0003729),0.31621277414786825,0.9691344086053527,0.5592369477911646,0.8984868311848695,1.0,36/249,14.89%,RBMS3;IGF2BP1;RBM46;RBMS1;ZFP36L1;IGF2BP2;RBFOX1;EIF4G2;SYNCRIP;EIF4G3;KHDRBS1;PUM1;CPEB1;SHFL;EIF4A1;PTBP3;CARHSP1;ACO1;FUBP1;SAMD4A;PABPC4;CELF1;NCBP2;SNRNP35;CALR;MARF1;GNL3;IREB2;LSM14B;YBX3;NSRP1;YTHDF3;FMR1;CPEB4;DCP1A;DXO
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31500972939721267,0.9690003067041376,0.5861723446893787,0.8956549787442273,1.0,65/346,16.63%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;TNFAIP3;BIRC3;CUL1;SMURF2;UBR5;TRIM21;UBR4;RNF2;CNOT4;RNF144A;ANAPC11;CDC42;SIAH2;MIB1;RNF111;KLHL13;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;UBE2L3;PELI3;TRIM44;UBE2R2;NEURL2;UBE2J1;FBXO7;RNF213;KCTD10;RNF19B;PJA2;FBXW11;RNF181;RNF149;UBE2K;TRAF2;KCMF1;MAEA;UBE2W;FBXO2;RNF11;DTX3L;RNFT2;RNF141;SMURF1;ITCH;NEDD4;TRIM56;PELI2;RBCK1;TRAIP;TRAF3IP2;TRAF5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4259689828654479,0.9678012746897707,0.5085714285714286,0.8954064113000405,1.0,3/18,9.05%,ALDH18A1;ALDH1A2;HSD17B12
prerank,microtubule motor activity (GO:0003777),0.3548078425448291,0.9676139246980917,0.522673031026253,0.8927560664149854,1.0,6/51,6.00%,KIF26B;KIFC1;KIF1C;KIF13B;KIF2A;APPBP2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.44386578589372605,0.9650722993257713,0.5089820359281437,0.8959975140758535,1.0,2/13,9.55%,DNA2;DICER1
prerank,kinase activator activity (GO:0019209),-0.28831789811479736,-0.9650086320079015,0.5313807531380753,0.8518955516668495,1.0,3/30,4.99%,PRKAG2;MALT1;MADD
prerank,exonuclease activity (GO:0004527),0.3533697156197114,0.9628354739970015,0.5237515225334958,0.8983296028479157,1.0,5/46,8.81%,ENPP1;REXO1;ERI1;DCLRE1C;EXOSC4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4516446949207356,0.9619499463658643,0.5031746031746032,0.8974708310990135,1.0,8/12,23.92%,CDK6;CDK7;MAPK1;BRD4;CDK9;CDK13;CDK12;CDK8
prerank,cation transmembrane transporter activity (GO:0008324),0.35795396788283385,0.9599961096240933,0.5400739827373613,0.8989560497537598,1.0,2/48,1.81%,SLC7A2;SLC38A3
prerank,3'-5' DNA helicase activity (GO:0043138),0.42705078253489936,0.9596769006900394,0.5238095238095238,0.8966422935421198,1.0,4/16,10.03%,ASCC3;MCM2;MCM7;FBH1
prerank,voltage-gated ion channel activity (GO:0005244),0.4337318745698726,0.9569476284192793,0.5470588235294118,0.8998055140891051,1.0,3/14,5.25%,HVCN1;PKD2;VDAC2
prerank,thioesterase binding (GO:0031996),0.45436298455261825,0.9558488548552406,0.5460218408736349,0.8992226518162789,1.0,4/11,16.63%,CDC42;TRAF2;RAC1;TRAF5
prerank,peptidase activator activity (GO:0016504),-0.317927811571066,-0.9540478322473445,0.47202797202797203,0.8736027995628523,1.0,7/22,12.72%,CAV1;MAL;APH1A;VSIR;APH1B;PCOLCE2;PINK1
prerank,methyltransferase activity (GO:0008168),0.35785521047213575,0.9519853621899383,0.5425790754257908,0.905205119835502,1.0,15/46,24.63%,ASMT;AMT;EHMT1;DNMT3B;MRM2;MGMT;COQ5;COMT;PRMT3;BCDIN3D;N6AMT1;FTSJ3;NDUFAF7;PRMT5;COQ3
prerank,acetylation-dependent protein binding (GO:0140033),0.40198911681417904,0.9509484354526713,0.5263157894736842,0.9015177148899528,1.0,6/20,19.16%,KMT2A;CARM1;BAZ2A;SMARCA4;BRD4;THAP7
prerank,lysine-acetylated histone binding (GO:0070577),0.40198911681417904,0.9509484354526713,0.5263157894736842,0.9015177148899528,1.0,6/20,19.16%,KMT2A;CARM1;BAZ2A;SMARCA4;BRD4;THAP7
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4022539664573883,0.9501591299416959,0.5301369863013699,0.9001621718626719,1.0,6/22,20.59%,DUSP2;DUSP5;DUSP6;MTMR3;MTMR2;DUSP15
prerank,histone methyltransferase binding (GO:1990226),0.45936668595314845,0.9500268892669497,0.5309446254071661,0.8974257943285089,1.0,4/11,17.86%,PHF1;LCOR;LCORL;PRDM4
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.45126349400143567,0.9485356238729972,0.5233333333333333,0.8977232101764542,1.0,1/11,3.41%,SLC25A47
prerank,myosin binding (GO:0017022),0.3481380156765905,0.9484264876346603,0.5515587529976019,0.8949473713937918,1.0,11/55,13.50%,NKD2;MLPH;CALD1;TRAK1;RALA;LLGL1;CXCR4;RAB27B;RHOA;GIPC1;RAB10
prerank,epidermal growth factor receptor binding (GO:0005154),0.38348720433459654,0.9483667458653422,0.5413839891451832,0.892139989310597,1.0,7/25,16.56%,ATXN2;EGF;GRB2;ARF4;SNX2;BTC;SNX4
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.37052236061722965,-0.9481394990523788,0.5677966101694916,0.8813468127080588,1.0,4/12,13.05%,PIK3R3;PIK3CB;PIK3R6;PIK3CD
prerank,phosphoric diester hydrolase activity (GO:0008081),0.36423885015154867,0.9473920024045878,0.5267857142857143,0.8912980590497579,1.0,9/35,15.26%,ENPP1;PLCXD3;PDIA3;PLCL1;PLD4;PLCB3;TDP2;SMPD3;SMPDL3B
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3348908735060701,-0.9461244297335085,0.4934640522875817,0.8792045459827746,1.0,3/16,8.47%,SLC25A42;SLC25A26;SLC22A4
prerank,LRR domain binding (GO:0030275),0.4370985035168411,0.9449508786745603,0.5479041916167665,0.893787825367911,1.0,4/14,19.75%,MRTFA;PAWR;ATF4;PMF1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.45876947224158304,0.9449457623442598,0.555895865237366,0.890866642592725,1.0,2/11,5.13%,ITPR1;TRPC6
prerank,SUMO binding (GO:0032183),0.4451147576226706,0.9442483611831204,0.5368421052631579,0.8894458433305382,1.0,3/13,9.90%,CASP8AP2;RNF111;USPL1
prerank,tropomyosin binding (GO:0005523),-0.34605417132508276,-0.941422806747346,0.555205047318612,0.8848969881034285,1.0,2/16,3.95%,NEBL;TMOD3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.3484287896067399,0.9410490649268268,0.5650118203309693,0.8936485534817813,1.0,10/55,16.24%,SLC7A2;SLC38A3;SLC38A4;SLC16A12;SLC36A2;SLC7A8;PDPN;ABCC1;SLC25A10;SLC16A6
prerank,cadherin binding (GO:0045296),0.30503938541846987,0.9377374821789038,0.6576032225579054,0.8980840400926179,1.0,84/315,17.95%,CDH11;MYO1B;EIF4G2;FMNL2;STAT1;GOLGA3;DNAJB1;CALD1;TNKS1BP1;EGFR;ASAP1;FSCN1;CHMP4B;MYH9;PARVA;LIMA1;BAG3;NCK1;BAIAP2;CEMIP2;DCHS1;ACVR1;ENO1;CDH6;VAPA;PTPN1;GIGYF2;ZC3H15;EPS15L1;CBL;UBFD1;EIF5;ANXA1;CCT8;LASP1;PPFIBP1;SND1;DBN1;MB21D2;CNN3;CLINT1;PLCB3;PTPRJ;SNX9;YWHAZ;CCNB2;CDH18;CDH24;RUVBL1;DBNL;PTPRM;SNX2;EPS15;NUMB;PI4KA;SNX5;KIF5B;RARS1;ABI1;PPME1;GIPC1;RPL14;RAB1A;RAB10;PCMT1;PSEN1;SRC;STK24;PHLDB2;HSPA5;CHMP2B;FLNB;CTNNA1;CDC42EP1;EXOC3;LYPLA2;SH3GLB1;DHX29;CSNK1D;YWHAE;CTTN;CKAP5;PICALM;CAPZA1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3992646605766563,0.936138373098343,0.5803183791606368,0.8957797200691022,1.0,10/21,23.92%,CDK6;CDK14;CDK10;CDK7;CDKL1;CDK9;CDK13;CDK12;CDK11B;CDK8
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3992646605766563,0.936138373098343,0.5803183791606368,0.8957797200691022,1.0,10/21,23.92%,CDK6;CDK14;CDK10;CDK7;CDKL1;CDK9;CDK13;CDK12;CDK11B;CDK8
prerank,histone acetyltransferase activity (GO:0004402),0.3742235470884204,0.9358172636331773,0.5621761658031088,0.8935508699201873,1.0,10/30,21.43%,BAZ1A;NAA50;CREBBP;EPC2;USP22;SRCAP;CLOCK;KAT6B;KAT7;TADA3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3655631049788812,0.935123297832382,0.5339925834363412,0.8921759738793276,1.0,10/38,14.72%,GAB2;LRRK2;IRS1;NCK1;NCK2;SH2B2;FRS2;PIK3R1;DLG5;MMS19
prerank,glucose transmembrane transporter activity (GO:0005355),-0.3246915899856014,-0.9346616093429196,0.5486111111111112,0.8952160368695531,1.0,3/17,19.98%,SLC2A1;SLC5A3;SLC2A8
prerank,pyridoxal phosphate binding (GO:0030170),-0.31698125532253196,-0.9338470157729692,0.543859649122807,0.8901767821150325,1.0,8/20,19.46%,ABAT;PYGM;PLPBP;PYGB;ACCS;PDXK;PSAT1;CBS
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.36962947052798484,-0.9285371293174534,0.5314285714285715,0.8964422614697463,1.0,8/11,52.87%,HCN1;CNGB1;HCN4;CNGB3;AQP1;CNGA2;CNGA4;CNGA3
prerank,ligand-gated calcium channel activity (GO:0099604),0.39878985589862703,0.9285089621822655,0.5590230664857531,0.9037439750545413,1.0,2/19,4.84%,RASA3;ITPR1
prerank,GTPase binding (GO:0051020),0.3043775267067398,0.9273176874216366,0.6394279877425945,0.9034167830912222,1.0,50/195,18.76%,ABCA1;MLPH;LRRK2;MYCBP2;STOML2;RAPGEF4;AMBRA1;FGD4;MYO5A;ENO1;RABGAP1L;UNC13D;EXOC4;ABI2;AIMP1;MAPKAP1;GOLGA5;CHML;RRAGC;LCP1;RABGAP1;TRIP11;RAB3GAP2;ANKFY1;BRK1;PIH1D2;FGD6;PDE6D;AKAP13;SPHK2;RAB3GAP1;ANKRD27;YBX3;RAB34;ATG16L1;RANBP9;RTKN;RABGGTB;EXOC5;ALS2;RCC1;RASA1;CCDC186;GNB2;TBC1D20;PICALM;CDC42EP4;GNB1;EPS8;SPTBN1
prerank,filamin binding (GO:0031005),-0.36615191595737234,-0.9255494192803286,0.5638888888888889,0.8970684817731345,1.0,1/11,0.02%,NEBL
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4513336817257836,0.9246804224591234,0.5714285714285714,0.906271758388109,1.0,2/10,14.25%,CDKN2B;CDKN1B
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.4443211875844874,0.923933220769579,0.5537313432835821,0.9049962783002746,1.0,4/12,23.10%,OPN1MW;OPN1MW3;GPR88;RRH
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3772467958681723,0.923665292768843,0.570855614973262,0.9026497395654469,1.0,10/25,20.47%,GAB2;SESTD1;DAPP1;MAPKAP1;KIF16B;PLA2G4E;PLEK;AKT1;PLEKHA2;ZFYVE1
prerank,C-C chemokine receptor activity (GO:0016493),0.40554562166287966,0.9221331128452342,0.579750346740638,0.9029464903995532,1.0,2/21,9.00%,CCR1;CXCR4
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.23540880552597054,-0.9217121395511642,0.6589147286821705,0.8997025896516635,1.0,7/55,5.30%,SLC24A2;CACNB2;ITPR2;TMEM165;ATP2B4;ATP2B2;TMCO1
prerank,proton transmembrane transporter activity (GO:0015078),0.3492062906594914,0.9205591934324321,0.572139303482587,0.9032945546253479,1.0,7/39,11.33%,SLC9A1;SLC11A2;CLCN5;COX7A2L;DMAC2L;UQCRC1;ATP6V1F
prerank,G protein-coupled receptor binding (GO:0001664),0.3139566580867264,0.9181543504107722,0.6468129571577848,0.9053573049286568,1.0,13/132,10.99%,WNT2;CXCL12;XCL1;WNT9A;ADM;CCL5;FZD1;SFRP1;LRP6;S1PR2;WNT5A;ARHGEF12;GNAI1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.38957328251292583,0.9166314022410592,0.5986301369863014,0.9056134906091203,1.0,5/20,12.34%,CASK;DTYMK;GUK1;AK2;AK8
prerank,deoxyribonuclease activity (GO:0004536),-0.3433758633570779,-0.9164871060900017,0.5621301775147929,0.9057321688539528,1.0,3/14,7.93%,ERCC5;MRE11;APLF
prerank,single-stranded RNA binding (GO:0003727),-0.25197169932666635,-0.9158688259495499,0.6598984771573604,0.900384348815077,1.0,15/43,22.00%,STRBP;HNRNPU;AQR;U2AF2;ADARB2;SNRPC;HNRNPA1;SRA1;POLR2G;EIF4H;CNBP;FXR1;IFIH1;AGO3;EXOSC10
prerank,calcium:sodium antiporter activity (GO:0005432),-0.37468989568957467,-0.9149279613566784,0.5487179487179488,0.8961389542110993,1.0,4/10,19.38%,SLC24A2;SLC8A3;SLC8B1;SLC8A2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.4193365413547411,0.9146199140896007,0.5838150289017341,0.9070123789292807,1.0,2/14,2.54%,FETUB;TIMP1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.3881419453605792,0.9143221930307008,0.5862068965517241,0.9047381976171293,1.0,4/21,15.69%,FGF7;FRS2;FGF2;FGF18
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.39532787068017894,0.9141507067958704,0.5794655414908579,0.9022744582415453,1.0,7/18,20.69%,ACVR1;TGFBR1;LTBP1;ACVR1B;ACVR2A;ACVRL1;BMPR1A
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.36844817229075866,-0.9141241086029532,0.5785340314136126,0.891481393332075,1.0,3/11,11.11%,SRRM2;LEF1;GATA2
prerank,tRNA methyltransferase activity (GO:0008175),-0.32712195123494414,-0.9132856243017609,0.5841584158415841,0.8868758499720328,1.0,8/16,27.66%,ALKBH8;TRMT9B;TRDMT1;LCMT2;TRMT5;TRMT44;TYW3;TRMT12
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.39125155147067225,0.9122705094211853,0.6050420168067226,0.9031400867226368,1.0,2/21,3.43%,PDE3A;PDE7B
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3073995704304996,0.9121113529442039,0.656282450674974,0.900731052578311,1.0,38/147,16.62%,FARP2;VAV2;FARP1;MYCBP2;VAV3;RAPGEF4;CYTH3;KALRN;ITSN1;DOCK1;ARFGEF2;RABIF;NUCB2;FGD4;EGF;DENND4C;RAB3GAP2;PREX1;FNIP1;DENND5A;FGD6;RASGEF1B;VAV1;RIN2;IQSEC2;AKAP13;SMCR8;SH3BP5L;RAB3GAP1;ANKRD27;ARHGEF18;DNMBP;ALS2;RCC1;RGL1;EIF2B3;DOCK2;LAMTOR5
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3837525295975115,0.9059060183349201,0.6194444444444445,0.9103655267768036,1.0,2/23,3.43%,PDE3A;PDE7B
prerank,clathrin adaptor activity (GO:0035615),0.41298890684536044,0.9055256285130813,0.60932944606414,0.9083370145238213,1.0,1/15,0.76%,STON2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3256732070117311,-0.9031194511305469,0.6191950464396285,0.8969537214542765,1.0,9/16,37.28%,ATP6V1B2;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP6V0A4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3256732070117311,-0.9031194511305469,0.6191950464396285,0.8969537214542765,1.0,9/16,37.28%,ATP6V1B2;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP6V0A4
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3300025782912138,0.9028983416574449,0.6187717265353418,0.9106831854453635,1.0,20/60,22.74%,LRRK2;PTEN;CTDSPL2;LRRK1;LRRC39;PPP3CA;PPP1CB;ILKAP;PPP4C;CDC14A;TIMM50;PPP6C;PHLPP2;MTMR3;RPAP2;MTMR6;CDC14B;LRRC40;PPM1H;PPM1D
prerank,GTP binding (GO:0005525),0.2978412113984993,0.8995705788553013,0.6829765545361876,0.9145200569465172,1.0,29/172,15.00%,RND3;RHOJ;LRRK2;RAB2A;TUBG1;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;ARF4;GNAI1;RIT1;RHOA;GNL3;RAB10;ARF1;RAC1;ANXA6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.31371208639156617,0.8993708243090828,0.6198439241917503,0.9121728196392025,1.0,18/75,21.13%,EHHADH;DHRS4;AKR1A1;RDH12;RDH10;HSD17B8;KCNAB1;H6PD;GLYR1;UGDH;DHDH;ADH1A;SORD;IMPDH2;DHRS3;DCXR;ADH5;HIBADH
prerank,sequence-specific mRNA binding (GO:1990825),0.44713320189681494,0.8986031180918043,0.6074313408723748,0.9108360121817154,1.0,4/10,24.51%,SHFL;FMR1;ETF1;TYMS
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4156125599729448,0.8984208165626224,0.6066066066066066,0.9084460177809784,1.0,2/13,5.33%,PIP5K1B;PIP4K2A
prerank,antiporter activity (GO:0015297),0.38745800440239603,0.8971774223163317,0.5836791147994468,0.9081186973064292,1.0,7/20,23.97%,SLC25A16;SLC35C1;TMEM241;SLC35D2;SLC25A10;CLCN4;SLC35E3
prerank,protein phosphatase 2A binding (GO:0051721),0.3692185878380297,0.8963560077232353,0.6159029649595688,0.9069466138100593,1.0,8/23,20.13%,SMG7;STRN;PPME1;CTTNBP2NL;PTPA;ANKLE2;MFHAS1;STRN4
prerank,protein kinase regulator activity (GO:0019887),0.3092186674045548,0.895622692116986,0.6666666666666666,0.9056889538217107,1.0,28/95,22.63%,CCNE2;PARVA;NCK1;CCNL1;CCND3;CXCL10;TAOK3;GSKIP;RPTOR;PRKAR1B;TPX2;CCNB2;GMFB;FGF13;CCNI;SMCR8;SH3BP5L;CDKN1B;TRIB1;CCNT1;DNAJC3;MAPK8IP1;CCNL2;DUS2;SPRY4;MARK2;RGCC;CCNH
prerank,vitamin D receptor binding (GO:0042809),0.4085806771182708,0.8930542504490047,0.5988200589970502,0.9080460097458724,1.0,6/14,22.53%,TAF7;MED13;THRAP3;MED12;MED1;MED14
prerank,microtubule binding (GO:0008017),0.29008147250273886,0.8915414108727763,0.7155870445344129,0.9083789372198363,1.0,47/222,17.93%,KIF26B;MID1;KIFC1;MAP4K4;CEP295NL;LRRK2;EML4;CCDC170;NAV3;KIF1C;MAP1S;KIF13B;KIF2A;HOOK2;RAE1;ALMS1;PLK1;VAPA;MAST2;EML3;FAM161A;TPGS1;TPX2;GAPDH;MAPRE2;CFAP157;MACO1;FMN1;CAMSAP2;FBXW11;FGF13;KIF5B;RMDN2;KIF16B;KIF27;FMR1;TUBGCP4;NDEL1;TOGARAM1;MAP4;FSD1;KIF5A;KIF9;TPPP;KIF20A;CKAP5;CLIP3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3783586928424385,0.8888237209323965,0.6152796725784447,0.9109671159536824,1.0,5/22,16.50%,TNFAIP3;IKBKE;RNF169;SQSTM1;ATRIP
prerank,ion gated channel activity (GO:0022839),0.36397614616146556,0.8884895537877455,0.6062176165803109,0.9089031063222722,1.0,6/24,20.68%,KCNT2;TRPM4;ANO10;TTYH1;ANO6;TMEM63B
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3408733503269345,-0.8870194138521407,0.6165644171779141,0.9289670249843529,1.0,3/13,14.31%,LPCAT2;AGPAT3;GPAT4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3226562705233798,-0.8863154047090506,0.5868852459016394,0.9239684738603375,1.0,1/16,0.62%,PIR
prerank,kinase activity (GO:0016301),0.30205343091537484,0.8859669745531784,0.6978723404255319,0.9110489861940698,1.0,24/109,17.14%,MAP4K4;PAPSS2;TAOK1;LRRK2;DCAKD;MVK;ITPKC;DGKH;FN3KRP;ADPGK;CSNK2A1;IP6K2;PANK2;GK;COQ8B;GSK3B;PI4KA;SPHK2;TRIB3;COASY;PANK1;NADK;PIK3C3;AKT1
prerank,pyrophosphatase activity (GO:0016462),0.33130040443911735,0.8856349944386195,0.651497005988024,0.9090436498462676,1.0,10/50,17.85%,ENPP1;PPA1;DCP2;ENTPD7;NUDT14;NUDT4;ENTPD6;DXO;DHX29;NUDT7
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.312106893521664,0.8843194036461087,0.6463276836158192,0.9087066911627779,1.0,10/72,10.66%,SVIL;MYO1B;SLC9A1;MARK1;SESTD1;TIRAP;MAPKAP1;SNX18;EXOC1;VILL
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3530842589723633,0.883909877489206,0.6377749029754204,0.9067526957552994,1.0,11/27,23.22%,TERT;CRCP;POLR3A;POLR1B;POLRMT;POLR2L;POLR3K;POLR1D;MED21;POLR1A;POLR2D
prerank,endopeptidase activator activity (GO:0061133),-0.36793502310318393,-0.8838030568820088,0.6035353535353535,0.9227783010869748,1.0,5/10,25.22%,APH1A;VSIR;APH1B;PSME1;ADRM1
prerank,aspartic-type peptidase activity (GO:0070001),0.42584722382453966,0.8833604537458248,0.6192733017377567,0.9051951661472801,1.0,2/10,13.92%,CTSD;PSEN1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.35749011667561265,0.8796471932019908,0.6316489361702128,0.9092436022342621,1.0,12/27,24.09%,RNF144A;SIAH2;DCUN1D1;ARIH1;RNF19B;ZMYM2;ARIH2;DCUN1D5;RNF14;UBE3D;RNF144B;RNF217
prerank,gap junction channel activity (GO:0005243),0.3675758981868408,0.878937453228174,0.6253443526170799,0.907888835642079,1.0,3/22,7.90%,GJC2;GJD3;GJC1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.24023855900869123,-0.8776079516376257,0.7092198581560284,0.9305068986029533,1.0,8/49,8.42%,ANXA3;C2CD5;MCTP1;ESYT2;PCLO;ESYT1;DYSF;SYT7
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.35919646698727214,0.8755939709797972,0.6169630642954856,0.9115244462932356,1.0,4/24,12.34%,ITPKC;DTYMK;IP6K2;AK8
prerank,N-methyltransferase activity (GO:0008170),-0.2993721576715156,-0.8746389469633085,0.6131386861313869,0.9308421039136462,1.0,7/20,18.35%,ZCCHC4;TRMT1L;HNMT;TFB1M;PRMT1;DIMT1;NNMT
prerank,wide pore channel activity (GO:0022829),0.3631930698335547,0.8732016873910065,0.6287671232876713,0.9131167944925543,1.0,3/23,7.90%,GJC2;GJD3;GJC1
prerank,histone deacetylase binding (GO:0042826),0.304034701192133,0.8712657122910654,0.7116630669546437,0.9140969333862629,1.0,22/88,19.93%,NCOR2;GLI3;SATB2;KCTD21;MIER2;USF1;ZMYND15;HDAC1;PRDM1;MTA2;TOP2B;LCOR;SPI1;DACT1;NIPBL;MTA3;YWHAE;RAD9A;HDAC5;BRMS1L;THAP7;KPNA2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.39792183021564065,0.8673127911936456,0.6275071633237822,0.9186610454084178,1.0,2/14,3.82%,CRYM;MTHFR
prerank,small GTPase binding (GO:0031267),0.2860503810613501,0.8662637725995904,0.7471736896197327,0.9178743575478916,1.0,36/170,16.92%,ABCA1;MLPH;LRRK2;MYCBP2;RAPGEF4;FGD4;MYO5A;RABGAP1L;UNC13D;EXOC4;ABI2;MAPKAP1;GOLGA5;CHML;RABGAP1;TRIP11;RAB3GAP2;ANKFY1;BRK1;PIH1D2;FGD6;PDE6D;AKAP13;SPHK2;RAB3GAP1;ANKRD27;YBX3;RAB34;RANBP9;RTKN;RABGGTB;EXOC5;ALS2;RCC1;CCDC186;TBC1D20
prerank,peptide hormone receptor binding (GO:0051428),-0.35047703277376274,-0.8639143916636758,0.6246498599439776,0.9492124882287469,1.0,8/11,55.71%,PTHLH;ADCYAP1;CCK;GNRH1;PSMC5;UCN2;GPHB5;GHRH
prerank,tau protein binding (GO:0048156),0.32070823392994785,0.85961222519911,0.6600496277915633,0.9275888920707999,1.0,4/40,3.78%,TAOK1;SMAD2;MARK1;APOE
prerank,nucleoside-triphosphatase activity (GO:0017111),0.27948634738490047,0.8593233070800171,0.7961654894046418,0.9254477503874594,1.0,48/248,17.54%,RND3;RHOJ;LRRK2;DNA2;RAB2A;KIF1C;MYH9;KIF2A;NUGGC;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;GNAI1;RIT1;RUVBL1;RNF213;ATP2B1;RHOA;RASD2;ENTPD7;ABCG4;RAB1A;DYNC2H1;GNAS;MYO1E;RAC1;GSPT1;RHOF;GPR88;GNB2;DHX29;GNA12;KIF5A;TPPP;RAB33B
prerank,ribonuclease activity (GO:0004540),0.31170431259045017,0.8548836581154337,0.6882966396292005,0.9306027133528159,1.0,18/56,24.18%,ERN2;RNASE7;SMG6;EXOSC4;RNASEH1;DICER1;SND1;RNASEH2A;RNASE1;RNASE12;AGO2;ZC3H12B;ZC3H12A;EXOSC5;RNASE3;RNASEL;CPSF3;AGO1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3280132921161678,-0.8546382096901771,0.6610169491525424,0.9642023113097492,1.0,2/12,7.53%,ENTPD1;SLC25A42
prerank,FAD binding (GO:0071949),0.3531539495217013,0.8545466798194413,0.6789617486338798,0.9286371948128299,1.0,2/24,3.82%,STEAP4;MTHFR
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.35578075549596155,0.8534588410979823,0.6502890173410405,0.927852058233581,1.0,6/21,14.67%,ARFGEF2;GSKIP;ACBD3;PJA2;AKAP9;AKAP1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.30326850431631414,-0.8523430028962117,0.6517571884984026,0.9627170712910182,1.0,4/15,11.57%,ALDH1A1;ALDH4A1;ALDH2;ALDH9A1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4176774430940078,0.8518924505578143,0.65086887835703,0.9278925822200215,1.0,2/10,15.11%,NAA50;NAA15
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3032315812895433,-0.8481770526423621,0.6788990825688074,0.9650282123695502,1.0,7/16,30.63%,MACROD2;CD38;SMUG1;SARM1;ADPRS;NEIL3;NTHL1
prerank,potassium ion antiporter activity (GO:0022821),0.38229816998249166,0.8468039532958926,0.6546003016591252,0.933776035238889,1.0,3/15,7.91%,SLC9A1;SLC24A5;SLC9A8
prerank,mannosyltransferase activity (GO:0000030),-0.2836162480383432,-0.8459208292658054,0.6942446043165468,0.9635094809558494,1.0,6/21,25.84%,TMTC1;PIGB;PIGZ;ALG1;PIGM;ALG12
prerank,solute:sodium symporter activity (GO:0015370),0.3463602653264108,0.8457839228147976,0.6614785992217899,0.9329884022390912,1.0,4/27,10.22%,SLC28A2;SLC20A1;SLC13A5;SLC4A7
prerank,store-operated calcium channel activity (GO:0015279),0.41303271157139654,0.8450322780866121,0.6530944625407166,0.9316647770492825,1.0,3/10,19.46%,TRPC6;ORAI1;STIM2
prerank,C-C chemokine binding (GO:0019957),0.3658684642710103,0.8448412019094225,0.6639344262295082,0.9294269306879693,1.0,2/22,9.00%,CCR1;CXCR4
prerank,potassium:proton antiporter activity (GO:0015386),0.4089187223214509,0.8435738884749369,0.6714060031595577,0.9289459476170625,1.0,2/10,7.91%,SLC9A1;SLC9A8
prerank,chemokine binding (GO:0019956),0.34472965177187537,0.8417744825204198,0.6818181818181818,0.9296170789656342,1.0,4/30,12.48%,CCR1;CXCR4;PDPN;FGF2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3444498035999082,0.8404966771862178,0.6630581867388363,0.92917951938018,1.0,7/24,16.10%,SESTD1;OSBPL5;PLEKHF1;PLA2G4A;PLEKHA5;PLA2G4E;RUBCNL
prerank,endoribonuclease activity (GO:0004521),0.3357921363965974,0.8404811142878483,0.6758793969849246,0.9266613755489855,1.0,11/32,24.18%,ERN2;SMG6;DICER1;SND1;AGO2;ZC3H12B;ZC3H12A;ENDOV;RNASEL;CPSF3;AGO1
prerank,5'-3' exonuclease activity (GO:0008409),0.37860344474161545,0.8402730480835884,0.6627906976744186,0.9244984636537528,1.0,4/14,14.89%,DCLRE1C;DCP2;XRN1;DXO
prerank,lysophospholipase activity (GO:0004622),0.3546761769109697,0.8387705278657986,0.6532593619972261,0.9244292045179865,1.0,6/20,19.58%,ASPG;ABHD16A;LYPLAL1;PLA2G4A;LYPLA2;GDPD3
prerank,GTPase activity (GO:0003924),0.2749509221841355,0.8387056510841707,0.7987742594484167,0.9220746517119144,1.0,35/192,17.54%,RND3;RHOJ;LRRK2;RAB2A;NUGGC;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;GNAI1;RIT1;RHOA;RASD2;ENTPD7;RAB1A;GNAS;RAC1;GSPT1;RHOF;GNB2;GNA12;TPPP;RAB33B
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3531805592324759,0.8380116002223519,0.6680790960451978,0.9207566872384223,1.0,4/21,15.53%,POLE3;POLI;REV1;POLG
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.32404408646240973,0.8327235245318784,0.7089084065244667,0.9269161234280228,1.0,14/37,24.03%,YARS1;CARS2;IARS2;TARS1;RARS2;RARS1;EARS2;GARS1;LARS2;NARS2;FARS2;NARS1;CARS1;DARS1
prerank,phosphatidylglycerol binding (GO:1901611),0.38576299654083923,0.8323557824509376,0.6713178294573643,0.9250323873835685,1.0,2/13,4.28%,STOML2;PLTP
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.345811190970555,-0.831750915368221,0.6794520547945205,0.9868070011008834,1.0,6/10,20.16%,ATXN3;STAMBP;DESI2;CYLD;YOD1;OTUD4
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4146041378259246,0.8315574763565571,0.68125,0.9238560474093918,1.0,1/10,2.07%,B4GALT5
prerank,titin binding (GO:0031432),-0.3148157893468421,-0.8301562451095424,0.6870967741935484,0.9837436844297908,1.0,2/13,2.77%,ACTN2;CALM1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.2918282810590378,-0.8293865204319957,0.7109634551495017,0.9786757099430496,1.0,3/16,11.25%,SLC13A3;SLC1A1;SLC25A12
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3308701243054306,0.8284988965081782,0.7027027027027027,0.9261253587611271,1.0,5/28,12.47%,POP1;RNASEH1;DICER1;RNASEH2A;POP4
prerank,FMN binding (GO:0010181),-0.3381858604492902,-0.8284307635224478,0.6780626780626781,0.9738394426444742,1.0,2/11,3.09%,NOS3;PPCDC
prerank,GABA receptor binding (GO:0050811),0.39071699075022354,0.8277369036213756,0.67601246105919,0.9248845281153387,1.0,2/11,4.47%,TRAK1;ARFGEF2
prerank,P-type ion transporter activity (GO:0015662),-0.32196865028877264,-0.8268815184072317,0.6894586894586895,0.970550185094731,1.0,4/12,14.73%,ATP2B4;ATP2B2;ATP2A3;ATP6V1E1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3769824121838281,0.8262288767076358,0.6875934230194319,0.9248031844327578,1.0,4/14,13.10%,ACO1;ACO2;SDHB;IREB2
prerank,insulin-like growth factor receptor binding (GO:0005159),0.3855352272998034,0.8253718478274132,0.6734992679355783,0.9237749133808569,1.0,3/12,14.17%,IRS1;PIK3R1;GNAS
prerank,ribonuclease P RNA binding (GO:0033204),0.3969161416226107,0.8241389826204555,0.6677316293929713,0.9232083046496128,1.0,2/10,12.47%,POP1;POP4
prerank,methyl-CpG binding (GO:0008327),0.35135055495962564,0.823661211609268,0.6953551912568307,0.9214984384538374,1.0,8/22,23.63%,MBD2;MBD1;ZBTB38;CXXC5;LRWD1;MBD3;ZBTB33;PRMT5
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3857228141894996,0.82257658212497,0.7023809523809523,0.9207300116239941,1.0,7/14,19.90%,PTEN;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3152016086432366,-0.8223658625426687,0.6786786786786787,0.9733204042470992,1.0,4/12,23.13%,CNOT8;CNOT6L;TOE1;NOCT
prerank,phosphatidic acid binding (GO:0070300),0.35044457954480773,0.8216736946856493,0.6845827439886846,0.9197702211240055,1.0,4/19,7.85%,MARK1;PLTP;SESTD1;MAPKAP1
prerank,TBP-class protein binding (GO:0017025),-0.2727545797420543,-0.8215742748705355,0.7181208053691275,0.9684224011963113,1.0,5/21,10.20%,ESR1;PSMC1;DR1;TAF13;GTF2A2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2562522412254384,-0.8208583367501512,0.7665198237885462,0.9636565247043962,1.0,9/27,19.38%,SLC9A2;SLC8A3;SLC9B2;SLC4A8;SLC9A6;SLC9A7;SLC8B1;SLC9A5;SLC8A2
prerank,ATP hydrolysis activity (GO:0140603),-0.2318410306778605,-0.8186371732863271,0.8368421052631579,0.9617961276014727,1.0,10/41,16.01%,HSP90AA1;SMCHD1;ABCA4;VWA8;MYO18A;ABCA3;CHD1L;KIF26A;ABCB10;TOR1A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.30554514595059756,-0.8136396956117393,0.7099697885196374,0.9653781144633061,1.0,4/13,11.57%,ALDH1A1;ALDH4A1;ALDH2;ALDH9A1
prerank,guanyl ribonucleotide binding (GO:0032561),0.26682802413475626,0.8094468043243137,0.8355329949238579,0.936029554148772,1.0,31/196,15.00%,RND3;RHOJ;LRRK2;RAB2A;TUBG1;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;PDE5A;RAB9A;RAB32;RAB27B;GBP7;RERG;ARF4;GNAI1;RIT1;RHOA;GNL3;RAB10;ARF1;RAC1;ANXA6
prerank,tubulin binding (GO:0015631),0.26291869458204037,0.8089061618652692,0.8892245720040282,0.9344320141066355,1.0,60/295,19.51%,KIF26B;MID1;KIFC1;DLEC1;MAP4K4;TAOK1;CEP295NL;LRRK2;EML4;CCDC170;NAV3;KIF1C;MAP1S;KIF13B;KIF2A;HOOK2;INO80;RAE1;ALMS1;NCALD;PLK1;VAPA;MAST2;RABGAP1;EML3;FAM161A;TPGS1;TPX2;SETD2;GAPDH;MAPRE2;IFT81;CFAP157;AGTPBP1;MACO1;FMN1;FGF13;KIF5B;RMDN2;KIF16B;KIF27;FMR1;WASHC1;TUBGCP4;NDEL1;TOGARAM1;MAP4;FSD1;KIF5A;KIF9;TPPP;KIF20A;CKAP5;CLIP3;BCAS3;HAUS6;PRNP;TBCEL;CAMSAP1;HOOK1
prerank,MHC protein binding (GO:0042287),-0.2651258772537007,-0.8049701461459422,0.7491166077738516,0.9752169850497193,1.0,5/20,28.95%,CD81;DERL1;TUBB4B;ABCB9;LAG3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.39293680571908995,0.8045462786364466,0.7125193199381762,0.9386981855071008,1.0,2/11,15.11%,NAA50;NAA15
prerank,calcium channel activity (GO:0005262),0.2829796519921649,0.8037634894971912,0.7814207650273224,0.9374471367863265,1.0,15/84,17.18%,CACNA1A;CACNA2D1;CACNA1C;CACNB1;PKD2;TRPC6;SLC24A5;TPCN2;SEC61A1;PSEN1;CATSPER3;TRPM4;ANXA6;PKD1L3;ORAI1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3114236917140362,0.8015063862894384,0.7363057324840764,0.9385096423720932,1.0,15/33,26.67%,RNF144A;SIAH2;DCUN1D1;ARIH1;RNF19B;TCERG1;ZMYM2;ARIH2;DCUN1D5;RNF14;UBE3D;RNF144B;RNF217;PPARA;RPS3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.390160611428532,0.7992987613316551,0.6944444444444444,0.9395082160646802,1.0,2/10,11.05%,SLC10A6;SLC10A1
prerank,phospholipase binding (GO:0043274),-0.30305456881541487,-0.7984870287924521,0.7347560975609756,0.9809986220412431,1.0,4/13,18.52%,PRKN;BLNK;DGKQ;SYK
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.32259143365359966,0.7951462339209249,0.7232375979112271,0.9433724391218369,1.0,7/29,14.25%,SPRED1;CDKN2B;SPRED2;RPTOR;PRKAR1B;SPRY2;CDKN1B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.3270311655381781,-0.794587310501242,0.7378378378378379,0.9817746599843107,1.0,3/10,13.05%,PIK3R3;PIK3CB;PIK3CD
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.33082348859464894,0.7932711425747642,0.7305061559507524,0.943626622486021,1.0,4/23,10.87%,EDNRA;CCR1;CCL5;PLCB3
prerank,ankyrin binding (GO:0030506),0.34337756906106576,0.7922929218276852,0.7396694214876033,0.9427462544645352,1.0,5/19,22.84%,FLNC;PTPRC;SPTBN1;SPTBN4;PLEC
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.38431809123467475,0.791846413243275,0.6990740740740741,0.9386070346485448,1.0,3/11,16.70%,BAG3;HSPH1;BAG4
prerank,adenyl nucleotide binding (GO:0030554),0.38431809123467475,0.791846413243275,0.6990740740740741,0.9386070346485448,1.0,3/11,16.70%,BAG3;HSPH1;BAG4
prerank,ATPase regulator activity (GO:0060590),0.3041905201157896,0.7866550744763283,0.7515923566878981,0.9438175452886423,1.0,9/38,18.43%,DNAJC1;DNAJB1;BAG3;FNIP1;DNAJB6;HSPH1;TOR1AIP2;BAG4;TOR1AIP1
prerank,calcium channel regulator activity (GO:0005246),-0.22853625845283948,-0.7864845249631517,0.8366336633663366,0.9903373717160167,1.0,8/37,15.15%,NRXN1;CALM1;NRXN2;MCUB;CACNG7;PACSIN3;STIM1;FKBP1A
prerank,death receptor binding (GO:0005123),0.35380599694596027,0.7859266730483706,0.7445255474452555,0.942512719027232,1.0,3/15,15.12%,CASP8AP2;EDA;RIPK1
prerank,protein phosphatase 1 binding (GO:0008157),0.33259872043019384,0.7843039386728083,0.7489239598278336,0.9424574599247212,1.0,3/21,13.49%,PPP1R9B;PPP1R16A;AKAP11
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.33925999862038736,0.7838854835707126,0.7403708987161198,0.9406795799508733,1.0,2/18,8.79%,HSD17B8;HSD11B1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3227371243977842,-0.7832485882738854,0.7677053824362606,0.9897641490601442,1.0,8/11,54.73%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3029617753209767,0.7831091986319747,0.7437908496732026,0.9392477222178103,1.0,7/32,12.31%,TMLHE;FTO;ALKBH5;HSPBAP1;ALKBH1;TET2;KDM2A
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.27892503918809775,-0.7826835396219337,0.7508417508417509,0.9783750223615949,1.0,8/16,33.23%,ANO3;ANO4;TTYH2;ANO1;ANO8;ANO2;ANO5;NMUR2
prerank,intracellular chloride channel activity (GO:0061778),-0.27892503918809775,-0.7826835396219337,0.7508417508417509,0.9783750223615949,1.0,8/16,33.23%,ANO3;ANO4;TTYH2;ANO1;ANO8;ANO2;ANO5;NMUR2
prerank,protein kinase activator activity (GO:0030295),0.28320183177960495,0.7804156834032161,0.8018648018648019,0.9406880224907145,1.0,13/60,16.20%,TAOK1;RICTOR;FAM20A;RPTOR;MAP2K1;TPX2;DBF4;SPRY2;FGF13;ABI1;CALM2;ALS2;STK4
prerank,myosin V binding (GO:0031489),-0.2851274000911382,-0.778473437366984,0.7613636363636364,0.979793930040761,1.0,6/15,25.01%,RAB3C;RAB11B;RAB14;RAB39B;RAB3D;RAB3B
prerank,5'-nucleotidase activity (GO:0008253),-0.29548272717675117,-0.7779933258820055,0.8023598820058997,0.9747439570611253,1.0,5/13,21.28%,NT5E;NT5DC3;NT5C3A;NT5C;NT5C3B
prerank,transaminase activity (GO:0008483),-0.31474229672000986,-0.7776166829178093,0.7472527472527473,0.969422886201493,1.0,2/11,16.37%,ABAT;PSAT1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.32801882233135204,0.7760687101363398,0.7270194986072424,0.9446104442314982,1.0,3/20,7.16%,USP9X;OTULINL;EIF3H
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3141508209334521,0.7751508756513108,0.7383177570093458,0.9435493744315427,1.0,4/28,9.84%,LRRK2;MAP2K4;MAP2K1;RPS6KB1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.25890389579419126,-0.7743720374358584,0.8081180811808119,0.9690516570684194,1.0,12/22,37.28%,ATP6V1B2;ATP2A3;ATP6V1E1;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP2C2;ATP6V0A4
prerank,RNA methyltransferase activity (GO:0008173),-0.26371193532359966,-0.7737905687539746,0.7727272727272727,0.9643302666458756,1.0,8/19,28.82%,TRMT9B;TRDMT1;METTL4;LCMT2;TRMT5;TYW3;TRMT12;FBL
prerank,voltage-gated cation channel activity (GO:0022843),0.2704248071178719,0.7720324725985079,0.8483870967741935,0.9457460300400782,1.0,8/97,5.01%,CACNA1A;HVCN1;CACNA2D1;CACNA1C;CACNB1;KCNF1;KCNA5;PKD2
prerank,GTPase inhibitor activity (GO:0005095),-0.298575582039398,-0.7718467918262941,0.7854984894259819,0.9616071671751841,1.0,5/13,23.38%,CDC42SE1;GPS2;SLIT2;RHOH;ARL2
prerank,ribonuclease P activity (GO:0004526),0.3672981504840833,0.7679793932312109,0.7380952380952381,0.9491038461249135,1.0,2/11,12.47%,POP1;POP4
prerank,RNA stem-loop binding (GO:0035613),0.362171591588862,0.7678131745955268,0.7477064220183486,0.9469615406202102,1.0,5/12,21.08%,METTL16;FMR1;RC3H2;CSDE1;ZC3H12A
prerank,histone deacetylase activity (GO:0004407),-0.26442701114440326,-0.7645176390903756,0.8506493506493507,0.9675710795779408,1.0,3/19,5.69%,HDAC4;HDAC9;SUDS3
prerank,telomeric DNA binding (GO:0042162),0.2987978032705363,0.7628366273598293,0.7661188369152971,0.9514846724404485,1.0,13/32,25.79%,SMG7;ZBTB48;TERT;SMG6;CTC1;KDM1A;TELO2;TERF1;RPA1;SMG5;TERF2IP;TERF2;HNRNPA2B1
prerank,nucleotidase activity (GO:0008252),-0.27484436616573593,-0.7604170825835813,0.815625,0.9681997807342616,1.0,5/15,21.28%,NT5E;NT5DC3;NT5C3A;NT5C;NT5C3B
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.35515569064011304,0.7583975151765814,0.7629179331306991,0.9554014375085125,1.0,6/12,23.91%,ACVR1;TGFBR1;LTBP1;ACVRL1;BMPR1A;BMPR2
prerank,symporter activity (GO:0015293),0.37523979231083493,0.7579885435904107,0.7397708674304418,0.9536192183835243,1.0,1/10,3.05%,SLC28A2
prerank,sodium:proton antiporter activity (GO:0015385),0.361930357557565,0.7578663079113629,0.7753510140405616,0.9514590886380734,1.0,2/11,7.91%,SLC9A1;SLC9A8
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3321050265052147,0.7578181757733387,0.7584683357879234,0.9491802042831851,1.0,5/18,15.64%,BAIAP2;ANXA1;CNN3;RAB10;CDC42EP1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.29599674623349037,-0.757552022795193,0.7796610169491526,0.9667626777702968,1.0,6/12,33.18%,SLC25A42;SLC25A25;SLC17A9;SLC25A17;SLC25A24;SLC35B2
prerank,BMP binding (GO:0036122),0.36256355533237083,0.7571859046888917,0.7574850299401198,0.9477488366030707,1.0,11/11,63.77%,GREM2;BMPR2;GREM1;NBL1;SOST;GDF5;HJV;UCMA;TCAP;SOSTDC1;ENG
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.3625125051542454,0.7570894196730423,0.75748031496063,0.945559071297222,1.0,2/11,11.72%,PABIR1;PPP1R2
prerank,ATPase activator activity (GO:0001671),0.3156910434172186,0.7546415016320147,0.7552155771905424,0.9464707179927916,1.0,5/20,18.43%,DNAJC1;DNAJB1;DNAJB6;TOR1AIP2;TOR1AIP1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2645422871724139,0.7536963859536076,0.8209806157354618,0.9453719940514953,1.0,13/69,18.64%,CERS6;ASPG;CREBBP;SOAT1;HHAT;PLA2G4A;ZDHHC6;ZDHHC9;NAA15;PLA2G4E;ZDHHC3;LPCAT3;KAT6B
prerank,endodeoxyribonuclease activity (GO:0004520),0.32209154505805604,0.749587062992616,0.7731811697574893,0.9484998144003545,1.0,7/20,23.01%,DNA2;DCLRE1C;SETMAR;RBBP8;MBD4;ZRANB3;ENDOV
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.29765694858961367,-0.7486258282204348,0.773841961852861,0.9746738479424706,1.0,6/11,33.18%,SLC25A42;SLC25A25;SLC17A9;SLC25A17;SLC25A24;SLC35B2
prerank,calcium channel inhibitor activity (GO:0019855),0.3643829482790042,0.7479651688170825,0.7582938388625592,0.948439458453667,1.0,3/11,13.64%,ITPR1;FKBP1B;CALM2
prerank,protein kinase C binding (GO:0005080),0.28593219348672944,0.7465049031536336,0.8105134474327629,0.9481205283197989,1.0,13/43,21.80%,IRS1;NELL1;PRKCSH;PRKD2;TIRAP;TOP2B;DACT1;SQSTM1;PLEK;HDAC5;ADAM9;HINT1;PKN1
prerank,actin monomer binding (GO:0003785),0.31999216850407,0.7461061925145089,0.7978723404255319,0.9463782655977678,1.0,2/22,4.59%,MRTFA;LIMA1
prerank,exoribonuclease activity (GO:0004532),-0.29188929023749094,-0.7443323996776376,0.8141361256544503,0.9752845782005303,1.0,5/12,22.00%,EXOSC7;EXOSC8;EXOSC3;EXOSC1;EXOSC10
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.309731158573332,-0.7442775627692939,0.7808988764044944,0.9697852163718373,1.0,4/10,13.46%,BRCA2;EP300;HAT1;NAA60
prerank,phosphoric ester hydrolase activity (GO:0042578),0.27717197934552185,0.7441631786683609,0.8244994110718492,0.9465697557373846,1.0,9/49,15.26%,PDXP;PLCXD3;DUSP5;EPHX2;PTPRJ;PPP1CB;DUSP28;SACM1L;SMPDL3B
prerank,sodium channel activity (GO:0005272),-0.21684381394644148,-0.7437119591324189,0.87,0.9650477827812928,1.0,11/37,27.72%,GRIK4;SCN2A;SCN8A;SCN9A;GRIK2;HCN1;SCN4B;CACNA1I;SHROOM2;SCN3A;PKD2L1
prerank,general transcription initiation factor binding (GO:0140296),-0.23596266459727674,-0.7428969719556062,0.8576923076923076,0.9606818150005055,1.0,5/25,10.20%,ESR1;PSMC1;DR1;TAF13;GTF2A2
prerank,protein phosphatase activator activity (GO:0072542),0.34481423070593503,0.7419976785690076,0.7575757575757576,0.9471751482561177,1.0,9/13,27.73%,PPP2R5A;CALM2;PTPA;PPP2R5C;PHACTR4;CALM3;PPP2R5E;PPP2R5D;B3GAT3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3359531692463724,0.737644467191915,0.7985507246376812,0.9506407151030853,1.0,8/16,19.90%,PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3365436505429359,0.7310293416416922,0.7728658536585366,0.956647612573954,1.0,3/14,21.28%,DTYMK;AK8;NME2
prerank,deubiquitinase activity (GO:0101005),0.25323496628357284,0.7299552888476775,0.8665207877461707,0.955698175371686,1.0,23/88,21.08%,TNFAIP3;USP9X;EIF3H;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;USP28;PSMD14;USP36;MINDY4;USP21;USP25;ZC3H12A
prerank,snoRNA binding (GO:0030515),0.2924720331249067,0.7284288375737086,0.8232258064516129,0.955356169398463,1.0,15/30,30.71%,NOP14;NUDT4;BYSL;PRKDC;NUDT7;DHX37;BMS1;DDX21;TSR1;NOP56;NUDT5;UTP6;TBL3;NUFIP1;HEATR1
prerank,glycine binding (GO:0016594),0.34730490034684236,0.7281853199036346,0.783206106870229,0.9533961694530312,1.0,2/11,6.35%,GLRB;GLDC
prerank,fibroblast growth factor binding (GO:0017134),-0.24411438236031485,-0.7274896503978624,0.8835616438356164,0.9751560289749045,1.0,7/21,22.81%,FGFR2;THBS1;FGFR4;KL;GPC1;RPS19;FGFBP3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3110228306334839,0.7273097975982536,0.791023842917251,0.9522033030900645,1.0,4/19,13.22%,CCL5;EGF;EFNA5;ABI1
prerank,omega peptidase activity (GO:0008242),0.25175920811995556,0.725972489405397,0.8725490196078431,0.9515415543004643,1.0,19/89,16.79%,TNFAIP3;USP9X;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;GGT7;USP28;GGH;PSMD14
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.29686266077045953,0.7258852980486983,0.8086500655307994,0.9449907663517473,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,G protein-coupled amine receptor activity (GO:0008227),0.29686266077045953,0.7258852980486983,0.8086500655307994,0.9449907663517473,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,serotonin receptor activity (GO:0099589),0.29686266077045953,0.7258852980486983,0.8086500655307994,0.9449907663517473,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.34863813490328166,0.723789973761338,0.8079268292682927,0.9453075396545405,1.0,4/10,14.92%,EHMT1;SETDB1;SETDB2;ASH1L
prerank,phosphatidylinositol kinase activity (GO:0052742),0.32500242839727844,0.7212260258416641,0.799396681749623,0.9462430437318375,1.0,4/15,16.47%,PI4K2B;ATM;PI4KA;PIK3C3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2792908591592102,0.7182631395467973,0.8377028714107366,0.94762242882804,1.0,10/34,22.02%,UBE2F;UBE2L3;UBE2R2;UBE2J1;UBE2K;UBE2W;UBE2Q1;UBE2E1;UBE2Z;UBE2L6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2604050186655661,-0.716287616524082,0.8498402555910544,0.9832201550821288,1.0,3/15,14.31%,LPCAT2;AGPAT3;GPAT4
prerank,actin binding (GO:0003779),0.23610990876197452,0.7109525448537269,0.9287925696594427,0.9539362718561674,1.0,27/170,13.76%,SLC6A2;MRTFA;MLPH;LRRK2;SYNPO;CALD1;FSCN1;MYH9;PARVA;MAP1S;LIMA1;NCALD;FHL3;ADD2;TMOD1;PDLIM4;LCP1;CXCR4;DBN1;SSH1;PTK2;DBNL;UTRN;GIPC1;SSH2;MAEA;PLEKHH2
prerank,carboxypeptidase activity (GO:0004180),-0.20578522044683575,-0.7103324353022967,0.9027777777777778,0.9851959657562859,1.0,9/35,21.50%,CPD;CPE;FOLH1;MINDY1;CPM;NAALAD2;AGBL5;ACE2;VASH1
prerank,kinesin binding (GO:0019894),0.2870350135499706,0.7087501005203782,0.8404669260700389,0.9543339242912068,1.0,2/27,6.19%,NEK6;IFT88
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2843529556535795,0.7083540966415846,0.8562259306803595,0.952573607987233,1.0,10/27,23.22%,CRCP;POLR3A;POLR1B;POLRMT;POLR2L;POLR3K;POLR1D;MED21;POLR1A;POLR2D
prerank,histone demethylase activity (GO:0032452),0.28205345663376175,0.7058679785000022,0.8474801061007957,0.9531935317850944,1.0,9/27,26.60%,PHF2;KDM2A;FBXL19;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,thiol-dependent deubiquitinase (GO:0004843),0.24513158288767747,0.7023087981076074,0.8967032967032967,0.9551052757205393,1.0,17/83,16.79%,TNFAIP3;USP9X;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;USP28;PSMD14
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.330059202380681,0.701340059504249,0.8261538461538461,0.9539957383917606,1.0,2/12,7.91%,SLC9A1;SLC9A8
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.28036952133204784,-0.6990630649604186,0.8602739726027397,0.9925519931490194,1.0,4/11,16.61%,SGMS1;SGMS2;AASDHPPT;PIGF
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.2906326060445802,-0.6958498718561124,0.8313953488372093,0.990512505092265,1.0,4/10,23.65%,DCLRE1A;MGME1;DCLRE1B;TATDN1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.2707156659083343,-0.6958037954553357,0.8660714285714286,0.9851639333216629,1.0,2/12,11.02%,CYFIP2;DCPS
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.1966849797723615,-0.69228683502432,0.9605263157894737,0.9837538446588338,1.0,10/34,23.13%,CNOT8;EXOSC7;CNOT6L;EXOSC3;ANGEL2;TOE1;ANGEL1;PDE12;EXOSC10;NOCT
prerank,voltage-gated chloride channel activity (GO:0005247),-0.29578153492364645,-0.6916624800477892,0.8586387434554974,0.979057304614766,1.0,3/10,16.94%,CLCN2;CLCN3;ANO1
prerank,N-acyltransferase activity (GO:0016410),0.27080896496548057,0.6910007370415271,0.8727272727272727,0.9629775277574919,1.0,2/32,4.17%,CERS6;NAA50
prerank,O-acyltransferase activity (GO:0008374),0.27145979292393535,0.6892707157064168,0.8727034120734908,0.9627008754467088,1.0,5/30,17.16%,PIGW;SOAT1;GPAT3;PLA2G4A;LPCAT3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.2841995911609152,-0.6883955744884697,0.8657894736842106,0.9771783507005478,1.0,2/10,10.15%,PHF8;RIOX2
prerank,SUMO transferase activity (GO:0019789),0.2979448703304516,0.685107074649388,0.8222543352601156,0.9648906078096826,1.0,4/16,17.55%,PIAS2;NSMCE2;EGR2;MDM2
prerank,phosphatidate phosphatase activity (GO:0008195),-0.2639822469683246,-0.6817295688131316,0.8793103448275862,0.9780153559517168,1.0,7/13,43.75%,LPIN1;PLPPR4;PLPP5;PLPP2;LPIN3;PLPP4;LPIN2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.32447219635503277,0.6808856851153501,0.8421052631578947,0.9671174205524125,1.0,2/12,10.07%,FXN;SDHB
prerank,metal ion:proton antiporter activity (GO:0051139),0.3172814243848822,0.6786976305974185,0.8564885496183207,0.9672618188137078,1.0,2/13,7.91%,SLC9A1;SLC9A8
prerank,cation channel activity (GO:0005261),0.23498355553741165,0.6781133826890742,0.9302832244008714,0.9656016803350386,1.0,20/94,18.83%,HVCN1;KCNF1;PIEZO2;PKD2;TRPC6;SLC24A5;CALHM2;KCNK1;SEC61A1;PSEN1;UNC80;TRPM4;ANXA6;ANO10;KCNK9;PKD1L3;ORAI1;ANO6;PANX1;PIEZO1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.2540291609931187,0.6781078164887273,0.8807017543859649,0.9634332690706267,1.0,18/51,23.97%,SLC28A2;SLC20A1;SLC25A16;SLC7A8;SLC35C1;TMEM241;SLCO1B1;SLC35D2;SLCO4C1;SLC25A10;SLC28A3;SLC16A2;SLCO5A1;SLCO2B1;CLCN4;SLC25A3;SLCO4A1;SLC35E3
prerank,CoA-ligase activity (GO:0016405),-0.2515417580396763,-0.6769810882554413,0.8716417910447761,0.9772158343652085,1.0,3/14,20.01%,ACSL1;ACSS1;ACSS2
prerank,calcium activated cation channel activity (GO:0005227),0.3005241925312635,0.675582260164997,0.8408759124087591,0.9638793278878895,1.0,5/17,20.68%,KCNMB4;TRPM4;ANO10;ANO6;TMEM63B
prerank,dynactin binding (GO:0034452),-0.26550780516815103,-0.6748659195746182,0.8844086021505376,0.9739249214504917,1.0,1/12,0.78%,BICD1
prerank,ribosomal small subunit binding (GO:0043024),0.3027285485576582,0.6748092295092456,0.8463810930576071,0.9624872641727107,1.0,4/17,16.97%,ABCE1;MTIF2;EIF1;DHX29
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.2957386212013102,0.673837613836953,0.8631732168850073,0.9613206803916474,1.0,1/18,2.96%,BIRC3
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.32276986996379964,0.6719430916215828,0.8476923076923077,0.961145837327649,1.0,4/11,20.43%,ALKBH1;HMCES;HMGA2;NEIL1
prerank,ribosomal large subunit binding (GO:0043023),0.3230247692323006,0.6715715189827707,0.8238021638330757,0.9593913792818186,1.0,3/11,20.78%,NMD3;LTN1;NEMF
prerank,adenylyltransferase activity (GO:0070566),-0.22500946015780682,-0.671087661749568,0.89,0.9720508324191632,1.0,4/21,16.25%,GPHN;NMNAT3;TUT1;OAS2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3139754557903136,0.6709329634708013,0.8465116279069768,0.9579127677930998,1.0,3/12,20.33%,TENT5A;PAPOLG;TENT4A
prerank,phospholipase A2 activity (GO:0004623),0.26942597965872983,0.6706630152122667,0.8590425531914894,0.955999831111038,1.0,4/26,15.97%,PLA2G7;PLA2G12A;PLA2G4A;PLA2G4E
prerank,U6 snRNA binding (GO:0017070),-0.2579970684483312,-0.6697817794039436,0.9063444108761329,0.9679866324949978,1.0,5/14,23.76%,PRPF4;LARP7;TUT1;PRPF8;DDX39B
prerank,DNA polymerase binding (GO:0070182),-0.23765295772027709,-0.668074482310715,0.928082191780822,0.9643922007862118,1.0,4/18,14.10%,HSP90AA1;RTEL1;FANCI;PCNA
prerank,MAP kinase kinase kinase activity (GO:0004709),0.3213212210335541,0.6669728477887651,0.8419405320813772,0.9575270489636188,1.0,2/11,13.57%,EGFR;MAP3K6
prerank,metallocarboxypeptidase activity (GO:0004181),-0.21129288136357063,-0.6593421820447052,0.932,0.9669034871267385,1.0,7/26,21.50%,CPD;CPE;FOLH1;CPM;AGBL5;ACE2;VASH1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.25902871062408694,-0.6592750959431608,0.8888888888888888,0.9619738376259039,1.0,5/11,27.59%,STN1;HNRNPA1;RAD50;RPA2;NABP2
prerank,endonuclease activity (GO:0004519),0.24575257502785794,0.6579713589140499,0.9066511085180864,0.9638716566217831,1.0,14/49,24.18%,ERN2;SMG6;DICER1;SND1;SETMAR;PNKP;MBD4;AGO2;ZC3H12B;ZC3H12A;ZRANB3;RNASEL;CPSF3;AGO1
prerank,acid-thiol ligase activity (GO:0016878),-0.24635147474201047,-0.6538817630806695,0.9171428571428571,0.9613995136007715,1.0,4/13,25.82%,ACSL1;ACSS1;ACSS2;AASDH
prerank,NF-kappaB binding (GO:0051059),0.2723312386211961,0.6518951481312241,0.8805369127516779,0.9674089762172181,1.0,8/24,26.31%,PSMA6;HDAC1;GSK3B;COMMD7;NFKBIA;COMMD6;RELA;TAF4B
prerank,ion channel inhibitor activity (GO:0008200),0.253760489187445,0.6511130251284003,0.8967254408060453,0.9659704145162262,1.0,7/35,16.40%,CAMK2D;ITPR1;FKBP1B;CALM2;KCNV1;NEDD4;RASA1
prerank,adrenergic receptor binding (GO:0031690),0.2925687965867361,0.6481261606694106,0.8708751793400287,0.9666171399350885,1.0,4/16,15.60%,DLG4;ARRDC3;GNAS;NEDD4
prerank,phosphatase activity (GO:0016791),0.22838812396745187,0.6402550589522799,0.9522222222222222,0.9712758583051885,1.0,9/73,13.66%,PDXP;DUSP5;EPHX2;NT5M;PTPRJ;PPP1CB;DUSP28;DUSP26;SACM1L
prerank,damaged DNA binding (GO:0003684),0.23975104092691077,0.6365584783646177,0.9258373205741627,0.9722723626817047,1.0,9/44,20.29%,MPG;CREBBP;DCLRE1C;HMGB2;XRCC1;PNKP;DDB1;RBBP8;ERCC2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.24647640971410859,-0.6336787314523855,0.9204892966360856,0.9709458796079722,1.0,6/12,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.23130083263616977,0.6327151378927199,0.9454329774614472,0.9734205583965558,1.0,6/54,9.69%,ASPG;MIER2;NADSYN1;NTAN1;HDAC1;PIGL
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2943864557313991,0.6284041205974157,0.8872180451127819,0.9747522338852008,1.0,2/14,7.63%,USP9X;MINDY3
prerank,NADP binding (GO:0050661),0.24624392172360796,0.6271076568580842,0.9101412066752247,0.9736537534293838,1.0,11/32,23.49%,CRYM;GMDS;HSD11B1;KCNAB1;DPYD;DECR1;MTRR;DUS2;QDPR;NDOR1;SPR
prerank,acetyltransferase activity (GO:0016407),0.2478629672714504,0.6254815971982997,0.9276485788113695,0.9728170354762277,1.0,5/31,18.64%,NAA50;CREBBP;NAT10;NAA15;KAT6B
prerank,NADPH binding (GO:0070402),0.2840086998294231,0.6250226021537556,0.8950617283950617,0.971080243556242,1.0,6/13,22.54%,KCNAB1;DECR1;MTRR;DUS2;QDPR;NDOR1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.24493712455965272,0.6238992696921829,0.928391959798995,0.9697388487830396,1.0,9/31,22.02%,UBE2L3;UBE2R2;UBE2J1;UBE2K;UBE2W;UBE2Q1;UBE2E1;UBE2Z;UBE2L6
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.248115628641955,0.6213183654367054,0.9099099099099099,0.9696070118999482,1.0,7/29,19.30%,HPSE;GAA;NEU3;GALC;NEU1;GANAB;MGAM
prerank,microtubule plus-end binding (GO:0051010),0.26202197867518373,0.6177324743584979,0.922971114167813,0.9701632993799367,1.0,10/20,28.84%,MAPRE2;FBXW11;CLIP3;DST;CLIP4;CLASP2;CLASP1;PAFAH1B1;CLIP2;MAPRE1
prerank,Hsp90 protein binding (GO:0051879),0.23825898364504255,0.6111827517279411,0.9320261437908497,0.9729409310874368,1.0,8/33,19.70%,PPID;AHR;CYP1A1;CSNK2A1;HIF1A;NPAS2;NR3C1;TELO2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.29701605362873246,0.6057152859473462,0.8962722852512156,0.9747421834497412,1.0,4/11,23.63%,CARM1;PRMT3;NDUFAF7;PRMT5
prerank,lipid phosphatase activity (GO:0042577),0.27679252726783143,0.6046134764949038,0.9230769230769231,0.9734534950855284,1.0,1/14,4.96%,EPHX2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.20555834179671184,-0.6024242289747005,0.9490909090909091,0.9840493671979684,1.0,10/18,34.39%,PIK3R3;PIK3R6;PIK3R2;SOCS7;SOCS2;SOCS3;CCKBR;AGAP2;SOCS1;CISH
prerank,rRNA binding (GO:0019843),0.22525130885771458,0.6013974046740461,0.9550970873786407,0.9735296944155618,1.0,10/42,19.35%,ERI1;MTERF4;DDX28;GTF3A;RPL12;MRPS18A;RPL11;MDM2;RPS9;MRPS27
prerank,voltage-gated sodium channel activity (GO:0005248),0.25557861752982686,0.5993975162016612,0.9181208053691275,0.9728332754403373,1.0,2/22,5.83%,PKD2;SCN7A
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.2769470510738133,0.5983740689360445,0.9178674351585014,0.9714310411342669,1.0,2/13,9.90%,METTL1;THUMPD3
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.2215609840797997,-0.5981046558443704,0.9487179487179487,0.9813649836433418,1.0,4/14,23.69%,MICAL1;NCF2;NOX1;CYB5R4
prerank,nuclear export signal receptor activity (GO:0005049),0.29064759709027216,0.5968044565729891,0.8958333333333334,0.9703873736904466,1.0,5/11,26.00%,XPO7;NUP214;XPO1;RANBP17;NUP42
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2279508712567138,0.5941768820016098,0.9487179487179487,0.9699703853687599,1.0,4/33,11.16%,ERI1;EXOSC4;DCP2;XRN1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.2617977546422484,0.5918624171353937,0.9125364431486881,0.9694142948193291,1.0,2/17,12.34%,DTYMK;AK8
prerank,nuclear import signal receptor activity (GO:0061608),0.2679535735736801,0.588609403793204,0.9174041297935103,0.9693970522635885,1.0,4/15,23.08%,KPNA3;TNPO1;KPNA2;KPNB1
prerank,transferrin receptor binding (GO:1990459),-0.243854179645598,-0.5827695499849742,0.9361702127659575,0.9840746373840661,1.0,1/10,2.25%,CD81
prerank,acyl-CoA hydrolase activity (GO:0047617),0.25419420275016663,0.5822018835860108,0.9411764705882353,0.9710176517018331,1.0,4/17,22.83%,ACOT13;ACOT9;THEM4;ACAA2
prerank,acetylcholine receptor activity (GO:0015464),-0.18591540489052083,-0.575809812547165,0.985663082437276,0.982372466806429,1.0,1/22,1.10%,CHRM2
prerank,water transmembrane transporter activity (GO:0005372),0.27572293505394807,0.572151606568646,0.9405320813771518,0.974535904316981,1.0,1/11,11.38%,PDPN
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.21183482596662656,0.5527840903642369,0.9745454545454545,0.9821079424048097,1.0,8/40,20.89%,ASMT;THUMPD3;DNMT3B;PCMT1;COMT;SETD3;THUMPD2;N6AMT1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.22453569236300847,-0.5507820070697564,0.9726775956284153,0.9867183191641518,1.0,7/10,47.46%,NCF2;NOX1;CYBA;NCF1;NOX3;NCF4;DUOX1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.2582506033453835,0.5489425866002452,0.9509493670886076,0.9817110135708801,1.0,3/12,21.40%,SPPL3;PSEN1;HM13
prerank,calcium-activated potassium channel activity (GO:0015269),-0.22464664212567184,-0.5437731761116017,0.9690140845070423,0.984288623259124,1.0,8/11,42.96%,KCNN2;KCNN3;KCNMB2;PKD2L1;KCNN4;KCNN1;KCNU1;KCNMB1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.2572063264683755,0.5324705032149618,0.9465648854961832,0.9861862259762034,1.0,3/11,17.85%,DCP2;NUDT4;NUDT7
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2114271728614766,0.5186361828542253,0.9738651994497937,0.9890181784435167,1.0,3/24,14.09%,CAMK2D;PHKA2;MKNK1
prerank,MHC class I protein binding (GO:0042288),-0.20076589867537198,-0.5181365871787383,0.9746835443037974,0.986410705107103,1.0,13/13,79.95%,DERL1;TUBB4B;ABCB9;LILRB1;ATP5F1B;TAP2;TUBB;PILRA;CD8A;TAPBP;CD8B;TAP1;ATP5F1A
prerank,tRNA binding (GO:0000049),0.1975054863284504,0.513290593497901,0.9962871287128713,0.9886230654853235,1.0,9/43,20.78%,XPOT;AIMP1;TERT;ALKBH1;NAT10;ELP1;MRPS27;FARS2;NEMF
prerank,snRNA binding (GO:0017069),0.18770720096701157,0.4978098477497454,0.9914110429447853,0.9911695915569633,1.0,9/42,19.40%,NCBP2;SNRNP35;SNRPB2;RNPC3;PRPF31;CCNT1;LSM7;CDK9;EFTUD2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.22329517852397918,0.4969060022963546,0.9782923299565847,0.9893727051309966,1.0,3/15,13.29%,PIK3R5;SOCS5;PIK3R1
prerank,RNA cap binding (GO:0000339),0.21836896741707545,0.4886935231087891,0.9814550641940085,0.9892798484633814,1.0,2/16,10.14%,EIF4A1;NCBP2
prerank,microtubule minus-end binding (GO:0051011),0.21626259706815304,0.45478504073684667,0.9848254931714719,0.9937308237478929,1.0,3/13,19.33%,CAMSAP2;TUBGCP4;CAMSAP1
prerank,RNA polymerase binding (GO:0070063),0.16295215090020868,0.37601177151164633,0.9970760233918129,0.9987988776651109,1.0,4/18,21.58%,CCNT1;NEDD4;TCERG1;PHRF1
